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C. difficile is an obligate anaerobic, Gram-positive, rod-
shaped and spore-forming bacterium. It is a well-recognised 
causative agent of antibiotic-associated diarrhoea and 
pseudomembranous colitis. C. difficile has emerged as an 
important nosocomial pathogen in recent years, associated 
with considerable morbidity, mortality and economic burden. 
Despite its importance, functional genomic studies have 
been lagging behind in comparison to other enteric 
pathogens. This is attributed to the fact that C. difficile 
is difficult to manipulate genetically and the lack of 
robust, reproducible mutagenesis systems for many years. 
The ideal mutation for robust functional genomic studies is 
a markerless, in-frame deletion of the gene of interest. 
All systems developed for C. difficile, up to the start of 
this study, involve insertional inactivation of the gene of 
interest. This study describes the development of a novel 
genetic system for C. difficile, to create precise and 
markerless chromosomal deletions, using the meganuclease I-
SceI. For validation of the system, the addBA genes in C. 
difficile were deleted. The AddAB enzyme complex is 
important in the survival of many bacteria, since it 
maintains genome integrity, by the repair of double-strand 
breaks. Deletion of addBA in C. difficile did not 
significantly affect growth and viability, but the mutant 
strains were sensitive to DNA damaging agents. In addition, 
it was shown that C. difficile is capable of initiating the 
SOS response after DNA damage and that AddAB is not 
necessary for the induction of this response. The genetic 
system was further optimised to delete type IV pili (TFP)-
associated genes, particularly pilT (CD3505) and pilA 
(CD3507), to investigate twitching motility. TFP are 
important in virulence and pathogenesis of many bacteria 
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and twitching motility is often involved. TFP in C. 
difficile may be expressed in vivo during infection and may 
be involved in biofilm formation and colonization. To study 
potential TFP-mediated motility, a non-flagellated C. 
difficile strain was first constructed by deleting the fliC 
gene. The pilT gene, predicted to encode a protein involved 
in TFP retraction, was then deleted in the ∆fliC strain. A 
∆pilT strain was also generated. Preliminary experimental 
work using these strains did not show any evidence for 
twitching motility and no difference between the ∆pilT 
strains and the parental strains. Examination of cells from 
the ∆fliC strain, under various conditions, did not reveal 
any pili, which indicates that TFP are regulated in C. 
difficile and that the TFP locus might be repressed at the 
transcriptional level. Preliminary work to investigate an 
intergenic region located upstream of the TFP locus in C. 
difficile, that might be involved in regulation, suggested 
that transcription is being initiated within a 500 bp 
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CHAPTER 1: Main introduction 
 
1.1: Clostridium difficile overview 
 
Microbiology: 
C. difficile is an obligate anaerobic, Gram-positive, rod-
shaped and spore-forming bacterium. It was first isolated 
in 1935 from the faecal microbiota of healthy neonates and 
was identified in the late 1970s as the aetiological agent 
of antibiotic-associated pseudomembranous colitis (Bartlett 
et al., 1978; George et al., 1978; Larson et al., 1978).  
 
Pathogenesis: 
Clinical manifestations of C. difficile infection (CDI) can 
range from asymptomatic carriage to diarrhoea. Severity of 
diarrhoea varies, from self-limiting to serious diarrhoea, 
with or without formation of pseudomembranes in the colon 
(FIG 1.1), with the possibility of toxic megacolon or bowel 
perforation, sepsis, shock and death (Poxton et al., 2001; 
Rupnik et al., 2009; Freiler et al., 2001; Gebhard et al., 
1985; Kawamoto et al., 1999; Riggs et al., 2007; Rubin et 
al., 1995; Shim et al., 1998; Triadafilopoulos and 




FIG 1.1 Pseudomembranous colitis 
A typical endoscopic appearance of C. difficile-induced 
pseudomembranous colitis is shown. Pseudomembranes (yellow-white) 
formed are composed of destroyed intestinal cells and leukocytes. The 
figure is adapted from (Rupnik et al., 2009).   
 
 
C. difficile is acquired through ingestion of vegetative 
cells or spores and it is widely accepted that CDI is 
predominantly a toxin-mediated disease. Disruption of 
normal colonic microbiota and thus colonisation resistance 
allows spore germination (spores germinate in response to 
specific bile salts in the small intestine) and 
multiplication of vegetative cells (Vedantam et al., 2012; 
Deneve et al., 2009; Giel et al., 2010; Sorg and 
Sonenshein, 2008). The organism then adheres to the mucus 
layer covering the epithelial surface of the 
gastrointestinal (GI) tract via multiple adhesins, 
penetrates the mucus and adheres to enterocytes marking the 
beginning of the first phase of the pathogenic process, 
colonization (Deneve et al., 2009; Carroll and Bartlett, 
2011). Several factors have been reported to be implicated 
in adhesion and colonization including, fibronectin-binding 
proteins Fbp68 and FbpA, surface layer and cell wall 
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proteins  SlpA, Cwp84, Cw66, CwpV and heat shock protein 
GroEL (Vedantam et al., 2012; Calabi et al., 2002; Barketi-
Klai et al., 2011; Lin et al., 2011; Waligora et al., 2001; 
Hennequin et al., 2001).  
The second phase of the pathogenic process is toxin 
production (Carroll and Bartlett, 2011; Deneve et al., 
2009). Many C. difficile strains, but not all, produce two 
major toxins, termed toxin A (TcdA) and toxin B (TcdB), 
which are recognised as the main virulence factors. They 
belong to a group of large clostridial toxins (LCTs), due 
to their high molecular mass, TcdA being 308 kDa and TcdB 
being 270 kDa, and their production increases as cells 
enter the stationary phase of growth (Davies et al., 2011; 
Rupnik et al., 2009; Dupuy and Sonenshein, 1998; 
Hundsberger et al., 1997; von Eichel-Streiber et al., 
1996). TcdA and TcdB are encoded by tcdA and tcdB genes, 
respectively and are both located in a 19.6 kb region known 
as the Pathogenicity Locus (PaLoc), (FIG 1.2) (Braun et 
al., 1996; Cohen et al., 2000). The PaLoc contains three 
additional genes, tcdC and tcdR which encode  proteins 
involved in the regulation of toxin expression and tcdE 
which encodes  a protein with pore-forming activity which 
allows release of toxins from the cell (Govind and Dupuy, 
2012; Mani and Dupuy, 2001; Mani et al., 2002; Matamouros 
et al., 2007; Tan et al., 2001). The PaLoc is conserved 
between toxigenic strains which encode one or both of the 
toxins. In non-toxigenic strains, the PaLoc locus is 
usually replaced by a 115-bp non-coding sequence and these 
strains are considered non-pathogenic (Rupnik et al., 2009; 






FIG 1.2 Schematic of Paloc in C. difficile 
Paloc (19.6 kb) comprises of five genes tcdA, tcdB, tcdR, tcdE and 
tcdC. Toxins A and B are encoded from tcdA and tcdB, respectively. The 
genes tcdR and tcdC encode for proteins that positively and negatively 
regulate transcription of toxins, respectively. The tcdE gene encodes 
for a protein with pore-forming activity. The figure is adapted from 
(Rupnik et al., 2009).  
 
 
The actual role of toxin A or B in the disease pathogenesis 
of CDI remains a matter of debate. Two groups have 
constructed C. difficile mutant strains deficient in the 
production of TcdA, TcdB or both toxins, and tested their 
virulence in the hamster model (Lyras et al., 2009; Kuehne 
et al., 2010). One group concluded that TcdB and not TcdA 
is essential for virulence, while the other, concluded that 
both toxins are important. It was suggested that these 
differences may be attributed to inherent differences 
between the hamsters used in each study, or to differences 
between the parent C. difficile strains used to create the 
mutants (Kuehne et al., 2010).    
Toxins A and B are structurally similar and contain 
multiple domains including; i) N-terminal glycotransferase 
domain, ii) cysteine protease domain, iii) translocation 
hydrophobic domain and iv) C-terminal binding domain (FIG 
1.3) (Davies et al., 2011; Jank and Aktories, 2008). The 
interaction between the C-terminal binding domain of the 
toxin and host cell receptors initiates receptor-mediated 
endocytosis, although, the precise mechanism of toxin 
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uptake remains unclear (FIG 1.3) (Davies et al., 2011; 
Oezguen et al., 2012; Frisch et al., 2003; Giesemann et 
al., 2008; Greco et al., 2006; Ho et al., 2005; Jank et 
al., 2007). Within the endosome, a decrease in pH causes 
conformational changes within the toxin, followed by pore 
formation in the endosomal membrane by the hydrophobic 
domain, and subsequent translocation of the N-terminal 
domain into the cytosol (Barth et al., 2001; Qa'Dan et al., 
2000). Then, the toxin undergoes self-cleavage after a 
conformational change of the cysteine protease domain, a 
process that requires inositol hexakisphosphate (InsP6), 
resulting in the release of the N-terminal domain into the 
cytosol (Egerer et al., 2007; Giesemann et al., 2008; 
Oezguen et al., 2012; Pfeifer et al., 2003; Pruitt et al., 
2009; Reineke et al., 2007; Rupnik et al., 2005). Once in 
the cytosol, the glycotransferase domain of the toxin, 
mono-O-glycosylates and inactivates Rho GTPases (Rho, Ras 
and Cdc42), the proteins that are important for maintaining 
cytoskeletal integrity (Davies et al., 2011; Voth and 
Ballard, 2005; Oezguen et al., 2012; Jank and Aktories, 












FIG 1.3 Schematic of functional domains of C. difficile toxin A and B and the processing 
machinery 
A] The four functional domains of toxins A and B are shown. A (dark 
blue) refers to N- terminal glycotransferase domain. C (green) refers 
to cysteine protease domain. D (magenta) refers to the translocation 
hydrophobic domain. B (purple) refers to the C-terminal binding domain. 
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B] The processing machinery of toxins is shown. The colour scheme of 
the toxin domains is maintained in this schematic. The C-terminal 
binding domain binds to the host cell and the toxin is endocytosed. 
Whithin the endosome, a decrease in pH causes conformational changes 
within the toxin, followed by pore formation in the endosomal membrane 
by the hydrophobic domain, and subsequent translocation of the N-
terminal domain into the cytosol. Then, the toxin undergoes self-
cleavage after a conformational change of the cysteine protease domain, 
a process that requires inositol hexakisphosphate (InsP6 binds to 
cystein protease domain), resulting in the release of the N-terminal 
domain into the cytosol. Once in the cytosol, the glycotransferase 
domain of the toxin, glycosylates and inactivates Rho GTPases. The 
figure is adapted from (Davies et al., 2011). 
 
 
Inactivation of Rho GTPases leads to loss of structural 
integrity, cell rounding and death of the intoxicated cell. 
The tight junctions between the intestinal epithelial cells 
are disturbed, increasing the permeability of colonic 
epithelial layers, allowing neutrophils to migrate to the 
intestines which contribute to the inflammatory response 
typical of colitis. Moreover, toxin exposure of intestinal 
epithelial cells leads to production of tumour necrosis 
factor and cytokines, which leads to fluid accumulation and 
further inflammatory response (Carroll and Bartlett, 2011; 
Voth and Ballard, 2005; Carter et al., 2012). This intense 
inflammatory response is an important contributory factor 
in causing intestinal injury in CDI (Kelly and Kyne, 2011). 
In addition to TcdA and TcdB, some C. difficile strains, 
produce the C. difficile transferase (CDT), otherwise named 
binary toxin. CDT is encoded by the Cdt locus (CdtLoc) 
which is 4.3 kb and comprised of the cdtA, cdtB and cdtR 
genes (FIG 1.4) (Carroll and Bartlett, 2011; Carter et al., 
2007; Carter et al., 2012; Davies et al., 2011; Perelle et 
al., 1997; Popoff et al., 1988; Rupnik et al., 2009). The 
CdtLoc is found in 6-12.5% of strains overall and those 
that lack CDT have a 68-bp sequence in place of the CdtLoc 
8 
 
(Carroll and Bartlett, 2011). CDT is composed of two 
proteins, the enzymatic component CdtA encoded by cdtA and 
the transport and binding component CdtB encoded by cdtB. 
The cdtR gene encodes a positive regulator of CDT (Carter 
et al., 2012; Rupnik et al., 2009; Carter et al., 2007).  
 
 
FIG 1.4  Schematic of CdtLoc in C. difficile 
CdtLoc is 4.3 kb and comprises of the cdtA, cdtB and cdtR genes. The 
cdtA gene encodes the enzymatic component CdtA and the cdtB gene 
encodes the transport and binding component CdtB of CDT. The cdtR gene 
encodes for a positive regulator of CDT. The figure is adapted from 
(Rupnik et al., 2009).  
 
 
CdtB binds to the host cells and translocates CdtA into the 
cytosol where this protein  ADP-ribosylates actin 
molecules, leading to disruption or rearrangement of the 
host cell cytoskeleton and subsequently excess fluid loss 
from the cells, rounding of the cell and cell death (Rupnik 
et al., 2009; Vedantam et al., 2012; Sundriyal et al., 
2010). The role of CDT in the pathogenesis of CDI has yet 
to be established. CDT has been shown to be cytotoxic for 
Vero cells in vitro (Sundriyal et al., 2010). It has 
recently been shown that CDT induces the formation of 
microtubule structures that consist of long microtubule-
based protrusions on the surface of epithelial cells, 
leading to increased adherence of C. difficile (Schwan et 




Risk factors, treatment, epidemiology, and economic impact: 
Risk factors: 
The most recognised risk factor associated with CDI is 
exposure to antibiotics. Almost every antibiotic has been 
associated with CDI, but some are linked with a higher risk 
of disease than others, including clindamycin, broad-
spectrum cephalosporins and fluoroquinolones (Rupnik et 
al., 2009; Ananthakrishnan, 2011; Freeman et al., 2010; 
Kachrimanidou and Malisiovas, 2011; McFarland et al., 1995; 
McFarland et al., 1990). This higher risk relates to 
antibiotics that disrupt the normal microbiota allowing C. 
difficile to multiply and produce toxins (Ananthakrishnan, 
2011; Owens et al., 2008). In addition, C. difficile is 
resistant to a wide range of antibiotics allowing it to 
thrive and cause disease (Kachrimanidou and Malisiovas, 
2011; Owens et al., 2008).  
Older age and hospitalization are other major risk factors. 
Patients older than 65 years of age are at 20-fold higher 
risk for disease than younger individuals (Bartlett and 
Gerding, 2008). In adults, the ability to produce adequate 
levels of IgG against toxin A defines whether the route to 
asymptomatic colonisation or CDI is followed (Kelly and 
Kyne, 2011; Kyne et al., 2000, 2001). The increased 
susceptibility and mortality in elderly populations is 
possibly attributed to inadequate immune response to toxin 
exposure (Rupnik et al., 2009; Kyne et al., 2000). 
Hospitalization but also duration in a hospital or long-
term care facility, increases the risk of CDI (Freeman et 
al., 2010). This is attributed to a mixture of multiple 
risk factors in this setting including, exposure to 
antibiotics, exposure to a spore-contaminated environment, 
inefficient hand hygiene (e.g. alcohol-based hand gels are 
10 
 
ineffective against spores) and the presence of a 
susceptible elderly population (Rupnik et al., 2009; Fawley 
and Wilcox, 2001; Debast et al., 2009; Gerding et al., 
2008; Labbe et al., 2008; Oughton et al., 2009; Riggs et 
al., 2007).    
Other factors that have been linked to CDI include, 
immunosuppression, gastric acid suppressants such as H2 
blockers and proton pump inhibitors, gastrointestinal 
diseases such as inflammatory bowel disease and 
gastrointestinal surgery (Ananthakrishnan, 2011; Freeman et 
al., 2010; Kachrimanidou and Malisiovas, 2011). 
CDI can also occur in the community setting despite no 
recent exposure to antibiotics or hospitalization (Hensgens 
et al., 2012). However, the incidence of CDI in the 
community is lower than the health care facilities. C. 
difficile is ubiquitous, it is found in soil, water, food 
products and it is a commensal or pathogen of the 
intestinal tracts of many animals. All can be possible 
community sources for CDI. However, direct transmission 
from these sources to humans has not been proven, although 
similar ribotypes have been found. As no outbreaks have 
been reported in the community, host factors may be more 
important for vulnerability to CDI than increased exposure 
to C. difficile (Hensgens et al., 2012).   
 
Treatment: 
Treatment of CDI depends on the clinical presentation of 
disease (Kachrimanidou and Malisiovas, 2011; 
Ananthakrishnan, 2011). The first therapeutic step in most 
CDI cases is the immediate discontinuation of the inciting 
antibiotic. For mild or moderate CDI, metronidazole is used 
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as the first line drug and for severe CDI, vancomycin is 
the first choice. A combination of metronidazole and 
vancomycin is recommended in the most severe and 
complicated cases of CDI, i.e. those with hypotension, 
shock, ileus or megacolon. In the most severe cases, 
colectomy may be required (Ananthakrishnan, 2011; 
Kachrimanidou and Malisiovas, 2011). A novel drug, 
fidaxomicin, appears superior to vancomycin in treating CDI 
and preventing CDI relapses (Poxton, 2010). Faecal transfer 
from a healthy donor has also been shown to be effective in 
treating patients with recurrent CDI (Ananthakrishnan, 
2011).      
 
Epidemiology: 
In the last decade, there has been a dramatic increase in 
the incidence and severity of CDI in the US, Canada and 
Europe (Kachrimanidou and Malisiovas, 2011; Carroll and 
Bartlett, 2011; Jones et al., 2013; Freeman et al., 2010). 
In 2003, the first reports were from Quebec, Canada which 
showed a 5-fold increase in incidence of CDI in the whole 
population from 1991 to 2003. In addition, an 8-fold 
increase in the incidence of CDI in the elderly was 
reported in North America (Pepin et al., 2004). Similarly, 
in Europe the incidence rate of CDI increased with 
associated outbreaks, first in the UK from 2003 to 2004, 
then in the Netherlands and Belgium, then in France and 
other European countries (Deneve et al., 2009; Kuijper et 
al., 2007). In the United States, from 1999 to 2008, CDI-
associated deaths increased 9-fold and from 2000 to 2008 
CDI cases increased 2-fold (Lessa et al., 2012).   
The increase in incidence rate and severity of CDI has been 
partially attributed to the emergence of a hypervirulent 
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strain C. difficile PCR-ribotype 027. The hypervirulence of 
this strain is attributed to several factors: i) increased 
toxin A and B production in comparison to control strains, 
due to mutations in the tcdC gene that normally negatively 
regulates the tcdA and tcdB genes. There is an 18-bp 
deletion and single base pair deletion at position 117 
relative to the tcdC ATG start codon, the latter resulting 
in formation of a stop codon and thus a truncated, inactive 
TcdC protein; ii) production of CDT in addition to toxins A 
and B; iii) altered surface proteins that increase 
adherence to the intestinal epithelium (Carroll and 
Bartlett, 2011; Deneve et al., 2009; Vohra and Poxton, 
2011; Curry et al., 2007; MacCannell et al., 2006; Warny et 
al., 2005). A further feature that may be a contributing 
factor to the emergence of 027 strains is resistance to 
fluoroquinolones, associated with mutations in the gyrA and 
gyrB genes (Deneve et al., 2009; McDonald et al., 2005; 
Spigaglia et al., 2008; Drudy et al., 2006; Drudy et al., 
2007). Depending on the country, other C. difficile strains 
have been responsible for outbreaks and severe cases, 
including ribotypes 001, 018, 078 and 106 (Kachrimanidou 
and Malisiovas, 2011).  
In the UK, several outbreaks have been reported, with a 
double outbreak at Stoke Mandeville Hospital 
(Buckinghamshire Hospitals NHS Trust) being prominent. The 
first phase, between October 2003 and June 2004, was caused 
by ribotype 027. This resulted in 174 cases and 19 (11%) 
deaths that were either definitely or probably due to C. 
difficile. The second phase occurred between October 2004 
and June 2005, which involved 160 cases and 19 (12%) deaths 
(HCC, 2006; Smith, 2005). The outbreaks were a consequence 
of poor practice in infection control, poor environmental 
hygiene, and lack of facilities for patient isolation (HCC, 
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2006). Although, there has been a dramatic increase in the 
incidence of CDI in England and Wales from 1990 to 2006, 
the reported cases of CDI have been decreasing since 2007 
(FIG 1.5) (Cartman et al., 2010). In addition, the number 
of deaths involving C. difficile, increased from 2004 to 
2007, from 2,238 to 8,324 and have decreased to 2,053 in 




FIG 1.5  Cases of C. difficile in England and Wales 
The increasing C. difficile incidence in England and Wales between 1990 
and 2007 is shown. The figure was adapted from (Cartman et al., 2010). 





FIG 1.6  Mortality rates for deaths mentioning C. difficile in England and Wales 
The number of death certificates in England and Wales mentioning C. 
difficile is shown between 2001 and 2011. Rates per million population 
are standardised to the European Standard population. The figure was 




The decrease in CDI cases is probably attributed to a 
combination of improved infection control, better 
environmental cleaning with chlorine-based disinfectants 
and good antibiotic stewardship, restricting the use of 
antibiotics that are known to precipitate CDI.  As in 
England and Wales, since 2008, other European countries 
reported significant decrease in the overall number of CDI 
cases (Jones et al., 2013). In Scotland, the predominant 
strains associated with recent outbreaks and severe cases 
have been ribotype 078 and to a lesser extent 027, and 
since 2009, CDI incidence rate and CDI-associated deaths 
have been decreasing (Health Protection Scotland, 2012; 
General Register Office for Scotland, 2001-2011). Similarly 
to ribotype 027, the ribotype 078 also contains mutations 
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in the tcdC gene of Paloc (39-bp deletion and single base 
pair deletion at position 184) and also contains binary 
toxin genes (Cartman et al., 2010; Goorhuis et al., 2008).   
 
Cost: 
The economic burden of CDI on the healthcare systems in 
Europe and US is high. The cost per case in England has 
been estimated to be €5,000-15,000. If the EU has 500 
million in population, then a potential estimate for CDI 
per year could be €3000 million, a number that might double 
over the next four decades (Jones et al., 2013). In the US 
the cost per year has been estimated to be $1.1 billion 
(Jones et al., 2013). An economic computer simulation model 
suggested that the annual US economic burden for CDI would 
be, ≥$496 million from the hospital perspective, ≥$547 
million from third-party payer perspective and ≥$796 
million from the societal perspective (McGlone et al., 
2012).     
 
 
1.2: Genetic manipulation of C. difficile 
Historical overview of C. difficile genetic manipulation and mutagenesis 
systems: 
Understanding the molecular basis of pathogenicity and 
virulence of a pathogen is of great importance as it is the 
way to provide knowledge for the development of measures 
for combatting disease. Despite the medical and economic 
importance of C. difficile and the availability of genomic 
and proteomic data, functional genomic studies have been 
lagging behind in comparison to other enteric pathogens 
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(Emerson et al., 2008; Janvilisri et al., 2009; Lawley et 
al., 2009; Lemee et al., 2005; Sebaihia et al., 2006; 
Stabler et al., 2006; Stabler et al., 2009). This is 
attributed to the fact that C. difficile is difficult to 
manipulate genetically and the lack of robust and 
reproducible genetic systems for many years.  
By 2007, only a handful of C. difficile mutants had been 
generated. For many years, until 2001, the only means of 
transfer of heterologous DNA into C. difficile was via 
conjugative transposons such as Tn916 with conjugative 
transfer involving Bacillus subtilis donors. In 1991, 
Mullany et al., showed that the conjugative transposon 
Tn916 and a derivative Tn916∆E can be transferred from B. 
subtilis into C. difficile CD37 by filter mating (Mullany 
et al., 1991). The transposon appeared to insert at a 
preferred site, later designated att916, in all C. 
difficile CD37 transconjugants obtained and thus was not an 
appropriate candidate for random mutagenesis (Mullany et 
al., 1991; Wang et al., 2000a). However, it was suggested 
that it may be used for introduction of cloned DNA into C. 
difficile (Mullany et al., 1991). In 1994, Mullany et al., 
used the pC1195 vector containing a 4.2-kb region of the 
conjugative transposon Tn919, which is homologous to Tn916, 
to introduce heterologous DNA into C. difficile (Mullany et 
al., 1994). A 1.1 kb fragment of C. difficile toxin B gene 
was inserted into pC1195, generating pPPM100, which was 
then introduced into C. difficile CD37 via filter mating 
from an isolated B. subtilis donor, into which the plasmid 
had integrated.  The plasmid entered the genome of C. 
difficile CD37 strain at a specific site. The frequency of 
transfer was extremely low, at 10
-8
 per donor, and the 
delivery system involved was cumbersome. However, these 
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experiments were the first example of gene cloning in this 
organism. 
In 2001, Liyanage et al., were the first to introduce a 
replication deficient plasmid into C. difficile from an 
Escherichia coli donor. Importantly, they were the first to 
report a targeted gene disruption in C. difficile (Liyanage 
et al., 2001). In their study, an internal fragment of the 
C. difficile gldA gene (encoding for glycerol 
dehydrogenase) was inserted into the oriT-based suicide 
vector pMTL31 and the resultant plasmid was conjugated from 
an E. coli donor into C. difficile CD37. Since the plasmid 
carried an erythromycin cassette, the integrants were 
selected by acquisition of erythromycin resistance. The 
plasmid was confirmed by PCR to have insertionally 
inactivated the gldA gene, via single cross-over 
integration. Interruption of the gldA gene, however, was 
lethal, as it gave rise to pinpoint colonies that could not 
be subcultured. This is the only report to date where a 
suicide vector has been used for the insertional 
inactivation of a gene in C. difficile. Subsequent, 
repeated efforts from other groups to inactivate genes 
using this method were unsuccessful, which raised questions 
about the reproducibility of this approach (Carter et al., 
2005; O'Connor et al., 2006).  
In 2003, to examine sporulation, Haraldsen and Sonenshein 
introduced a Tn916-based conjugative transposon carrying an 
intact copy of the C. difficile sigK gene, from B. subtilis 
into C. difficile CD196, that had a naturally inactive copy 
of sigK (Haraldsen and Sonenshein, 2003). Unexpectedly, the 
transposon did not insert at the preferred site, but 
integrated into the chromosome at the sigK gene location 
via homologous recombination. The reproducibility of this 
method, however, has not been established. 
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A more encouraging approach was described in 2006 by 
O’Connor et al., that reported the first example of a 
reproducible method for the insertional inactivation of 
target genes in C. difficile JIR8094 (an erythromycin-
sensitive derivative of C. difficile 630). In this case, 
the authors utilised the instability of E. coli-Clostridium 
perfringens shuttle vectors in C. difficile, such as 
pJIR1456 and pJIR2816, to inactivate two genes, rgaR and 
rgbR, via a homology-driven single cross-over event. 
However, in some cell populations of the rgaR mutant, there 
was reversion back to wild-type (O'Connor et al., 2006). 
This is expected from mutants created via single cross-over 
recombination. Recently, the same group has used this 
method to insertionally inactivate the tcdA and tcdB genes 
in C. difficile JIR8094, in which case the mutants were 
stable (Lyras et al., 2009). However, this method was also 
used by Dineen et al., to inactivate the C. difficile codY 
gene, which emphasized the instability of the insertional 
inactivation by a single cross-over event (Dineen et al., 
2007). An internal region of the C. difficile codY gene was 
inserted into pJIR1456, generating pSD21. The mutant C. 
difficile JIR8094::pSD21 strain with interrupted codY gene 
was generated by the single cross-over integration of the 
recombinant plasmid pSD21 into the chromosome. This strain 
grew more slowly than the wild type and stable integration 
could only be maintained in the presence of antibiotic, 
since resistance was conferred by the integrated plasmid. 
In the absence of antibiotic selection, however, the codY 
mutant could revert back to wild type, with functional codY 
after excision of the integrated plasmid, and overpopulate 
the culture (Dineen et al., 2007).   
Heap et al. (2007), developed a mutagenesis system, named 
ClosTron, to overcome the instability observed with single 
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cross-over integration and to bypass the difficulty of 
isolating rare double cross-over events in the Clostridia; 
which had been only observed in C. perfringens (due to the 
high DNA transformation frequencies in this organism) (Heap 
et al., 2007). This is to date the most widely used genetic 
system in C. difficile and since its appearance there has 
been a dramatic increase in the construction of C. 
difficile mutant strains. The ClosTron system was based on 
the TargeTron technology (Sigma-Aldrich) and has been 
modified for use in the Clostridia. In this approach, the 
mobile group II intron from the ltrB gene of Lactococcus 
lactis (Ll.ltrB) was utilised. Group II introns are 
catalytically active RNA molecules that can self-splice 
from an RNA transcript, via a lariat intermediate, and 
insert into a new target gene (Kuehne and Minton, 2012). 
These retro-homing ribozymes can be designed to target 
almost any gene of interest and thus interrupt the gene via 
insertion. The first ClosTron plasmid was named pMTL007 and 
was used to inactivate five genes in C. difficile and other 
Clostridia, including C. acetobutylicum and C. sporogenes 
(Heap et al., 2007). Subsequently, the system was optimised 
to include features for a faster, less-labour intensive 
mutagenesis in the Clostridia. In addition, features were 
added for the possibility of interruption of multiple genes 
in a Clostridial strain of interest. The second generation 
ClosTron plasmids for mutagenesis in C. difficile strains 
were named pMTL007C-E2 and pMTL007C-E5 (FIG 1.7) (Heap et 
al., 2010; Cartman et al., 2010). The ClosTron plasmid 
pMTL007 and derivatives, pMTL007C-E2 and pMTL007C-E5, carry 
a group II intron which contains an ermB 
retrotransposition-activated selectable marker (RAM), which 
itself is interrupted by a group I intron that abolishes 
antibiotic resistance. Due to the relative orientations of 
the group II intron and RAM element, a functional ermB gene 
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is only produced if the group II intron inserts into the 
chromosomal target gene, following retrotransposition and 
self-splicing of the group I intron from the group II 
intron mRNA. The mutants are thus selected by resistance to 
erythromycin and then confirmed by PCR assay. The frequency 
of intron integration at the site of interest can range 
from 7% to 100%, depending on the gene of interest (Heap et 
al., 2007; Heap et al., 2010; Cartman et al., 2010; Kuehne 
and Minton, 2012). The Clostron mutagenesis procedure is 





FIG 1.7  The second generation plasmid pMTL007C-EC2 of ClosTron  
The Group II intron expression is directed by the constitutive promoter 
from the fdx gene of Clostridium sporogenes. The promoter of the thlA 
gene from Clostridium acetobutylicum is used for expression of the ermB 
element. The plasmid contains FRT sites flanking the RAM to facilitate 
FLP-mediated removal. It also features a lacZ stuffer sequence that is 
replaced during retargeting for the identification of re-targeted 
plasmids by blue/white screening, restriction analysis or PCR. The 





FIG 1.8  ClosTron mutagenesis procedure using pMTL007C-EC2 
The ClosTron mutagenesis procedure involves inserting around a 350-bp 
fragment in an appropriate ClosTron plasmid (e.g pMTL007C-E2) which 
changes the specificity of the group II intron for insertion in the 
gene of interest. (A) The ClosTron plasmid is conjugated in C. 
difficile (B) Expression from thlA promoter, does not confer 
erythromycin resistance since the ermB gene is interrupted by the group 
I intron. Group I introns are self-catalytically spliced from RNA 
transcripts but the process is orientation specific. The group I intron 
cannot splice out of the ermB transcript, as it is in the reverse 
orientation (C) Expression of the group II intron gives a transcript 
that binds to the LtrA protein leading to the formation of a 
ribonuclear protein complex (RNP). In this case, the group I intron is 
in the correct orientation and it splices out of the transcript. The 
antibiotic resistance is still not conferred, because the gene is in 
the reverse orientation (D) The RNP complex recognises and binds to 
specific sequences in the target gene, the LtrA protein nicks the 
target DNA and inserts the group II intron RNA. LtrA reverse 
transcribes the complementary DNA strand. Host nucleases degrade the 
RNA strand and DNA polymerase synthesizes the opposite strand. Host 
ligases seal the insertion site leading to completion of the process, 
in which a functional ermB gene is present in the target gene. The 
mutants are selected by resistance to erythromycin and intron insertion 
into the target chromosomal site is confirmed by PCR assay. The 
ClosTron plasmid is then lost due to segregational instability. The 




1.3: Introduction to the development of a novel markerless deletion 
mutagenesis system for C. difficile 
 
Aim of the study: 
The primary aim of the study was to develop a novel genetic 
system for C. difficile to produce markerless deletions. 
The mutagenesis systems developed, for C. difficile, 
including the widely used ClosTron system, up to the start 
of this study, produce mutant strains by the insertional 
inactivation of genes of interest. An insertion of DNA into 
any given gene can interfere with the expression of 
downstream genes. In addition to polar effects, gene 
interruption by insertion of an antibiotic marker can 
prevent multiple manipulations of the genome, particularly 
in multidrug resistant strains such as C. difficile 630 
(Sebaihia et al., 2006). The ideal mutation for robust 
functional genomic studies is a markerless, in-frame 
deletion of the gene of interest.  
 
Strategy for the development of a novel markerless deletion mutagenesis 
system for C. difficile: 
As exemplified above, the construction of mutants via 
single cross-over can be unstable. However, a spontaneous 
second cross-over to generate a deletion can be a rare 
event, laborious to isolate and it may not occur if the 
diploid is stable. Posfai et al. (1999), exploited the 
homing endonuclease, I-SceI, as a tool for the promotion of 
allele exchange in E. coli, stimulated by a double strand 
break (DSB) and developed a method that permits the 
targeted construction of markerless deletions in this 
bacterium (Posfai et al., 1999). The basic principle of the 
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method is that cleavage of the chromosome at an 
artificially introduced I-SceI site stimulates 
intramolecular recombination by a DSB (known to stimulate 
homologous recombination in many microorganisms) (Posfai et 
al., 1999). Subsequently, this method was successfully 
adapted by various groups to generate deletion mutants of 
other bacteria including the anaerobe Bacteroides fragilis 
(Patrick et al., 2009).  
Homing endonucleases cleave double-stranded DNA with high 
specificity in the presence of divalent metal ions and 
recognise long DNA sequences (12-40 bp) (Belfort and 
Roberts, 1997). I-SceI is encoded by the group I intron of 
the large rRNA gene of Saccharomyces cerevisiae and it is a 
member of the largest class of homing enzymes, 
characterised by the presence of either one or two 
conserved amino acid residue sequence motifs (LAGLIDADG 
motifs) (Belfort and Roberts, 1997; Beylot and Spassky, 
2001). The I-SceI protein acts as a monomeric endonuclease 
of 235 amino acids and cleavage of its 18 bp recognition 
sequence (TAGGGATAACAGGGTAAT) generates 4 bp overhangs with 
3’-hydroxyl termini (Beylot and Spassky, 2001; Perrin et 
al., 1993; Monteilhet et al., 1990). This sequence is 
absent from all eukaryotic (except the source S. 
cerevisiae) and prokaryotic sequenced genomes which 
abolishes the risk of genome fractionation by the 
meganuclease and this makes the enzyme a useful tool for 
genetic engineering (Lopez et al., 2009).  
The present study has adapted the method of Posfai et al. 
(1999), to generate markerless deletions in C. difficile. 
An overview of the method is shown in FIG 1.9. The method 
uses two vectors, one I-SceI site delivery plasmid, 
containing the recognition site of I-SceI and one I-SceI 
expression plasmid. The allele replacement vector, made 
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from the insertion of homologous sequences flanking the 
gene to be deleted into the I-SceI site delivery vector, is 
introduced into C. difficile. Homologous recombination 
between either flanking sequence on the plasmid and its 
chromosomal homologue, results in plasmid integration into 
the chromosome. The I-SceI expression vector is then 
introduced into confirmed plasmid integrants. I-SceI 
meganuclease recognises its integrated site and introduces 
a DSB into the chromosome, stimulating diploid resolution 
via homologous recombination. Depending on the site of the 
cross-over, diploid resolution results in either a deletion 
mutant, or the wild type genotype.  
The method was developed and first applied to generate a 
deletion of the addBA genes in C. difficile, which is 
described in chapter 3. Subsequently, the method was 
optimised for the deletion of the pilA and pilT genes and 















FIG 1.9  Strategy for generation of markerless deletion in C. difficile 
(1)Sequences (~500 bp) flanking the gene to be deleted (red boxes) are 
inserted in the I-SceI site delivery vector, generating the allele 
replacement vector (2) The allele replacement vector is introduced into 
C. difficile (3) Homologous recombination between either flanking 
sequence on the allele replacement plasmid and its chromosomal 
homologue, results in plasmid integration into the chromosome (4) The 
I-SceI expression vector is then introduced into confirmed merodiploids 
(5) I-SceI meganuclease (expressed by an appropriate promoter) 
recognises its integrated site and introduces a DSB into the chromosome 
of the merodiploid (6) The DSB stimulates repair via homologous 
recombination. Depending on the site of the cross-over, diploid 






CHAPTER 2: Materials and Methods 
 
2.1: LIST OF STRAINS, PLASMIDS AND OLIGONUCLEOTIDES 
 
 
List of strains: 
Strain Name  Genotype Reference 





(Simon R., 1983) 











sensitive strain of 
C. difficile 630 






















































C. difficile ∆fliC 
∆pilT  234 
C. difficile 
630∆erm ∆fliC ∆pilT 
This study  
C. difficile ∆fliC 
∆pilT  238 
C. difficile 
630∆erm ∆fliC ∆pilT 
This study 
C. difficile ∆fliC 
∆pilT  250 
C. difficile 




List of Plasmids: 
Plasmid Name Description Reference 
pJIR1456 E. coli-C. perfringens 
shuttle vector (pIP404 +ve 






(Lyras and Rood, 
1998) 
pJIR2816 E. coli-C. perfringens 
shuttle vector (pIP404 +ve 








pES185 pJIR1456 + I-SceI 







pES2761 pJIR2816 + I-SceI 







pMTL82254 E. coli-Clostridium  
shuttle vector (pBP1 +ve 




(Heap et al., 
2009) 
pMTL83353 E. coli-Clostridium 
shuttle vector (pCB102 +ve 
replicon, aad9 marker), Sp
R
 
(Heap et al., 
2009) 
pGB920 pLYL01 with I-SceI under 
control of B. fragilis fucR 
promoter (tetQ marker), Tc
R 




pES288 pMTL82254 + Pfdx::I-SceI  
(SbfI site), ErmR  
This study 










pMTL84422 E. coli-Clostridium 
shuttle vector (pCD6 +ve 
replicon, tetA marker), Tc
R
 
(Heap et al., 
2009) 
pES271 pES185 +  addBA deletion 







pMTL83151 E. coli-Clostridium 
shuttle vector (pCB102 +ve 






(Heap et al., 
2009) 
pES242 pMTL83151 + I-SceI 







pES2921 pES242 + fliC deletion 







pMTL84151 E. coli-Clostridium 
shuttle vector (pCD6 +ve 






(Heap et al., 
2009) 
pES196 pMTL84151 + fliC gene and 





   
This study 
pES2922 pES242 + pilT deletion 





     
This study 
pES2923 pES242 + pilA deletion 





       
This study 





































* TmR -thiamphenicol resistance in C. difficile; CmR -
chloramphenicol resistance in E. coli; Sp
R
 –spectinomycin 
resistance in E. coli; Tc
R
 –tetracycline resistance in B. 
fragilis and E. coli; Erm
R
 –erythromycin resistance in C. 
difficile and E. coli 
 
List of Primers:  





















































*Underlined sequences indicate restriction enzyme sites. 
All primers were supplied by Eurofins MWG Operon, Germany. 
Primers were resuspended in 1 x TE at 100 pmol/μl. These 













2.2: GROWTH MEDIA 
 
LB (L-broth): Difco Bacto-Tryptone (10 g/l), Difco Bacto-yeast 
extract (5 g/l), NaCl (5 g/l), dH2O (1 l), pH adjusted to 
7.2 with NaOH. 
 
BHI (Brain Heart Infusion): Difco Bacto Brain Heart Infusion (37 
g/l), yeast extract (Oxoid) (5 g/l), distilled H2O (1 l). 
 
AIM (Anaerobic Identification Medium): Proteose peptone (Oxoid) (20 
g/l), yeast extract (Oxoid) (5 g/l), trypticase peptone 
(BBL) (5 g/l), NaCl (5 g/l), Na2CO3 (0.4 g/l), distilled H2O 
(1 l). 
 
BHIS or AIMS: BHI or AIM containing L-cysteine and Haemin. 
L-cysteine: Stock solution was made at 10% w/v in dH2O and 
filter sterilised using a 0.22 μm filter. 1 ml of stock was 
added per 100 ml of medium. 
Haemin: Stock solution was made with 50 mg Haemin, 1.74 g 
K2HPO4, 0.4 g NaOH and 100 ml dH2O and then was autoclaved. 
1 ml of stock was added per 100 ml of medium. 
 
Blood agar: Columbia blood agar base (39 g/l), 5% 





Agar medium concentration:  
Unless otherwise stated, the agar concentration used for 
solid media was 1.5% w/v. 
 
Antibiotics:  
 Antibiotics were supplied from Sigma and were prepared and 
stored according to the manufacturer’s instructions. 
Antibiotics were added at the following final 
concentrations: erythromycin 500 μg/ml for E. coli and 10 
μg/ml for C. difficile; chloraphenicol 30 μg/ml for E. 
coli; thiaphenicol 15 μg/ml for C. difficile; spectinomycin 
250 μg/ml for E. coli; cefoxitin sodium salt 8 μg/ml; D-
cycloserine 250 μg/ml.  
 
 
2.3: BACTERIAL METHODS 
 
Growth conditions:  
E. coli strains were cultured aerobically using LB as 
appropriate, at 37°C, with liquid cultures shaking at 160-
200 rpm. C. difficile strains were grown in a Don Whitley 
Scientific (UK) MiniMacs anaerobic work station at 37°C, 
with an anaerobic gas mix of 10% hydrogen, 10% carbon 
dioxide and 80% nitrogen. BHI, AIM (broth or agar) or Blood 
agar medium (supplemented when appropriate) were used to 
culture C. difficile. Unless otherwise stated, all media 




Growth measurement of liquid culture: 
The growth of liquid cultures was monitored by measuring 
the optical density at 600 nm (OD600) with a Hitachi U-2000 
spectrophotometer (Hitachi Instruments, Japan). Since 
spectrophotometer readings above an OD600 of 1 are not 
accurate, the sample was diluted in appropriate medium in 
the cuvette and mixed before a reading was taken. The 
reading was then multiplied by the dilution factor, to give 
the optical density. 
 
Growth curves:  
A single colony of C. difficile was used to inoculate 10 ml 
AIM broth and incubated anaerobically overnight. Fresh AIM 
broth was then inoculated with the overnight culture at 
1/100 dilution and OD600 was measured at 1-h time intervals 
for 10-h. Growth curves were performed in triplicate. 
 
Preparation of competent cells:  
A single colony of the E. coli strain of interest was used 
to inoculate 5 ml LB. Pre-warmed LB (250 ml) containing 20 
mM MgSO4 was inoculated with the overnight culture at 1/100 
dilution and was incubated at 37°C shaking, until an OD600 
of ~0.4 was reached. The culture was centrifuged at 4,500 x 
g in a Sorvall RC-5B centrifuge, with GSA rotor (Sorvall 
Ltd, UK) for 5 min at 4°C. The supernatant was discarded 
and the pellet was resuspended in 100 ml ice-cold TFB1, 
followed by a 5 min incubation on ice. The cells were 
pelleted by centrifugation, as described above, the 
supernatant was discarded and the pellet was resuspended in 
10 ml ice-cold TFB2. Cells were incubated for 1-h on ice. 
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Aliquots (100-200 μl/tube) of the competent cells were 
snap-frozen in dry ice containing isopropanol and stored at 
-80°C.    
TFB1: 30 mM CH3COOK, 10 mM CaCl2, 50 mM MnCl2, 100 mM RbCl, 
15% v/v glycerol, pH adjusted to 5.8 with 1 M acetic acid 
and filter sterilised with a 0.22 μm filter. 
TFB2: 10 mM MOPS, 75 mM CaCl2, 10 mM RbCl, 15% v/v glycerol, 
pH adjusted to 6.5 with 1 M potassium hydroxide and filter 
sterilised with a 0.22 μm filter.  
 
Heat-shock transformation of competent cells:  
Competent cells were thawed on ice. An appropriate amount 
of plasmid DNA was added to 20-100 μl of competent cells, 
followed by 30 min incubation on ice. The cells were heat-
shocked at 37
o
C for 2 min, followed by 5 min incubation on 
ice. Pre-warmed LB was added to the cells, followed by 
incubation at 37
o
C for 1-h. The culture was centrifuged at 
13000 rpm for 1 min, the supernatant was discarded and the 
pelleted cells were then resuspendend in appropriate volume 
of LB (usually 100 μl). The cells were then spread on media 
with appropriate antibiotics and incubated overnight at 
37
o
C. The usual strain used for transformation was S17-
1λpir. Occasionally, competent cells were purchased from 
various companies including, NEB 5-alpha competent E. coli, 
Invitrogen DH5a E. coli competent cells or Clontech Stellar 
competent cells that were transformed using the protocol 
described or according to the manufacturer’s instructions, 





Transfer of plasmid DNA into C. difficile:  
Plasmids were introduced into C. difficile by conjugation 
from E. coli S17-1λpir. Conjugations were performed using 
cultures of donor and recipient from either stationary or 
exponential phase of growth.  A single colony of E. coli, 
containing the appropriate plasmid, was inoculated into 5 
ml of LB with appropriate antibiotic and incubated 
aerobically overnight. A single colony of the C. difficile 
recipient strain was inoculated into 10 ml of appropriate 
broth and incubated overnight. For stationary mating, 1 ml 
of overnight E. coli culture was centrifuged at 5000 rpm 
for 2 min and then the cell pellet was washed twice in 1 ml 
of 1 x PBS (centrifuging as before), to remove traces of 
antibiotics. The pellet of donor cells was then transferred 
to the anaerobic workstation and resuspended in 150-200 μl 
of C. difficile overnight culture. For exponential mating, 
overnight culture of E. coli, prepared as described, was 
used to inoculate fresh LB without antibiotic and grown 
until an OD600 of 0.2-0.4. Then, 1 ml of E. coli culture was 
centrifuged at 5000 rpm for 1 min, followed by transfer of 
the cell pellet in the anaerobic workstation. The pellet of 
donor cells was resuspended in 150-200 μl of C. difficile 
culture, also grown to an OD600 of 0.2-0.4. Occasionally, 
different donor-recipient ratio was used, to optimize for a 
particular mating. The donor-recipient suspension (from 
stationary or exponential cultures) was spotted onto agar 
medium without antibiotic, as appropriate for the 
recipient, and incubated anaerobically at 37°C for 16 to 
24-h. The conjugation mixture was then harvested in 2 ml of 
1 x PBS (reduced overnight) and spread on growth medium 
suitable for the recipient, containing appropriate 
antibiotic to select for the plasmid-encoded resistance and 
also containing cycloserine (250 μg/ml) and cefoxitin (8 
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μg/ml)to counter-select against the E. coli donor. Plates 
were incubated anaerobically at 37°C for 24 to 120-h, 
before colonies were picked and purified by re-streaking. 
Putative transconjugants were replica patched on LB and 
incubated aerobically to exclude E. coli contamination. 
Since background growth would appear over time, donor-only 
and recipient-only mock mating controls were used, to help 
judge when background growth should be expected. 
 
Sporulation measurement:  
A starter culture was prepared in AIM broth using a 1% 
inoculum of C. difficile overnight culture (grown from a 
single colony in AIM broth) and incubated until the optical 
density at OD600 was approximately 0.3. This culture was 
then diluted at 1/100 into fresh AIM broth and this was 
considered the start of sporulation T0. The sporulation 
culture was incubated for five days, where the optical 
density OD600, heat-resistant colony formation and untreated 
colony formation, were measured every 24-h. To measure heat 
resistant CFU, 0.5 ml of sample was transferred out of the 
anaerobic workstation, heated at 60
o
C for 25 min, 10-fold 
serially diluted in 1 x PBS and 5 μl of each dilution 
spotted (4-6 times)on AIM agar containing 0.1% sodium 
taurocholate. The spots were left to dry and plates were 
returned to the anaerobic chamber. To measure untreated 
viable CFU, 0.5 ml of sample was serially diluted in 1 x 
PBS (reduced overnight) and 5 μl of each dilution was 
spotted (4-6 times) on AIM containing 0.1% sodium 
taurocholate. This was performed in the anaerobic 
workstation. Plates were incubated for 48-h before CFU were 




Total toxin production:  
Total toxin (A + B) was measured using the C. difficile TOX 
A/B II ELISA kit (Techlab), according to the manufacturer’s 
instructions. AIM broth was inoculated with overnight 
culture of C. difficile (grown from a single colony in AIM 
broth) at 1/100 and was incubated for 24-h. Culture 
supernatants were collected by centrifugation at 13200 rpm 
for 2 min, when optical density OD600 was approximately 0.5, 
0.8 and 1 and stored at -20
o
C until required. Total toxin 
levels were determined by measuring A450/OD600.  
Culture supernatants were given to Dr. Allison Wroe (MPRL) 
to measure toxin production. 
 
Metronidazole sensitivity assay: 
AIM broth was inoculated with overnight culture of C. 
difficile (grown in AIM from a single colony) at 1/100 
dilution and was incubated until an OD600 of ~0.3 was 
reached. The culture was then diluted at 1/100 into fresh 
AIM broth and incubated until an OD600 of ~0.3 was reached. 
Then, 10-fold serial dilutions of this culture were 
prepared in 1 x PBS (reduced overnight) and 5 μl of each 
dilution was spotted on AIM without metronidazole or on AIM 
with metronidazole concentration of 0.25, 0.125 and 0.06 
μg/ml. Plates were incubated for 48-h before the result was 
recorded. All experiments were performed in triplicate. 
 
UV sensitivity assay:  
AIM broth was inoculated with overnight culture of C. 
difficile (grown in AIM broth from a single colony) at 
1/100 dilution and was incubated until an OD600 of ~0.3 was 
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reached. The culture was then diluted at 1/100 into fresh 
AIM broth and incubated until an OD600 of ~0.3 was reached. 
Then, 10-fold serial dilutions of this culture were 
prepared in 1 x PBS (reduced overnight) and 5 μl of each 
dilution was spotted on AIM. Four sets of AIM agar were 
spotted. All plates were briefly transferred out of the 
anaerobic workstation. Plates were exposed to either just 
atmospheric O2 i.e. not UV irradiated, or exposed to UV 
irradiation of 10, 15 or 20 J/m
2
, using the Stratalinker UV 
2400 (Stratagene). All plates were returned to the 
anaerobic chamber and incubated for 48-h before results 
were recorded.  All experiments were performed in 
triplicate. 
 
SOS induction and cell morphology visualization:  
AIM broth was inoculated with overnight culture of C. 
difficile (grown in AIM broth from a single colony) at 
1/100 dilution and was incubated until an OD600 of ~0.3 was 
reached. This was then inoculated into fresh AIM broth at 
1/100 dilution, containing metronidazole at a concentration 
of 0.25, 0.125 or 0.06 μg/ml and into fresh AIM broth 
without metronidazole. The culture was incubated for 24-h. 
At 0-h (T0, inoculation time), 4-h (T4), 6-h (T6) and 24-h 
(T24), the optical density at OD600 was measured and 1 ml 
sample was centrifuged at 5000 rpm for 1 min, followed by 
resuspension of the cell pellet in 100 μl of cell fixative. 
All samples were stored at 4 
o
C until they were required for 
microscopy. All experiments were performed in triplicate. 
The morphology of cells was visualised by phase-contrast 
microscopy using a 10 μl wet mount, prepared from a fixed 
sample. To visualise the septum, the membrane stain FM4-64 
(Molecular Probes) was added to 1 ml of culture at 
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different time points and incubated in the anaerobic 
workstation for 20 min. The stained sample was centrifuged 
at 5000 rpm for 1 min, followed by resuspension of the cell 
pellet in 100 μl of cell fixative and stored at 4 
o
C in the 
dark until required. The FM4-64-stained sample (8–10 μl) 
was applied onto a poly-L-lysine microscope slide, a 
coverslip was placed on top and the coverslip edges were 
sealed with varnish. The stained cells were viewed by 
fluorescence microscopy.  
The Leitz Wetzlar Metalux II microscope (Leitz Wetzlar now 
Leica-microsystems, Germany) was used and images were 
captured with a Hamamatsu digital c4742-95 camera 
(Hamamatsu Photonics K.K., Japan) and Improvision Openlab 
software (PerkinElmer Inc., USA).   
Cell fixative: 20% v/v formaldehyde solution (Sigma) in 
bacterial buffer. 
Preparation of poly-L-lysine microscope slide: A drop (15 
μl) of poly-L-lysine (Sigma) was spread thinly on an 
ethanol-cleaned and dried microscope slide. Poly-L-lysine 
was left to dry before samples were applied.  
 
Flagella-mediated motility stab assay:  
A single colony of C. difficile was stab inoculated into 
motility agar tube containing appropriate medium with 
0.175% agar. The swim agar tube was incubated anaerobically 
at 37
o






Transmission electron microscopy:  
A 48-h grown colony of C. difficile from an appropriate 
medium was resuspended in 10 μl reduced 1 x PBS, in the 
anaerobic workstation. The suspension was transferred out 
of the anaerobic chamber and 100 μl of 3% glutaraldehyde 
made in 1 x PBS was added, followed by 30 min incubation at 
room temperature (RT), to fix the cells. Then, a drop of 
the fixed sample was placed onto carbon-coated grid, 
incubated at RT for 5 min and excess liquid was blotted 
away with filter paper. The cells were stained with 1% 
phosphotungstic acid for 1 min and excess liquid was 
blotted away with filter paper and then each grid was air 
dried. The grids were examined using a Philips CM120 
Biotwin transmission electron microscope.  
 
Surface twitching motility assay:  
BHI broth was inoculated with overnight culture of C. 
difficile (grown in BHI broth from a single colony) at 
1/100 dilution and was incubated until an OD600 of ~0.3 was 
reached.  Next 1 ml of culture was concentrated two-fold by 
centrifugation at 5000 rpm for 1 min and resuspension of 
pellet in 0.5 ml 1 x PBS (reduced overnight). Then, 5 μl of 
concentrated culture was spotted onto appropriate, well-
dried medium containing 0.7 % agar. Plates were incubated 
for 5 days anaerobically, with the growth medium facing 
upwards and in sealed bags to maintain humid conditions. 
The morphology and spread of the colony (whole diameter and 
translocation of inoculation spot) were recorded. 




Subsurface twitching motility assay:  
Appropriate growth medium containing 1% agar was poured 
very thinly (~3 mm) into a plastic petri dish and was dried 
and reduced overnight before inoculation. To inoculate the 
interface between the agar and the petri dish, a single 24-
hr grown colony of C. difficile, was picked with a 
toothpick and was stabbed through the agar to the plastic 
dish at a single point, tapping lightly to ensure 
inoculation. The agar medium was incubated for 5 days, with 
the growth medium facing upwards. Plates were then 
transferred out of the anaerobic workstation, the agar was 
removed, leaving behind bacterial growth attached on the 
plastic dish, which was subsequently dried under a lamp. 
The dried bacteria were stained with Coomasie blue by 
flooding the dish with the stain for 1 min. The excess 
stain was removed with destaining solution by several 
washes, until clear. The staining solution contained 0.5% 
Coomassie Brilliant blue R250, 40% methanol and 10% acetic 
acid in water. The destaining solution contained 40% 
methanol and 10% acetic acid in water. The stained bacteria 
were then dried at 37
o
C and the diameter of colony expansion 
was measured.   
 
 
2.4: DNA METHODS 
 
Chromosomal DNA extraction: 
C. difficile genomic DNA from liquid culture was extracted 
using the DNeasy Blood and Tissue kit (Qiagen) according to 
the manufacturer’s instructions. Alternatively, a C. 
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difficile pellet from liquid culture or a loop-full of 
colonies were vortexed in a 100 μl of 5% suspension of 
Chelex 100 Molecular biology grade resin (Bio-Rad), 
prepared in sterile water. An incubation of 10-15 min at 
100
o
C followed, to destroy the cell membranes and proteins 
and denature genomic DNA. The suspension was then 
centrifuged at 13200 rpm for 10 min and the supernatant 




Plasmid DNA extraction: 
Plasmid DNA was prepared using the QIAprep Spin Miniprep 
kit (Qiagen) according to manufacturer’s instructions. An 
additional step was included for C. difficile. The C. 
difficile cell pellet (usually from 5-10 ml culture), was 
resuspended in 250 μl Buffer P1 containing lysozyme (Sigma) 
at a final concentration of 1 mg/ml and incubated at 37
o
C 
for 30-60 min before addition of the Buffer P2. Then the 
protocol continued as specified by the manufacturer. If a 
QIAfilter Midi kit (Qiagen) was used, when a large volume 
of plasmid was required from E. coli, a 100 ml of overnight 
culture was used and DNA was eluted in 1 ml of 1 x TE 
buffer. Isolated plasmid DNA was stored in -20
o
C.   
1 x TE buffer: 10 mM Tris-HCl, 1 mM EDTA pH8 
 
Quantification of DNA:  
DNA concentration was quantified using a nanodrop ND-1000 
or ND-2000 spectrophotometer (Thermo Scientific). The 
260/280 (nm) and 260/230 (nm) absorbance ratio was 




Annealing of complementary pairs of oligonucleotides: 
Oligonucleotides were mixed in equal molar amounts in an 
Eppendorf tube and used the Eppendorf Mastercycler gradient 
cycler programmed to heat at 98
o
C for 5 min, followed by 
gradual decrease in temperature until 20
o
C was reached and 
incubated for 5 min. Alternatively, the Eppendorf tube 
containing the mixture of oligos was placed in a beaker 
with boiling water and left to cool until it reached room 





Polymerase Chain Reactions: 
PCR reactions were performed in an Eppendorf Mastercycler 
gradient cycler and using Phusion High-Fidelity DNA 
polymerase (New England Biolabs). A typical PCR reaction 
contained 10 μl of 5x Phusion HF or GC buffer, 1 μl of 10 
mM dNTPs mix, 1 μl of 10 pmol/μl forward primer, 1 μl of 10 
pmol/μl reverse  primer, appropriate amount of template DNA 
as required, 0.5 μl Phusion DNA polymerase and dH2O to give 
a final volume of 50 μl. Initial denaturation was performed 
at 98
o
C for 30 sec. This was followed by 31 cycles of 
denaturation at 98
o
C for 10 sec, annealing at primer 
specific temperature for 30 sec, and extension at 72
o
C for 
the time appropriate for the template size. Final extension 
was at 72
o
C for 10 min.  PCR products were purified using 







Agarose gel electrophoresis: 
DNA was separated by electrophoresis at 80 V for 60-80 min 
through 1% agarose gel (occasionally 0.8% for large-sized 
DNA) in 1 x TAE, using Bio-Rad electrophoresis tanks (small 
mini/wide mini subcell, subcell), powered by a BIO-RAD 
Power-Pak 300. DNA samples were loaded onto the gel, mixed 
with 6x blue gel loading dye (NEB) to final concentration 
of 1x. The DNA size was determined by loading 1 kb ladder 
or 100 bp ladder (NEB) mixed with loading dye as described. 
Following electrophoresis, the gel was stained in ethidium 
bromide (1 μg/ml) for 20 minutes and then destained in dH2O 
for 10-20 minutes. The DNA was visualised under UV light.  
50 x TAE Buffer: 2 M Tris, 0.95 M glacial acetic acid, 50 
mM EDTA pH8 
 
DNA extraction from agarose gel:  
Agarose gel containing DNA of interest was excised under UV 
light, and DNA was extracted using the QIAquick Gel 
Extraction Kit (Qiagen) or the Wizard SV Gel and PCR clean-
up system (Promega), according to manufacturer’s 
instructions. 
 
Digestion of DNA with restriction endonuclease: 
DNA was cleaved using appropriate restriction endonucleases 
supplied by NEB, according to the manufacturer’s 
instructions. The volume of enzyme was kept below 10% of 
the total reaction volume, to reduce star activity. 
Incubation times varied from 1 to 24-h. The enzymes were 
inactivated as necessary, according to the manufacturer’s 
instructions. When appropriate, digested DNA was purified 
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using the QIAquick PCR purification kit (Qiagen) according 
to the manufacturer’s instructions. 
 
Dephosphorylation of DNA: 
To remove 5′ phosphate groups from linearized plasmid DNA 
fragments, to prevent self-ligation, NEB Alkaline 
Phosphatase (CIP) or NEB Antarctic Phosphatase was used, 
according to the manufacturer’s instructions. Antarctic 
Phosphatase was inactivated as instructed by the 
manufacturer. Before ligation, linear and dephosphorylated 
plasmid DNA was purified using the QIAquick PCR 
purification kit (Qiagen), according to the manufacturer’s 
instructions.  
 
Phosphorylation of DNA:   
DNA products that required addition of 5’-phosphates, prior 
to ligation, the enzyme T4 Polynucleotide Kinase (NEB) was 
used, according to the manufacturer’s instructions. The 
reaction was incubated at 37
o
C for 30 min, followed by heat 
inactivation of the enzyme at 65
o
C for 20 min. 
Phosphorylated DNA products were purified using the 
QIAquick PCR purification kit (Qiagen), according to the 
manufacturer’s instructions. 
 
Ethanol precipitation of DNA: 
To concentrate DNA by ethanol precipitation, 1/10 volume of 
3 M sodium acetate (pH 5.2) was added to the DNA solution, 
followed by addition of 2x volume of chilled 100% ethanol. 
The mixture was incubated either overnight at –20
o





C for 1 to 2-h. The DNA was pelleted by centrifugation 
at 15000 rpm for 30 min at 4 
o
C, the supernatant was 
discarded and the pellet was resuspended in 0.5 ml 70% 
ethanol. The mix was centrifuged at 15000 rpm for 20 min at 
4 
o
C, the supernatant was discarded, and the DNA pellet was 
dried by centrifuging at the highest drying rate in a 
Savant DNA Speed Vac DNA110. The dried DNA pellet was 
resuspended in an appropriate volume of dH2O or Elution 




Ligation of DNA: 
DNA fragments were purified and quantified, as previously 
described, before ligation. The T4 DNA ligase (Promega) was 
used for ligation, according to the manufacturer’s 
instructions. Depending on the ligation, various 
vector:insert molar ratios were used. Typically, a 10 μl 
reaction contained 3 Weiss units of T4 DNA ligase. A 
control ligation without insert was also set up to assess 
any re-ligation of the vector. Incubation time and 
temperature varied, as appropriate for each ligation. 





Single colony gel:   
To determine whether cells contained the construct of 
interest, following transformation with the ligated 
mixture, single colony gels were run. Single colonies from 
the transformation plates were patched on fresh plates with 
appropriate selection and incubated at 37°C overnight. A 
toothpick was used to transfer and resuspend cells from a 
patched out colony into 150-200 μl of SCFS buffer. The 
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toothpick was left to stand in the buffer for 10-15 min at 
room temperature, it was then removed and the suspension 
was centrifuged at 13200 rpm for 30 min. 30 μl of the 
supernatant containing plasmid DNA was run on a 1% gel at 
80 V for 80 min. Supercoiled plasmid DNA was used as a 
control. The DNA was stained and visualised as described 
previously.  
SCFS Buffer: 2.5% v/v Ficoll, 1.25% w/v SDS, 0.015% w/v 




DNA was sequenced by the GenePool facility, at the 
University of Edinburgh, from appropriately prepared 













CHAPTER 3: The development of a novel markerless deletion 




Aim and Objectives:  
 To construct a markerless genetic system for C. 
difficile using I-SceI. 
To identify and use tools for the construction of the 
system including working strain, vectors for I-SceI 
site and allele delivery into the C. difficile 
chromosome and promoters and vectors for I-SceI 
expression. 
 To validate the system via the targeted deletion of 
addBA genes using the I-SceI system.  




It is essential for all organisms to ensure the integrity 
of genomic DNA and the accurate transmission of their 
genetic material to progeny. Bacterial genomic DNA is 
constantly faced with damage from endogenous and exogenous 
sources. It has been suggested that under normal aerobic 
conditions E. coli can suffer 3000 – 5000 DNA lesions per 
cell per generation, the majority being due to oxidative 
damage (Cox, 2001). One type of damage that is considered 
lethal, if not repaired, is a double-strand break (DSB). It 
has been estimated that in E. coli a spontaneous double-
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strand break occurs once per chromosome replication cycle 
(Reuter et al., 2010).  
Double-strand breaks (DSBs) can be caused directly or 
indirectly from various endogenous and exogenous sources 
including, ionizing radiation (e.g. X rays and γ rays), UV 
light, DNA damaging chemicals, desiccation, mechanical 
stress, oxygen radicals and inappropriate cleavage of DNA 
by host restriction-modification systems (Dillingham and 
Kowalczykowski, 2008; Kuzminov, 1999). Ionizing radiation, 
for example, can directly break DNA with the production of 
two free DNA ends (Kuzminov, 1999; Dillingham and 
Kowalczykowski, 2008; Kowalczykowski, 2000). 
In the absence of exogenous damaging agents, during normal 
cell growth, a DSB can result from an encounter of the 
replication fork with discontinuities or blockages in the 
DNA template (Kuzminov, 1999; Dillingham and 
Kowalczykowski, 2008; Kreuzer, 2005; Michel et al., 1997; 
McGlynn and Lloyd, 2002; Cox, 2001; Michel et al., 2007; 
Kuzminov, 2001; Rothstein et al., 2000). These include 
gaps, secondary structures, tightly bound proteins, nicks 
which for example can occur from free radicals arising from 
intermediary metabolism or when a SbcCD endonuclease cuts a 
hairpin structure at palindromic DNA sequences, etc. If a 
replication fork encounters an unrepaired nick in the 
template strand which disturbs the continuity of the 
replication fork, this can result in replication fork 
collapse and generation of an intact chromosome and a 
detached double-strand end (Kuzminov, 1999; McGlynn and 
Lloyd, 2002). Blockage of replication due to a DNA lesion 
in the lagging strand can be bypassed if the replication 
complex stays intact, by restarting lagging strand 
synthesis with a newly primed Okazaki fragment downstream 
of the lesion. This leaves a gap which can eventually lead 
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to a DSB if left unrepaired prior to the arrival of the 
replisome in the next round of duplication (McGlynn and 
Lloyd, 2002; Kuzminov, 1999). Moreover, replication fork 
stalling due to a defective replisome, DNA damage, blockage 
due to secondary structures or tightly bound proteins can 
lead to replication fork reversal, where the ends of the 
newly synthesized leading and lagging strands anneal. This 
can lead to different outcomes including DSBs at stalled 
replication forks or resetting of the replication fork and 
reassembly of the replisome (aided by the RecBCD enzyme 
complex discussed below) (Dillingham and Kowalczykowski, 
2008; De Septenville et al., 2012).  
Bacteria have evolved two primary mechanisms for the repair 
of DSBs: non-homologous end joining (NHEJ) and homologous 
recombination (HR) (Lenhart et al., 2012; Ayora et al., 
2011; Bowater and Doherty, 2006; Shuman and Glickman, 2007; 
Kowalczykowski, 2000). In NHEJ the broken ends, after minor 
processing, are joined together by ligation using minimal 
or no sequence homology. Therefore, this is a low fidelity 
DSB repair pathway accompanied by nucleotide insertions or 
deletions (Lenhart et al., 2012). In addition, NHEJ only 
exists in a subset of bacteria (Della et al., 2004). In 
contrast, homologous recombination is a high fidelity DNA 
repair pathway that requires a homologous sequence to 
repair the break. It is highly conserved among viruses, 
bacteria, archaea and eukaryotes (Cromie, 2009; Lenhart et 
al., 2012). NHEJ is used when HR is impaired or an intact 
homologous template is not available, for example during 
prolonged stationary phase in specialised cell stages such 
as sporulation (Yeeles and Dillingham, 2010; Bowater and 
Doherty, 2006; Shuman and Glickman, 2007).   
HR is recognised to have three stages and the RecA protein 
is central in this (Yeeles and Dillingham, 2010; Cromie, 
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2009; Kowalczykowski, 2000). In the first stage, 
presynapsis, the DNA ends are processed to form suitable 
single-stranded 3’ overhangs to which RecA binds and forms 
a functional RecA-ssDNA complex. In the second stage, 
synapsis, the RecA nucleoprotein filament performs a 
homology search, pairs with its homologous DNA followed by 
strand exchange resulting in a joint molecule called a 
Holliday junction. The third stage, postsynapsis, involves 
resolution of the junction to form recombinant repaired DNA 
products.  
 
In bacteria there are three distinct classes of helicase-
nuclease enzyme complexes namely, RecBCD, AddAB (also 
called RexAB) and AdnAB that process DSBs to form a 3’-
ssDNA overhang for the production of a RecA nucleoprotein 
filament (Rocha et al., 2005; Cromie, 2009). The AddAB and 
RecBCD proteins are widely distributed across the bacterial 
kingdom, with a single RecBCD- or AddAB-type enzyme complex 
being present in the majority of bacterial species; 
although several members of the Actinobacteria contain both 
enzyme types (Cromie, 2009; Yeeles and Dillingham, 2010). 
Structural homologues of these enzyme complexes have not 
been found in eukaryotes (Yeeles et al., 2009). The 
majority of the genes encoding the enzymes are generally 
clustered in an operon (Cromie, 2009). Recently, the AdnAB 
type enzyme has been identified in Mycobacteria species 
(Sinha et al., 2009; Gupta et al., 2011). The E. coli 
RecBCD and the B. subtilis AddAB have been the paradigms 
for these enzymes.  
 
The RecBCD and AddAB enzyme complexes are structurally 
distinct but they are functionally analogous, supported by 
the observation that the heterologous expression of 
Bacillus subtilis AddAB or Lactobacillus lactis RexAB can 
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nearly fully compensate for the DNA repair defect in 
∆recBCD E. coli strain (Yeeles and Dillingham, 2010; 
Dillingham and Kowalczykowski, 2008). Both complex types 
are regulated by a recombination hotspot sequence Chi 
(crossover hotspot instigator) (Yeeles and Dillingham, 
2010; Chedin and Kowalczykowski, 2002; Wigley, 2013). 
RecBCD and AddAB essentially follow the same steps for the 
production of the RecA nucleoprotein filament (Wigley, 
2013). The enzymes bind to blunt or nearly blunt duplex DNA 
ends, the DNA is unwound and digested at the same time 
until a Chi site is recognised which this changes the 
activity of the enzyme complex to produce a 3’-ssDNA 
overhang to which RecA binds with the aid of the enzymes. 
The length and sequence of Chi recognised by different 
enzyme complexes vary between different bacterial species 
but are conserved between different strains of the same 
species. For example, E. coli RecBCD recognises the 
octameric sequence 5’-GCTGGTGG-3’, B. subtilis AddAB 
recognises the pentameric sequence 5’-AGCGG-3’, L. lactis 
AddAB the heptameric sequence 5’-GCGCGTG-3’, Staphylococcus 
aureus AddAB the heptameric sequence 5’-GAAGCGG-3’ and 
Haemophilus influenzae RecBCD the octameric sequence 5’-
GNTGGWGG-3’ (Wigley, 2013; Yeeles and Dillingham, 2010; 
Chedin and Kowalczykowski, 2002). In addition Chi sequences 
are over-represented in the genome (e.g. in E. coli one 
site per 5 kb) and most are skewed towards the origin of 
replication to promote recombination of collapsed 
replication forks (Yeeles and Dillingham, 2010; Smith, 
2012; Halpern et al., 2007).  
RecBCD is a 330 kDa heterotrimeric complex composed of the 
RecB, RecC and RecD proteins (Yeeles and Dillingham, 2010; 
Singleton et al., 2004). The complex contains two helicase 
motors, RecB and RecD with opposite polarities that are 
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powered by ATP hydrolysis (Dillingham and Kowalczykowski, 
2008; Lenhart et al., 2012; Taylor and Smith, 2003; 
Dillingham et al., 2003). The C-terminus of RecB also 
contains a nuclease domain that is responsible for 
cleavages made on both DNA strands (Yeeles and Dillingham, 
2010; Wang et al., 2000b). The N-terminus of RecB contains 
a Superfamily 1A (SF1A) helicase with 3’-5’directionality, 
while the C-terminus is a λ-family nuclease (Wigley, 2013; 
Singleton et al., 2007). RecD is a SF1B helicase with 5’-3’ 
specificity (Wigley, 2013; Singleton et al., 2007). The 
RecC subunit is responsible for recognizing Chi (Wigley, 
2013; Singleton et al., 2004). RecBCD binds to the duplex 
DNA end (FIG 3.1) and the complex travels along the DNA 
using energy from the ATP hydrolysis in the RecB and RecD 
helicase motors. RecB travels in 3’-5’ direction and RecD 
in 5’-3’ direction, with RecD being the faster motor and 
consequently a loop of ssDNA is formed ahead of the RecB 
motor. As the DNA is being unwound, the nuclease domain of 
RecB degrades both strands with the 3’ strand being more 
vigorously hydrolysed than the 5’ strand (Wigley, 2013; 
Smith, 2012; Dillingham and Kowalczykowski, 2008; Dixon and 
Kowalczykowski, 1993; Taylor and Smith, 2003; Dillingham et 
al., 2003). During unwinding, the 3’ stand may pass through 
a tunnel in RecC where it is scanned for the Chi sequence 
(Smith, 2012; Singleton et al., 2004). Upon recognition of 
the Chi sequence, the RecC subunit binds tightly to the Chi 
site and the complex pauses translocation and resumes at a 
reduced rate due to the complex being led by the slower 
RecB motor instead of the RecD motor. Moreover, following 
Chi recognition, cleavage of the 3’-5’ strand is attenuated 
whilst cleavage of the 5’-3’ strand is enhanced, resulting 
in the formation of a 3’ ssDNA overhang close to the Chi 
sequence. The single-strand-binding protein (SSB) binds 
rapidly and tightly to the 3’ssDNA tail produced and RecA 
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is unable to compete with this. However, following Chi 
recognition, the RecB nuclease domain is released from RecC 
and RecB actively loads RecA proteins onto ssDNA, 
displacing SSB and generating the RecA nucleoprotein 
filament (Dillingham and Kowalczykowski, 2008; Lenhart et 
al., 2012; Wigley, 2013; Anderson and Kowalczykowski, 1997; 
Dixon and Kowalczykowski, 1993; Spies et al., 2003; Spies 
et al., 2007).  
 
FIG 3.1  Schematic of processing of 
DNA ends by RecBCD 
a) A double strand break on 
DNA is represented by a star. 
b) RecBCD binds to the DNA end 
and the complex travels along 
the DNA unwinding the duplex 
at the same time. A Chi site 
is shown in red. c) RecB 
travels in 3’-5’ direction and 
RecD in 5’-3’ direction. A 
loop of ssDNA is formed ahead 
of the RecB motor due to RecD 
being the faster motor. RecB 
nuclease domain degrades both 
strands with 3’ssDNA end being 
more vigorously hydrolysed 
than the 5’ ssDNA end. d) A 
Chi site is encountered e) At 
encounter, the 3’-5’ nuclease 
activity is attenuated and 
cleavage of the 5’-3’ strand 
is enhanced resulting in the 
formation of a 3’ ssDNA. f) 
RecBCD loads RecA onto the 
ssDNA resulting in the RecA 
nucleoprotein filament 
formation. The image is 




The AddAB complex consists of two subunits, AddA (135 kDa) 
and AddB (141 kDa) (Chedin and Kowalczykowski, 2002). AddA 
is both a helicase and an endonuclease, the N-terminal 
region is a SF1A family helicase with 3’-5’ specificity and 
the C-terminal region is a RecB-type nuclease which digests 
DNA at 3’-5’ direction (Lenhart et al., 2012; Wigley, 2013; 
Saikrishnan et al., 2012; Yeeles and Dillingham, 2007). The 
AddB subunit is also a nuclease, with the C-terminus 
forming a RecB-like nuclease domain that cuts ssDNA with 
5’-3’ polarity (Yeeles and Dillingham, 2007). In addition, 
the C-terminus of AddB contains a 4Fe-4S iron-sulphur 
cluster that seems to have a structural role by binding to 
duplex DNA ends and stabilizing the protein structure 
(Yeeles and Dillingham, 2010; Saikrishnan et al., 2012). 
AddB is analogous to RecC facilitating Chi recognition 
(Wigley, 2013; Saikrishnan et al., 2012). Similarly to 
RecBCD, the AddAB enzyme initiates end processing by 
binding to the dsDNA end, the DNA is unwound and cleaved as 
the enzyme complex translocates along the DNA. In contrast 
to RecBCD, unwinding of duplex DNA by AddAB requires SSB 
(Wigley, 2013; Yeeles et al., 2011). Before a Chi site is 
encountered, AddA and AddB nucleases each cleave a single 
DNA strand at equal frequencies as the DNA is extruded from 
the translocating complex (Yeeles and Dillingham, 2007; 
Chedin et al., 2000). When AddAB recognises a Chi site the 
complex binds tightly, unwinding continues and the cleavage 
of the 3’-5’ strand is attenuated resulting in the 
production of a 3’-ssDNA for RecA binding (Lenhart et al., 
2012; Chedin et al., 2000; Chedin et al., 2006; Yeeles and 
Dillingham, 2007).  
AddAB and RecBCD are involved in a range of important 
processes in addition to DNA damage and DSB repair 
including, bacterial conjugation, transduction, bacterial 
57 
 
competence, degradation of host and foreign DNA and the SOS 
response (Chedin and Kowalczykowski, 2002; Dillingham and 
Kowalczykowski, 2008; Lenhart et al., 2012). The importance 
of AddAB or RecBCD activity in bacteria is evident from the 
fact that bacteria deficient in these genes have reduced 
viability, are defective in DSB repair and have increased 
sensitivity to DNA damaging agents (Chedin and 
Kowalczykowski, 2002). During bacterial conjugation, the 
DNA enters the cell as a single-strand and is converted to 
linear dsDNA, by replication, which is a substrate for 
RecBCD to initiate HR with host homologous sequences 
(Dillingham and Kowalczykowski, 2008; Smith, 1991). 
Moreover, during transduction, the ends of injected linear 
DNA of a previous host can be a substrate for RecBCD/AddAB 
enzymes for recombination and integration of the linear DNA 
at homologous sites in the new host (Dillingham and 
Kowalczykowski, 2008; Smith, 1991). In B. subtilis, 
expression of addAB is directly linked to competence in 
this organism and AddAB is required for recombination of 
incoming donor DNA (Haijema et al., 1995). Inactivation of 
addA or addB genes in B. subtilis and L. lactis showed 
reduced frequency of homologous recombination during 
conjugation and transduction (Chedin and Kowalczykowski, 
2002; Kooistra et al., 1997; el Karoui et al., 1998). 
However, RecBCD can also contribute to resistance of 
intruding foreign DNA, e.g. phage DNA that exposes free DNA 
ends is subject to degradation by the enzyme (Dillingham 
and Kowalczykowski, 2008; Benzinger et al., 1975). In 
addition, linear DNA fragments produced from cleavage of 
foreign DNA from restriction modification systems are 
further degraded by RecBCD (Dillingham and Kowalczykowski, 
2008; Handa et al., 2000; Simmon and Lederberg, 1972). In 
many bacteria DNA damage induces the SOS response (Simmons 
et al., 2009; Lenhart et al., 2012). In E. coli, a critical 
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step in this reaction is the formation of RecA-ssDNA 
nucleoprotein filament which is either produced by RecBCD 
if the DNA substrate is a DSB, or by RecFOR when the DNA 
substrate is a single-strand gap (Simmons et al., 2009). 
The RecA-ssDNA filament stimulates the self-cleavage of the 
LexA repressor, inactivating the protein and subsequently 
activating transcription of SOS regulated genes (Lenhart et 
al., 2012; Michel, 2005).  
DSB-processing enzymes are also important in the adaptation 
of microorganisms in extreme environments and bacterial 
virulence. For example, RecD of the RecBCD complex is 
required for the normal growth and cell morphology of the 
marine bacterium Photobaterium profundum at high pressures 
(Bidle and Bartlett, 1999). The ability of Salmonella 
enterica typhimurium to repair DNA damage is essential for 
survival and virulence, as mutants lacking RecBCD function 
are avirulent in the murine typhoid model and are also 
sensitive to reactive oxygen species, nitric oxide, H2O2 
(produced by phagocytes) or bile salts (Buchmeier et al., 
1993; Buchmeier et al., 1995; Cano et al., 2002; Prieto et 
al., 2006). RecBCD contributes to the survival of Neisseria 
gonorrhoeae following oxidative damage produced by 
neutrophils and lactobacilli encountered during infection 
(Stohl and Seifert, 2006). Moreover, E. coli recBCD mutants 
are highly sensitive to nitric oxide (Spek et al., 2001). 
Coxiella burnetti is able to survive in the hostile 
environment of a parasitophorous vacuole, with lysosomal 
characteristics, possibly aided by the strong upregulated 
expression of addAB under conditions of oxidative stress 
(Mertens et al., 2008). Helicobacter pylori undergoes 
oxidative damage soon after infection due to infiltration 
of neutrophils and macrophages during the innate immune 
response (Amundsen et al., 2008). DSB repair by AddAB in 
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this organism is required for successful in vivo 
colonization (Amundsen et al., 2008). In addition, H. 
pylori AddAB promotes recombination-dependent variation of 
cell surface proteins that may allow evasion of adaptive 
immune response or, alternatively, may modify bacterial 
tropism (Amundsen et al., 2008). 
Taking into consideration the importance of RecBCD and 
AddAB enzymes in bacterial infection and in SOS-induced 
mutagenesis and their presence in most sequenced bacterial 
species, these enzymes could be possible targets for the 
development of novel broad spectrum antibacterial 
therapeutics.  
In this study a novel markerless genetic system for C. 
difficile was constructed via the deletion of addA and addB 
genes. Furthermore, the function of AddAB enzyme complex in 





3.2.1: Identification and construction of tools for the development of the I-
SceI deletion system in C. difficile: 
 
Choice of working strain: 
The first task towards the development of the genetic 
system was the choice of a C. difficile strain. Ideally, a 
working strain had to have two characteristics: sensitivity 
to two different antibiotics, to allow selection of the 
plasmid constructs in the process; and an available genome 
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sequence to enable the design of gene deletion primers. In 
2006, Sebaihia et al., determined the first complete genome 
sequence of C. difficile 630, which was a multidrug 
resistant isolate from a hospital patient with 
pseudomembranous colitis in Zurich, Switzerland (Sebaihia 
et al., 2006). This was the only sequenced strain at the 
start of this study. In addition, Hussain et al. (2005) 
generated an erythromycin-sensitive derivative of C. 
difficile 630, named 630∆erm, which is also sensitive to 
thiamphenicol (Hussain et al., 2005). This strain was later 
used by Heap et al. (2007) to develop the ClosTron genetic 
system in C. difficile, as it allowed the introduction of 
plasmids that encoded erythromycin and thiamphenicol 
resistance in the bacterium (Heap et al., 2007). Moreover, 
a similar strain to 630∆erm, designated JIR8094, was also 
generated by O’Connor et al. (2006)and was used for the 
construction of C. difficile chromosomal mutants via the 
integration of plasmids encoding thiamphenicol resistance 
(O'Connor et al., 2006; Dineen et al., 2007; Lyras et al., 
2009). In all, strain C. difficile 630∆erm was chosen for 
the development of the system in this study. Despite the 
later availability of information on genome sequence and 
genetic modification of other C. difficile strains, 
including the hypervirulent C. difficile 027, this study 
focused on 630∆erm. 
 
Construction of I-SceI site delivery vectors:  
The next step in the development of the genetic system was 
the identification and construction of the I-SceI site 
delivery vectors to be used for allelic replacement in the 
chromosome of C. difficile. Ideally, the allele replacement 
vectors would be delivered and integrated into the 
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chromosome via suicide vectors to allow efficient selection 
of merodiploids through the antibiotic resistance conferred 
from the integrated plasmid. However, as mentioned, 
conjugative transfer of a suicide plasmid in C. difficile 
has been achieved only once, despite subsequent attempts 
from other groups (O'Connor et al., 2006; Carter et al., 
2005; Liyanage et al., 2001). Thus, replicative but 
unstable plasmids introduced via conjugation have been used 
instead to transfer DNA into C. difficile (O'Connor et al., 
2006; Cartman et al., 2012).  
In this study, plasmids pJIR1456 and pJIR2816 (FIG 3.2) 
were chosen for the construction of the I-SceI site 
delivery vectors pES185 and pES2761 (O'Connor et al., 
2006). These plasmids can be transferred into C. difficile 
by RP4-mediated conjugation from an E. coli donor and have 
been used for the insertional inactivation of C. difficile 
chromosomal genes due to their instability, stemming from 
the presence of a Clostridium perfringens-derived pIP404 
replication region (O'Connor et al., 2006; Purdy et al., 
2002). Both plasmids carry a thiamphenicol resistance gene 
catP allowing their selection at required stages in this 
genetic system. To construct the I-SceI site delivery 
vector pES185, oligos ISceI_F_SacI and ISceI_R_SacI 
carrying the I-SceI recognition site were annealed to each 
other, 5’-phosphates were added and the oligos ligated into 
the SacI site of pJIR1456 (FIG 3.3). Similarly, oligos 
ISceI_F_PvuI and ISceI_R_PvuI were phosphorylated at 5’ 
ends, annealed to each other and ligated into the PvuI site 




         
 
FIG 3.2  Schematic representation of pJIR1456 and pJIR2816 
Both plasmids have oriCP and oriEC, origins of replication from pIP404 
and pUC18, respectively; rep, replication gene from pIP404; catP, 
chloramphenicol resistance gene from C. perfringens; RP4oriT, origin of 
DNA transfer. pJIR1456 adapted from (Lyras and Rood, 1998) and pJIR2816 








FIG 3.3  Schematic representation and agarose gel analysis of pES185 
A] Oligos ISceI_F_SacI and ISceI_R_SacI carrying the I-SceI recognition 
site  and a SacI restriction site (underlined) were ligated into the 
SacI site of pJIR1456 generating pES185 (6892 bp). B] Restriction 
digest analysis of pES185. Lane 1 refers to 1 kb ladder. Lanes 2, 3, 4 
and 5 refer to supercoiled pES185, I-SceI digested, SacI digested and 







FIG 3.4  Schematic representation and agarose gel analysis of pES2761 
A] Oligos ISceI_F_PvuI and ISceI_R_PvuI carrying the I-SceI recognition 
site and a PvuI restriction site (underlined) were ligated into the 
PvuI site of pJIR2816 generating pES2761. The plasmid features a lacZ 
gene to aid cloning. B] Restriction digest analysis of pES2761. Lane 1 
corresponds to 1 kb ladder. Lanes 2 and 3 refer to supercoiled pJIR2816 
and PvuI digested pJIR2816, respectively. Lanes 8 and 9 refer to 
supercoiled pES2761 and I-SceI digested pES2761, respectively.  
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Construction of I-SceI expression vectors: 
To construct the I-SceI expression vector, an appropriate 
promoter to express I-SceI and an appropriate plasmid i.e., 
a replicative plasmid encoding an antibiotic resistance 
different from the I-SceI site delivery vector, were 
required. This study utilised the ferredoxin (fdx) promoter 
of the fdx gene from Clostridium sporogenes to express I-
SceI. This promoter had previously been used to express the 
Group II intron in the second generation ClosTron plasmid 
pMTL007C-E2 (Heap et al., 2010; Cartman et al., 2010). The 
E. coli-Clostridium shuttle vector pMTL82254, that carries 
an erythromycin marker, was utilised for the construction 
of the I-SceI expression vector (Heap et al., 2009). The 
fdx promoter (Pfdx) and ribosome binding site (RBS) were 
amplified by PCR, from pMTL83353, using primers SbfI-
PfdxFor and PfdxRev and the I-SceI encoding gene was 
amplified by PCR from pGB920 using primers PfdxIsceI and 
SbfI-IsceIRev (FIG 3.5) (Heap et al., 2009; Patrick et al., 
2009). The Pfdx and I-sceI PCR products were mixed and used 
as template for a cross-over PCR, using primers SbfI-
PfdxFor and SbfI-IsceIRev, resulting in a fused product 
between the promoter and I-SceI; named Pfdx::I-SceI (0.9 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































Subsequently, Pfdx::I-SceI was ligated into the SbfI site 
of pMTL82254 generating the I-SceI expression vector pES288 
(FIG 3.6). In this scenario, selection of thiamphenicol 
resistant co-integrants containing pES288 would be via 
erythromycin resistance. This vector was used for 
merodiploid resolution and construction of various C. 






FIG 3.6  Schematic representation and agarose gel analysis of pES288   
Pfdx::I-SceI was ligated into the SbfI site of pMTL82254 generating 
pES288. Gel 1 lanes 1, 2 and 3 correspond to 1 kb ladder, supercoiled 
pES288 (6843 bp) and SbfI digested pES288 (releasing Pfdx::I-SceI), 
respectively. Gel 2 lanes 1, 2 and 3 correspond to 1 kb ladder, 
supercoiled pMTL82254 (5935 bp) and SbfI digested pMTL82254, 
respectively. Plasmid pES288 features: plasmid replication gene repA, 
putative plasmid replication gene orf2, erythromycin resistance marker 
ermB, Gram –ve replicon ColE1, Gram +ve replicon pBP1 and plasmid 




Other I-SceI expression vectors were constructed in an 
attempt to increase expression of I-SceI; namely pES124 and 
pES86, where the I-sceI gene was fused to the glutamate 
dehydrogenase promoter (gdh)from C. difficile 630 or to the 
thiolase promoter (thl) from Clostridium acetobutylicum 
ATCC 824 (using pMTL84422 as PCR template), respectively 
(Mani et al., 2006; Heap et al., 2009). However, their use 
resulted in no expression of I-SceI enzyme, implied from 
the absence of merodiploid resolution i.e. no thiamphenicol 
sensitive strains were obtained from loss of the integrated 
allele replacement vector (data not shown). All I-SceI 
expression vectors were sequenced to validate their 
construction and I-SceI expression was tested via 
conjugation of each construct into thiamphenicol resistant 
co-integrants and screening for resolution via loss of 
thiamphenicol resistance (experiments with pES288 are 
described below). In addition, it was attempted to validate 
the I-SceI expression from pES124 or pES288 transconjugants 
via western blotting with anti-I-SceI antibodies, but these 
data were inconclusive because the I-SceI antibody used, 
despite being monoclonal, bound to multiple proteins from 











3.2.2: Construction of C. difficile addBA deletion strain 
 
Arrangement of addBA genes and strategy for deletion: 
Following the construction of the I-SceI genetic system, 
its effectiveness was initially tested in C. difficile 
630∆erm to delete the addBA genes. Using the available 
genomic sequence of C. difficile 630, suitable primers were 
designed to delete addA and addB genes. Figure 3.7 shows 
the arrangement of these genes in C. difficile 630, the 
deletion primers and target deletion region. Upstream of 
the addB gene, there is a putative helicase (CD630_10380) 
of the UvrD family which is known to be involved in 
excision and mismatch repair and SOS induction (Janion, 
2008; Ossanna and Mount, 1989; Selby and Sancar, 1994). 
Downstream of the addA gene, there is a predicted sbcD gene 
(CD630_10420) encoding the nuclease SbcCD subunit D, 
followed by the predicted nuclease SbcCD subunit C encoding 
gene (CD630_10430) which recognises and cleaves secondary 
DNA structures formed from long DNA palindromes (Connelly 
et al., 1998; Eykelenboom et al., 2008). Primer sets 
SphI_addBA1 / addBA2 and addBA2_addBA3 / SphI_addBA4 were 
designed such that their use in the I-SceI genetic system 
would result in the markerless deletion of a 7.256 kb 












































































































































































































































































































































































































































































































































































Construction of allele replacement vector pES271: 
To deliver the ∆addBA recombinant allele into the 
chromosome of C. difficile 630∆erm, the construction of 
allele replacement vector pES271 was required. The first 
step in achieving this was the construction of the addBA 
deletion cassette. Around 0.5 kb sized regions flanking the 
addB and addA genes were amplified by PCR using primer sets 
SphI_addBA1 / addBA2 and addBA2_addBA3 / SphI_addBA4, with 
genomic DNA from C. difficile 630 as template (FIG 3.8). 
The resulting products were mixed and used as template for 
subsequent cross-over PCR using primers SphI_addBA1 and 
SphI_addBA4, generating the addBA deletion cassette where 
the two flanking regions were fused together via their 
homologous region introduced by addBA2 and addBA2_addBA3 
primers (FIG 3.8). The addBA cross-over PCR resulted into 
two products, possibly due to the presence of homologous 
regions in the PCR mixture. However the product of 
interest, the addBA deletion cassette of ~1 kb in size was 
detected. To generate the allele replacement vector pES271, 
the addBA deletion cassette was ligated into the SphI site 
of pES185 (FIG 3.9). This construct was also sequenced to 










































































































































































































































































































































































































































































































































































































































































































































































FIG 3.9  Schematic representation and agarose gel analysis of pES271 allele replacement 
vector 
The addBA deletion cassette was ligated into the SphI site of pES185 
generating the allele replacement vector pES271. Gel lanes 1, 2, 3 and 
4 correspond to 1 kb ladder, supercoiled pES271, I-SceI digested pES271 





Conjugation and integration of pES271 in C. difficile 630∆erm: 
Following the construction of pES271 the next step was the 
introduction of the construct into C. difficile followed by 
integration into the chromosome. As the plasmid harbours a 
catP gene in its backbone, this allowed selection of 
thiamphenicol resistance in strains carrying the plasmid 
either in free replicative or chromosomal integrated form. 
The recombinant plasmid was conjugated from E. coli S17-
1λpir into C. difficile using exponential cultures grown in 
BHIS (BHI supplemented with haemin and L-cysteine). Ten 
putative transconjugants, No. 1-10, were recovered after 
72-h and subsequently streaked twice on BHIS containing 
Tm15 μg/ml (BHISTm15) for purity and to allow for a single 
cross-over event. E. coli contaminants were excluded by 
replica screening the colonies via aerobic incubation on 
Luria-Bertani (LB) agar. The presence of pES271 in C. 
difficile was confirmed via amplification of the addBA 
deletion cassette using PCR with SphI_addBA1 and 
SphI_addBA4 primers and template chromosomal DNA extracted 
from 48-h grown putative transconjugants. The addBA 
deletion cassette was only amplified from transconjugant 






FIG 3.10  Schematic diagram and agarose gel image analysis for PCR screening of pES271 
transconjugants  
Primers SphI_addBA1 and SphI_addBA4 were used to confirm the presence 
of pES271 via the amplification of the addBA deletion cassette (~1 kb) 
by PCR from chromosomal extract of putative transconjugants. Wild type 
strains not containing pES271, result in the amplification of wt addBA 
(8 kb) using the same primers. Gel lanes 1, 2, and 3 correspond to 1 kb 
ladder, primers control PCR and addBA deletion cassette (undigested), 
respectively. Lane 4 corresponds to wt addBA product from wt C. 
difficile 630∆erm and lane 5 to addBA deletion cassette product from 





To allow for the loss of non-integrated pES271 and for the 
selection of putative merodiploid strains, transconjugant 
strains were passaged through BHIS lacking thiamphenicol 
multiple times and then plated on BHISTm15. From this 
process, 11 possible thiamphenicol resistant integrants 
were selected. Confirmation of pES271 integration into the 
chromosome of these strains was achieved by PCR 
amplification of a 1.2 kb integration product using 
SphI_addBA1 and INTBARev or SphI-addBA4 and INTBAFor primer 
sets and chromosomal DNA of putative merodiploids. Figures 
3.11 & 3.12 show the integration of pES271 in No. 1-10 
merodiploids via the region downstream of the addA gene and 
the integration of pES271 in No. 11 merodiploid via the 
region upstream of the addB gene. For experiments aiming to 
test for the expression of I-SceI, resolution and deletion 
of target genes in the recombinant strains, merodiploids 




FIG 3.11  Schematic diagram and agarose gel image analysis for PCR screening of pES271 
single cross-over integration via the left flanking homologous region 
Primers INTBAFor and SphI_addBA4 were used to confirm the event of 
single cross-over chromosomal integration of pES271 though the LF 
homologous region via the amplification of a 1.2 kb product by PCR from 
chromosomal extractions. Note that INTBAFor anneals 220 bp upstream of 
LF onto the chromosome. Solid line represents plasmid sequence. Dashed 
line represents chromosomal sequence. Gel lanes 1, 2 and 3 correspond 
to 1 kb ladder, primers control PCR, and wt C. difficile 630∆erm 
control PCR, respectively. Lanes 4 to 14 correspond to merodiploids 
pES271/630∆erm/No.1-11. Single cross-over integration of pES271 via LF 





FIG 3.12  Schematic diagram and agarose gel image analysis for PCR screening of pES271 
single cross-over integration via the right flanking homologous region 
Primers SphI_addBA1 and INTBARev were used to confirm the event of 
single cross-over chromosomal integration of pES271 though the RF 
homologous region via the amplification of a 1.2 kb product by PCR from 
chromosomal extractions. Note that INTBARev anneals 270 bp downstream 
of RF onto the chromosome. Solid line represents plasmid sequence. 
Dashed line represents chromosomal sequence. Gel lanes 1, 2 and 3 
correspond to 1 kb ladder, primers control PCR, and wt C. difficile 
630∆erm control PCR, respectively. Lanes 4 to 14 correspond to 
merodiploids pES271/630∆erm/No.1-11. Single cross-over integration of 




Introduction of I-SceI expression vector and induction of a double-strand 
break: 
Following the construction of the ∆addBA plasmid 
integrants, the next step involved the introduction of the 
I-SceI expression vector pES288 into these strains and 
generation of a DSB at the integrated I-SceI site. Since 
the fdx promoter had been used for the constitutive 
expression of the Group II intron in the ClosTron system it 
was assumed that I-SceI under the control of this promoter 
would result in constitutive expression, giving rise to a 
DSB as soon as the plasmid entered the integrants (Heap et 
al., 2010; Cartman et al., 2010). Identification of 
resolved strains would therefore be easily achieved via 
screening for loss of thiamphenicol resistance following 
loss of integrated plasmid which carried a catP marker.  
To test for the expression of I-SceI under Pfdx, initial 
experiments involved the introduction of I-SceI expression 
vector pES288, into the merodiploid pES271/630∆erm/No.8 
strain via stationary mating. From this mating, the 
resulting 176 putative transconjugants were screened for 
loss of thiamphenicol resistance to detect for resolution, 
screened for erythromycin resistance to confirm the 
presence of pES288, and screened for aerobic growth to 
exclude E. coli contamination. All transconjugants were 
erythromycin resistant and 97% were anaerobes. Moreover, 
all were thiamphenicol resistant suggesting that, in this 
experiment, resolution did not occur when the I-SceI 
expressing vector entered the cells or there was a low I-
SceI concentration in cells. Therefore, to enrich for a 
population of cells expressing I-SceI with an increased 
probability of obtaining a DSB and for purity, two 
erythromycin resistant pES288 transconjugants were 
subcultured two to four times on BHISErm10 or AIMSErm10 
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(BHIS or AIMS supplemented with erythromycin at 10 μg/ml) 
agar medium to keep the selective pressure for pES288. 
Colonies were selected at random from second or fourth 
subcultures and were screened for thiamphenicol resistance 
and aerobic growth. All the resolved colonies (28.6%) i.e. 
thiamphenicol sensitive colonies isolated (54 sensitive 
colonies from total 189 screened) were confirmed via 
subsequent tests (not described here) to have reverted to 
wt, which suggested that an addBA deletion might be lethal 
to C. difficile or might reduce the growth rate of the 
strain to an extent where it was hard to isolate because 
the wild type might dominate the population.  
Up to this point, isolation of an addBA deletion strain had 
been attempted via resolution of the merodiploid 
pES271/630∆erm/No.8 strain where integration had occurred 
via the downstream region of the addA gene. The next 
attempt to isolate an addBA deletion strain involved the 
introduction of the I-SceI expression vector pES288 into 
the merodiploid pES271/630∆erm/No.11, where integration of 
allele replacement vector occurred via the upstream region 
of addB gene. To isolate two independent addBA deletion 
mutants, the vector pES288 was conjugated into the 
merodiploid pES271/630∆erm/No.11 strain via stationary 
mating at two independent occasions using AIMS medium. On 
both occasions, putative transconjugants were recovered and 
subcultured twice (sub1 & sub2) on AIMSErm10, then from 
each subculture (sub1 & sub2) colonies were picked and 
screened for thiamphenicol sensitivity to test for 
resolution. It was postulated that an addBA deletion would 
delay the growth of C. difficile and so smaller sized 
colonies were preferentially picked.  
From the first mating, 55 putative transconjugants were 
obtained, then screened for thiamphenicol sensitivity and 
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their resistance implied no resolution, which agreed with 
the previous result from pES271/630∆erm/No.8 – pES288 
transconjugants that further sub-streaking may be required 
to increase resolution. Therefore, any subsequent 
resolution screening tests were performed after 
subculturing putative pES288 transconjugants at least once, 
i.e. after enrichment for a resolved population. Following 
this reasoning, putative transconjugants were streaked 
twice on AIMSErm10 (sub1 and sub2) and colonies from each 
subculture were screened for thiamphenicol sensitivity, 
indicative of resolution. Screening for thiamphenicol 
sensitive strains from AIMSErm10 (sub1) resulted in 33.3% 
resolved colonies (10 sensitive colonies from total 30 
screened) and screening of thiamphenicol sensitivity from 
sub2 resulted in 11.8% resolved colonies (4 sensitive 
colonies from total 34 screened). From the second mating, 
13 putative transconjugants were obtained which were 
streaked on AIMSErm10 twice (sub1 & sub2). Screening for 
thiamphenicol sensitivity from sub1 gave 7% resolved 
colonies (9 sensitive colonies from total 135 screened) and 
from sub2 gave 11.9% resolved colonies (14 sensitive 
colonies from total 118 screened). All resolved strains 
obtained, were further tested to confirm reversion to wt or 
deletion of addBA genes (described below). 
 
Screening for double recombination events and confirmation of resolved 
wt or ∆addBA strains: 
It was anticipated that deletion of addBA genes would 
result in sensitivity to DNA damaging agents. This allowed 
the initial screening for putative deletion strains via 
metronidazole sensitivity. All resolved strains isolated 
above, together with wt 630∆erm and the merodiploid 
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pES271/630∆erm/No.11 strain were streaked on AIMS 
containing metronidazole at 0.5 μg/ml (AIMSMZ0.5). This 
resulted in the identification of two metronidazole 
sensitive strains, each isolated from the two independent 
matings. The efficiency of obtaining an addBA deletion 
strain was 7% in the first occasion and 4.3% in the second. 
To investigate whether the phenotype of metronidazole 
sensitivity of the strains was due to resolution and 
deletion of addBA, the next step involved screening of the 
strains via PCR. Chromosomal DNA extracted from all 
isolated thiamphenicol sensitive strains and genomic DNA 
from wt 630∆erm, was used as template for the amplification 
of the addBA region by PCR using primers SphI_addBA1 and 
SphI_addBA4. The addBA deletion cassette (~1 kb) was 
amplified from the two metronidazole sensitive strains, 
while the wt addBA region (~8.2 kb) was amplified from the 
wt 630∆erm and from the thiamphenicol sensitive but 
metronidazole resistant strains (FIG 3.13). This result 
confirmed the isolation of strains that resolved to wt and 
two resolved addBA deletion strains, from two independent 
events, which were named ∆addBA 24 and ∆addBA 242. To 
provide further confirmation of the genotype of the ∆addBA 
strains, the addBA deletion cassette PCR products from 
above were sequenced. The data confirmed that the addBA 
deletion cassette, that replaced the wt allele in ∆addBA 24 
and ∆addBA 242, and the cross-over point between the two 




FIG 3.13  Schematic diagram and agarose gel image analysis for screening of second 
cross-over recombination event 
A] Upon introduction of pES288 into the merodiploid, expressed I-SceI 
creates a DSB resulting in a second recombination event and resolution 
to wild type (1) or addBA deletion strain (2). Solid line represents 
plasmid sequence. Dashed line represents chromosomal sequence. Primers 
SphI_addBA1 and SphI_addBA4 were used to screen for a second cross-over 
event via the amplification of an 8 kb or 1 kb PCR product confirming 
resolution to wt or addBA deletion strain, respectively. Gel image 
represents the amplification by PCR of the wt addBA gene from wt 
strains or the addBA deletion cassette from the deletion strains. Gel 
lane 1 and 2 correspond to 1 kb ladder and primers control PCR, 
respectively. Lanes 3, 5 and 6 correspond to the amplification of addBA 
84 
 
deletion cassette from pES271, ∆addBA 24 and ∆addBA 242, respectively. 
Lanes 4 and 7 correspond to amplification of wt addBA genes from C. 
difficile 630∆erm and resolved wt R20, respectively. B] A partial 
sequence alignment is shown of the sequenced addBA deletion cassettes 
amplified from ∆addBA 24 and ∆addBA 242 above with the sequenced addBA 
deletion cassette from pES271. The sequences show the joining point 




Confirmation of construction of addBA deletion strain due to I-SceI: 
The next step towards the validation of the I-SceI genetic 
system was to confirm that the isolation of the addBA 
deletion strains was due to I-SceI induced DSB repair and 
not due to rare spontaneous second cross-over event. To 
test this, the shuttle vector pMTL82254 from which pES288 
was made, was conjugated into the merodiploid 
pES271/630∆erm/No.11 via stationary mating. Forty of the 
transconjugants obtained were streaked on AIMErm10 (sub 1) 
and in total 80 colonies (two from each sub 1 culture) were 
screened for thiamphenicol sensitivity. Subsequently, ten 
randomly selected transconjugants from sub 1 were further 
subcultured on AIMErm10 (sub 2) and eight colonies from 
each sub 2 culture were screened for thiamphenicol 
sensitivity. All colonies screened were thiamphenicol 
resistant, which indicated that no resolution had occurred. 
This result was in contrast to the resolution observed 
following the introduction of pES288 into merodiploid 
pES271/630∆erm/No.11. It was therefore concluded that, 
resolution was not due to spontaneous secondary 






3.2.3: The function of AddAB in C. difficile 
 
Sporulation and toxin production: 
In C. difficile infection, as mentioned, sporulation is the 
aetiologic agent and toxins are well-established virulence 
determinants. Therefore, sporulation and toxin production 
were measured in the ∆addBA strains, the wt 630∆erm and the 
resolved wt R20 (generated from resolution of 
pES271/630∆erm/No.11 from the first mating above).  
 
Spore measurement: 
To compare sporulation characteristics between the strains 
wt 630∆erm, ∆addBA 24, ∆addBA 242 and resolved wt R20, the 
development of heat resistant spores was measured over a 
five day period at 24-h intervals, during which time the 
growth (OD600) and viability of non-heat-treated samples 
were also measured. To determine heat resistant and 
untreated viable cfu/ml counts, samples were plated onto 
AIM agar supplemented with 0.1% sodium taurocholate(AIMTA), 
which had been previously shown to enhance C. difficile 
spore recovery when used in rich medium (Burns et al., 
2010; Wilson et al., 1982). The data from the heat-treated 
cfu/ml counts (FIG 3.14) showed that all strains, except wt 
630∆erm, displayed a similar sporulation pattern through 
the 120-h period with an increase in spore numbers until 
24-h and a slower increase thereafter. In contrast, the wt 
630∆erm strain yielded sporulation numbers at 72-h similar 
to those produced at 24-h by the other strains (at 24-h 
630∆erm produced 100-fold less spores in comparison to the 
rest), but showed a steady gradual increase in heat 
resistant spore development throughout the assay period, 
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reaching final numbers similar to ∆addBA 24 and ∆addBA 242 
at 120-h.  The wt strain R20 yielded an average of 10-fold 
more heat resistant spores at 0-h but the final spore yield 
at 120-h was an average of 10-fold lower than the rest of 
the strains. In addition, the data from the non-heat-
treated cfu/ml counts showed that all strains had similar 
CFU and viability patterns through the 120-h period, with 
an increase in viable CFU until 48-h at which time numbers 
peaked and decreased thereafter (FIG 3.14). The strain 
∆addBA 24 showed slightly lower viability at 48-h, but a 
triplicate experiment from another occasion resulted in 
similar CFU at 48-h to the rest of the strains, suggesting 
an erroneous result. The measurement of growth by OD600 
showed the same pattern in all strains, with a maximum 
optical density at 24-h and a decline in growth thereafter 
(FIG 3.14). There was little difference in growth 
measurement between the strains during the sporulation 
experiment, although, ∆addBA 24 and ∆addBA 242 displayed 

















        0 24 48 72 96 120 
630∆erm 1.04 x 106 1.73 x 106 8.66 x 106 2.89 x 106 2.71 x 106 1.46 x 106 
∆addBA 24 4.53 x 105 1.27 x 106 2.44 x 106 2.33 x 106 3.09 x 106 8.48 x 105 
∆addBA242 5.52 x 105 1.04 x 106 5.16 x 106 2.73 x 106 2.63 x 106 1.24 x 106 




































630∆erm ∆addBA 24 ∆addBA242 R20
Heated 
cfu/ml 
        0 24 48 72 96 120 
630∆erm 1.67 x 101 1.64 x 102 9.62 x 103 4.03 x 104 1.36 x 105 2.97 x 105 
∆addBA 24 5.87 x 101 5.81 x 104 4.07 x 104 9.62 x 104 9.12 x 104 1.22 x 105 
∆addBA242 4.17 x 101 3.01 x 104 5.73 x 104 1.67 x 105 1.73 x 105 1.82 x 105 








        0 24 48 72 96 120 
630∆erm 0.006 1.297 0.912 0.374 0.294 0.262 
∆addBA 24 0.008 1.024 0.841 0.582 0.352 0.302 
∆addBA242 0.010 1.069 0.849 0.584 0.377 0.318 
R20 0.010 1.272 0.976 0.544 0.286 0.245 
 
 
FIG 3.14  Sporulation assay of C. difficile strains 630∆erm, ∆addBA 24, ∆addBA 242 and 
R20 over a five day period 
The development of heat resistant spores of C. difficile strains 
630∆erm, ∆addBA 24, ∆addBA 242 and R20 was measured over five days. 
Sporulation cultures were incubated anaerobically at 37 oC in AIM broth 
and at 24-h intervals the colony forming units per millimetre (cfu/ml) 
of (A) untreated and (B) heat-treated samples were determined on AIMTA 
agar medium (AIM supplemented with 0.1 % sodium taurocholate) after 48-
h anaerobic incubation period. The (C) growth of the same samples was 
also measured over five days at 24-h intervals. The graphs and 
accompanying tables represent the averages of three experiments and the 
error bars indicate the standard error of the means. At the end of the 
experiment all strains tested were confirmed for their genotype, 



















630∆erm ∆addBA 24 ∆addBA242 R20
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In addition, other sporulation measurement experiments 
revealed an over-sporulating phenotype at 48-h for the 
merodiploid pES271/630∆erm/No.11 strain and derivatives, 
including ∆addBA 24 and ∆addBA 242 and resolved wt strains 
R20 and R215 (generated from resolution of 
pES271/630∆erm/No.11 from the second mating) compared to wt 
630∆erm and other pES271/630∆erm merodiploids (FIG 3.15). 
Therefore, in subsequent experiments, particularly those 
measuring UV and metronidazole sensitivity and SOS 
response, cultures were maintained in exponential growth 
with the presence of a minimum number of spores. As a 





FIG 3.15  Sporulation of merodiploid pES271/630∆erm/No.11 and derivatives 
Sporulation cultures were started by inoculation of 10 ml AIM broths 
with a single colony of each strain. At 48-h incubation period, 0.5 ml 
of each culture were incubated at 65 oC for 25 min, diluted in 1 x PBS 
and then 10 μl of each was spotted onto AIMTA agar medium. The image 
shows heat resistant colonies of each strain after 48-h incubation 
period. Strains C. difficile 630∆erm (1), merodiploid 
pES271/630∆erm/No.1 (7), merodiploid pES271/630∆erm/No.8 (8) and 
merodiploid pES271/630∆erm/No.10 (9) have similar sporulation 
phenotype. In contrast, merodiploid pES271/630∆erm/No.11 (2) and 
derivatives including; ∆addBA 24 (3), ∆addBA 242 (4) and resolved wt 
strains R20 (5) and R215 (6) overproduce heat resistant spores at 48-h 




Total toxin (A+B) production was measured from cultures of 
an optical density OD600 of ~0.5, ~0.8 and ~1 (FIG 3.16). 
Both addBA deletion strains showed a 2-3- fold higher toxin 
production compared to wt strains taken from different 
growth stages. Total toxin (A+B) was measured once in these 
strains and further measurements are required to confirm 









Total toxin A+B (OD450) control values: 
positive control: 1.683  
negative control: 0.047 
 
FIG 3.16  Total toxin production in C. difficile strains 630∆erm, ∆addBA 24, ∆addBA 242 
and R20 
Total toxin production (A+B) in C. difficile strains 630∆erm, ∆addBA 
24, ∆addBA 242 and R20 was measured from culture supernatants at 
optical densities OD600 of around 0.5, 0.6 and 1. The bars and 
accompanying table indicate the result of one experiment. In this 
experiment the addBA deletion strains yielded 2-3 fold higher combined 
toxin titre compared to both wt strains. 
SAMPLE OPTICAL DENSITY (OD600) TOXIN A+B (OD450)
630∆erm 0.593 0.059
R20 0.584 0.057
∆addBA  24 0.54 0.108
∆addBA  242 0.585 0.119
630∆erm 0.877 0.08
R20 0.855 0.058
∆addBA  24 0.773 0.214
∆addBA  242 0.804 0.224
630∆erm 1.452 1.071
R20 1.368 1.735
∆addBA  24 1.008 3.07
∆addBA  242 1.104 3.633
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Growth measurement and colony morphology: 
It was predicted that deletion of addBA genes in C. 
difficile would result in a growth defect (i.e. reduced 
growth rate and small colony morphology) due to the 
requirement to repair DSBs that occur during normal cell 
growth (Dillingham and Kowalczykowski, 2008; Kuzminov, 
1999). The growth of 630∆erm, ∆addBA 24, ∆addBA 242 and 
resolved wt R20 was measured in triplicate for 10-h at 1-h 
intervals (FIG 3.17). All strains had similar growth rates 
with doubling times of 40 min for both wt strains and 45 
min for both ∆addBA strains. It was also noted that the wt 
strains had shorter lag phases in comparison to the 
deletion strains. From the average optical density data 
obtained, it was shown that the wt strains reached an OD600 
of around 1 in 7-h, while the ∆addBA strains reached this 
density in 10-h of incubation. Additionally, all strains 











FIG 3.17  Growth curves of C. difficile strains 630∆erm, ∆addBA 24, ∆addBA 242 and R20 
The growth of C. difficile strains 630∆erm, ∆addBA 24, ∆addBA 242 and 
R20 was measured over 10 hours at 1-h intervals. Combined growth curves 
of all strains with accompanying table are shown. All strains had 
similar doubling time of 40 min and 45 min for wt and addBA deletion 
strains, respectively. The graph and accompanying table represent the 
averages of three experiments and the error bars indicate the standard 


















Growth of 630∆erm, ∆addBA 24, ∆addBA 242, R20 
630∆erm ∆addBA 24 ∆addBA 242 R20
0 hr 1 hr 2 hr 3 hr 4 hr 5 hr  6 hr 7 hr 8 hr 9 hr 10 hr 
630∆erm 0.013 0.026 0.075 0.22 0.426 0.744 0.877 1.041 1.09 1.148 1.208
∆addBA 24 0.012 0.02 0.049 0.143 0.293 0.607 0.728 0.835 0.908 0.982 1.037
∆addBA 242 0.012 0.02 0.051 0.148 0.3 0.622 0.731 0.842 0.924 0.989 1.057





Sensitivity to DNA damaging agents: 
 
UV sensitivity: 
Previous studies have shown that DNA damage caused by UV 
irradiation can eventually lead to double-strand breaks as 
a result of attempts to repair UV-induced photoproducts via 
nucleotide excision repair (Bonura and Smith, 1975; Wang 
and Smith, 1983). It was therefore hypothesised that UV 
irradiation would greatly affect the viability of C. 
difficile ∆addBA strains due to lethality from accumulated 
unrepaired DSBs. To test this, exponential cultures of 
similar optical density (OD600=~0.3) of wt 630∆erm, ∆addBA 
24, ∆addBA 242 and wt R20 were diluted and spotted onto AIM 
agar followed by irradiation with UV at 10, 15 or 20 J/m
2
. 
To compare survival from UV irradiation, non-UV irradiated 
cultures (No UV) were carried through the experiment. This 
experiment was performed in triplicate and a representative 
example is shown (FIG 3.18). In the absence of UV 
irradiation all strains showed similar viability. However, 
there was a 3 log10 to more than a 4 log10 reduction in cell 
survival of the UV irradiated ∆addBA strains (3 log10 at 10 
J/m
2
 and ≥ 4 log10 at 15 and 20 J/m
2
). UV irradiation had 
very little effect on the survival of the wt strains (1 






FIG 3.18  UV sensitivity assay of C. difficile strains 630∆erm, ∆addBA 24, ∆addBA 242 and 
R20 
Exponential cultures (OD600 of ~0.3) of C. difficile strains 630∆erm, 
∆addBA 24, ∆addBA 242 and R20 were serially diluted and 5 μl of each 
was spotted onto AIM agar medium. Replica plates were made which were 
either irradiated with UV at 10, 15 or 20 J/m2 or not exposed to UV 
irradiation. The results were taken after a 48-h incubation period. 
Representative photos are shown from a triplicate experiment. UV 
irradiated plates show that the addBA deletion strains are more 
sensitive to UV in comparison to wt strains as all strains show similar 




The mode of action of metronidazole is not fully understood 
but it is believed to cause chromosomal fragmentation 
including single- and double-strand breaks (Dachs et al., 
1995; Lofmark et al., 2010; Sisson et al., 2000; Steffens 
et al., 2010). It was therefore expected that deletion of 
addBA genes in C. difficile would lead to enhanced 
sensitivity to metronidazole. To test this, exponential 
cultures of similar optical density (OD600=~0.3)of wt 
630∆erm, ∆addBA 24, ∆addBA 242 and wt R20 were spotted onto 
AIM agar containing either no metronidazole, or different 
concentrations of metronidazole including 0.25 μg/ml, 0.125 
μg/ml  and 0.06 μg/ml. This experiment was performed in 
triplicate and a representative example is shown (FIG 
3.19). Deletion of addBA genes in C. difficile resulted in 
increased sensitivity to all metronidazole concentrations 
tested, compared to the wt strains. Survival of the ∆addBA 
strains was reduced by 4 log10 at MZ 0.06 μg/ml, by 5 log10 
at MZ 0.125 μg/ml and resulted to total death at MZ 0.25 
μg/ml, compared to the survival of the population without 
exposure to metronidazole. In contrast, there was no effect 
on the survival of the wt strains at MZ 0.06 μg/ml, there 
was a 3 log10 survival reduction at MZ 0.125 μg/ml and more 
than 4 log10 reduction at MZ 0.25 μg/ml, compared to the 




FIG 3.19  Metronidazole sensitivity assay of C. difficile strains 630∆erm, ∆addBA 24, 
∆addBA 242 and R20 
Exponential cultures (OD600 of ~0.3) of C. difficile strains 630∆erm, 
∆addBA 24, ∆addBA 242 and R20 were serially diluted and 5 μl of each 
was spotted onto AIM agar medium containing varying concentrations of 
metronidazole including 0.06 μg/ml, 0.125 μg/ml, 0.25 μg/ml or no 
metronidazole. The results were taken after a 48-h incubation period. 
Representative photos are shown from a triplicate experiment. The addBA 
deletion strains were more sensitive to metronidazole compared to the 
wt strains.  
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Tests to complement the sensitivity phenotype of ∆addBA 
strains to DNA damaging agents were not possible, as 
multiple attempts to construct a complementation vector 
were unsuccessful, possibly due to the size of the required 
insert.  
 
SOS response and addBA genes in C. difficile:  
In most bacteria, an SOS response is induced when cells are 
treated with DNA damaging agents (Fernandez De Henestrosa 
et al., 2000; O'Reilly and Kreuzer, 2004). To explore 
whether C. difficile has an SOS response system and whether 
addBA genes are involved, cells were treated with 
metronidazole. A filamenting phenotype is indicative of an 
SOS response considering that during an SOS response cell 
division is inhibited to allow cells to repair DNA damage 
(Dajkovic et al., 2008; Hill et al., 1997; Huisman et al., 
1984). In addition, in E. coli RecBCD is required for SOS 
induction because it is responsible for the formation of 
the RecA/ssDNA filament and subsequent autodigestion of 
LexA repressor allowing transcription of SOS genes (Janion, 
2008; Michel, 2005). Taking this into consideration and in 
keeping with the results above, it was expected that in the 
presence of metronidazole the wt strains, if capable of SOS 
response, would filament while the addBA deletion strains 
would show a non-filamenting lethal phenotype. Exposure of 
exponential cultures of 630∆erm, ∆addBA 24, ∆addBA 242 and 
R20 to metronidazole resulted in the filamentation of cells 
compared to the cell morphology of non-exposed cultures 
(FIG 3.20). The wt strains showed long filaments at higher 
metronidazole concentrations of 0.25 μg/ml and 0.125 μg/ml 
while filamented cells were rare and shorter in length at 
0.06 μg/ml. The addBA deletion strains showed long 
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filaments at metronidazole concentrations of 0.06 μg/ml and 
0.125 μg/ml while the 0.25 μg/ml concentration was lethal, 
which is also indicated by the OD600 measurements taken at 
24-h (T24 average No MZ OD600= 1.548 & MZ 0.25 μg/ml OD600= 
0.006)which also correlates with the metronidazole spot 
testing (FIG 3.19). Also, filaments from the wt and 
deletion strains were more wavy shaped at MZ 0.025 μg/ml 
and 0.0125 μg/ml, respectively, compared to other 
concentrations suggesting a direct or indirect effect of MZ 
on peptidoglycan.  
 
T4 OD600 630∆erm  ∆addBA 24 ∆addBA 242 R20 
No MZ 0.414 0.351 0.358 0.443 
MZ 0.25 0.024 0.013 0.013 0.04 
MZ 0.125 0.146 0.049 0.05 0.168 






T6 OD600 630∆erm ∆addBA 24 ∆addBA 242 R20 
No MZ 0.735 0.656 0.659 0.752 
MZ 0.25 0.033 0.015 0.014 0.059 
MZ 0.125 0.402 0.055 0.053 0.435 
MZ 0.06 0.624 0.165 0.159 0.647 
 
FIG 3.20  Morphology of C. difficile strains 630∆erm, ∆addBA 24, ∆addBA 242 and R20 
cells in the presence of metronidazole at 4 and 6 hours of SOS induction 
Exponential cultures (OD600 of ~0.3) of C. difficile strains 630∆erm, 
∆addBA 24, ∆addBA 242 and R20 were diluted at 1:100 into AIM broths 
without metronidazole or with metronidazole at a concentration of 0.06 
μg/ml, 0.125 μg/ml or 0.25 μg/ml. The optical density was measured at 
inoculation time T0. At T4 (A) and T6 (B) hours of incubation, the 
optical density was measured and the morphology of fixed cells was 
visualised by wet mount microscopy. Representative photomicrographs are 
shown from triplicate experiments. The wt strains showed filamenting 
cell morphology at metronidazole concentrations of 0.125 μg/ml and 0.25 
μg/ml with a wavy phenotype particularly at 0.25 μg/ml. The addBA 
deletion strains showed filamenting cell morphology at metronidazole 
concentrations of 0.06 μg/ml and 0.125 μg/ml with a wavy phenotype 




strains at 0.25 μg/ml showed fewer cells due to reduced survival which 
agreed with the optical density recorded in the tables above. Samples 
that had not been subjected to metronidazole showed normal morphology. 




To confirm that the filamenting cells of wt 630∆erm had one 
division septum, samples from time point T6 (6-h after MZ 
addition) from cultures containing MZ 0.125 μg/ml or 
without MZ, were stained with the lipophilic membrane dye 
FM4-64.  Fluorescence microscopy of FM4-64 stained cells 
showed the presence of one septum in induced and non-
induced wt 630∆erm cells but unexpectedly, it has also 
showed the presence of bright foci (FIG 3.21). In most 
cells that had not been exposed to metronidazole there were 
usually two bright foci, one on each side of the septum. 
Similarly, filamenting cells had either bright spots on 
each side of the septum or multiple less bright spots 
throughout the cytoplasm. However, due to the shape of the 
filamenting cells microscope focusing was not ideal and 
possibly the use of confocal microscopy would be more 
informative. The nature of these foci is not clear. They 
could simply be an artefact of the experimental procure 
used or alternatively, considering FM4-64 stains lipids, 






























FIG 3.21  Septal ring in C. difficile 630∆erm in the absence and presence of metronidazole 
Representative photomicrograph from fluorescence microscopy of FM4-64 
stained C. difficile 630∆erm in the absence of metronidazole (A) and in 
the presence of metronidazole at 0.125 μg/ml (B) at T6 of the SOS 
induction experiment. Blue arrows point to the septal ring. Also, note 












Development of C. difficile markerless I-SceI genetic system: 
C. difficile is known to be notoriously resistant to 
genetic manipulation. In addition, C. difficile is a 
multidrug resistant organism and particularly 630∆erm 
strain which is the most widely used lab strain. This poses 
a limitation in the use of antibiotic resistance markers 
for the manipulation of this organism. Most developed 
methods (including the most widely used ClosTron system) of 
C. difficile, result in the interruption of the target gene 
via the integration of an antibiotic resistance marker or a 
whole plasmid carrying antibiotic resistance, which in 
addition to a possible polar effect on neighbouring genes, 
can prevent multiple manipulations of the genome. This 
study has described the development of a novel genetic 
system for C. difficile to create targeted, precise, 
markerless chromosomal deletions using the meganuclease I-
SceI. For validation of this system, the addBA genes in C. 
difficile 630∆erm were deleted. The method developed here, 
results in the deletion of target genes without any foreign 
DNA remaining in the host genome, including resistance 
genes. The system requires the use of two plasmids; one 
that carries the recognition site of I-SceI (I-SceI site 
delivery vector), into which the deletion cassette is 
inserted (allele replacement vector) for single cross-over 
integration, and one that expresses the I-SceI (I-SceI 
expression vector) under an appropriate promoter 
(ferredoxin promoter, Pfdx) to stimulate a double cross-
over via DSB repair. Here, the I-SceI recognition vectors 
pES185 or pES2761 carry a thiamphenicol resistance marker 
and the I-SceI expression vector pES288 constitutively 
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expresses I-SceI and carries an erythromycin resistance 
gene in its backbone. With the use of this system, the 
deletion of a target gene is identified by; 1) the loss of 
thiamphenicol resistance resulting from deletion of the 
integrated plasmid after DSB and resolution, 2) the PCR 
amplification of the deletion cassette (~1 kb) that 
replaces the wt allele and 3) by confirming the new 
sequence joints. In theory, the system could be used to 
delete genes in other C. difficile strains of interest, 
however, the genome sequence is required to aid the design 
of primers for the precise targeted chromosomal deletion 
and provided the strain is sensitive to erythromycin and 
thiamphenicol. In the case of the hypervirulent C. 
difficile R20291 (027) the erythromycin resistance marker 
ermB present in pES288 would confer resistance to 
lincomycin at 20 μg/ml (Heap et al., 2009). It should be 
noted that, the transfer of plasmids into BI/NAP1/027 
strains relying on RP4-mediated conjugation from E. coli, 
was reported to be unsuccessful, although, the reported 
efficiency of RP4-mediated plasmid transfer in C. difficile 









, respectively (Carter et al., 2011; O'Connor et 
al., 2006; Mullany et al., 1990). In this study multiple 
attempts were required to transfer pES271 into C. difficile 
630∆erm, with only one transconjugant obtained. In 
addition, O’ Connor et al. (2006), reported that ‘some 
difficulty was experienced’ in the introduction of pJIR2816 
(similar to pJIR1456 from which pES271 was generated) into 
C. difficile. 
With the genetic system constructed in this study, any gene 
can be deleted, irrespective of size. In contrast, a 
limitation of genetic systems based on the TargeTron 
technology might have, is that DNA sequences less that 400 
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bp may not contain target sites for mobile group II intron 
recognition (TargeTron user guide, Sigma-Aldrich). 
The low resolution rate and the increasing resolution 
percentage with sub-streaking of co-integrates in the 
presence of pES288, suggested that a low I-SceI 
concentration was present in cells. The effect of I-SceI 
levels on resolution has been previously demonstrated by 
Posfai et al. (1999). These authors showed that in E. coli 
stimulation of intramolecular recombination by I-SceI is 
dependent on the concentration of I-SceI in the cell and 
how long I-SceI is allowed to exert its effect (Posfai et 
al., 1999). It was shown that for a 3.4 kb deletion, when 
high I-SceI levels were expressed in the cells, only 8-10% 
of potential transformants survived, but 100% resolution of 
the co-integrates was obtained. When a low I-SceI level was 
expressed, 100% of potential transformants survived but a 
mixed population of resolved and unresolved strains was 
obtained and colonies had to be restreaked to increase 
resolution (> 90%). When extremely low I-SceI levels were 
expressed in the cell, for the same deletion, growth of up 
to 60 generations was required to achieve resolution close 
to 100% (Posfai et al., 1999). If, in the current study, 
the constitutive expression of I-SceI is considered, it 
might be expected that a high concentration of I-SceI was 
present and a high resolution rate should be observed. 
However, the low resolution rate observed may suggest 
inefficient translation of I-SceI or instability of 
messenger RNA or protein. Despite this, it was confirmed 
that the resolution observed was due to I-SceI expression 
and not due to spontaneous recombination. The efficiency of 
obtaining a ∆addBA was an average of 5.7%. This rare 
isolation of ∆addBA strains may have been attributed to the 
moderately large size (7.2 kb) of the targeted deletion, 
107 
 
where reversion to wt is favoured with the efficiency of 
obtaining a deletion mutant decreasing with increasing size 
of deleted region (Posfai et al., 1999; Suzuki et al., 
2005).  
 
Function of AddAB in C. difficile: 
A further aspect of this study was to analyse the function 
of AddAB in C. difficile using the two isolated addBA 
deletion strains, the parental C. difficile 630∆erm and one 
resolved wt strain R20. Here, the sporulation-frequency, 
toxin production and growth were measured. Sensitivity to 
DNA damaging agents was determined and the involvement of 




The measurement of sporulation over a five day period 
showed that ∆addBA 24, ∆addBA 242 and wt R20 produce at 
least 100-fold more heat resistant spores at least 24-h 
earlier than the parental strain 630∆erm. This was not due 
to a difference in growth rate or due to a difference in 
viability, and this characteristic exists only in 
derivative strains of merodiploid pES271/630∆erm/No.11 
where integration occurred via the upstream region of addB 
gene.  An explanation for this phenomenon cannot be given 
at this point and perhaps chromosomal sequencing of these 
strains would shed light on any genomic alteration in these 
strains that provides them with such a phenotype. However, 
deletion of addBA did not affect sporulation since reduced 
numbers were not observed in the mutant strains when 
compared to wt R20, as one would expect for two reasons. 
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First, wet heat does not kill spores by DNA damage but 
instead it can damage spore proteins (Coleman et al., 2007; 
Zhang et al., 2010; Setlow, 2007). Secondly, the fact that 
spores have a single chromosome means that HR would not be 
used as the DSB repair pathway at spore germination, since 
this pathway requires a second homologous chromosome 
(Moeller et al., 2007). In B. subtilis, NHEJ is responsible 
for the DSB repair during spore germination (Moeller et 
al., 2007). Bioinformatic analysis of the C. difficile 
genome did not reveal a Ku homologue. In addition, it was 
noted from the heat-treated data that both addBA deletion 
strains displayed a 10-fold lower spore number compared to 
wt R20 at time 0-h of the sporulation assay. Considering 
that the amount of cells used to inoculate the sporulation 
culture at 0-h (according to OD600 measurement) and that 
viable CFU were similar between the strains, it is 
therefore suggested that either DNA damage inhibits and 
delays sporulation or that wt R20 simply sporulates more 
rapidly, even though this is not observed from 24-h 
onwards. Multiple studies have shown that DNA damage and 
disruption of DNA replication can delay sporulation, which 
might explain the presence of 10-fold reduced spore numbers 
of exponential cultures of addBA deletion strains, where an 
intact replicated chromosome may not be present to initiate 
sporulation (Bejerano-Sagie et al., 2006; Michael, 2001; 
Lemon et al., 2000; Burkholder et al., 2001; Ireton and 
Grossman, 1992; Ireton et al., 1993). 
 
Toxin production: 
Preliminary data for toxin measurement showed that both 
∆addBA strains produced 2-3 times more total toxin (A+B) 
compared to the wt strains at all cell growth stages. There 
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are no previous reports of increased toxin production due 
to loss of addAB genes in other organisms. Evidence 
suggests an association between toxin production and 
sporulation in C. difficile (Underwood et al., 2009; 
Karlsson et al., 2008; Akerlund et al., 2006; Kamiya et 
al., 1992). Although, the resolved wt R20 strain and both 
deletion mutant strains have an altered sporulation 
phenotype, the wt R20 does not produce more total toxin 
compared to the parental strain. It is unclear thus, at the 
moment, why increased toxin production in the mutant 
strains is observed. However, these tests need to be 
repeated. 
 
Growth measurement and Viability: 
Deletion of addBA in C. difficile had little effect on the 
exponential phase of bacterial growth and there was not a 
defect in colony formation. This was in contrast to our 
expectation, taking into account the importance of 
RecBCD/AddAB complexes during normal cell growth (e.g. DNA 
replication, replication fork stalling/collapse etc.). 
Previous studies have shown reduced growth rate and 





 had generation time increased by 16 min, 
rexA and rexB mutants of S. pneumoniae were severely 
impaired for growth and B. fragilis ∆addAB had increased 
doubling time by 31 min and impaired colony growth (Capaldo 
et al., 1974; Halpern et al., 2004; Parry, 2010). It may be 
suggested that in C. difficile replication does not stop as 
frequently during exponential growth. It was noted that the 
mutant strains displayed a longer lag time. This 
observation may suggest a requirement for AddAB for DNA 
maintenance during stationary phase, as recently 
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demonstrated in E. coli for the RecBCD counterpart, and 
this may be reflected in the starting inoculum population, 
or it may be accumulated DNA damage that has to be repaired 
before exponential growth commences (Williams et al., 
2011). 
In the absence of exogenous DNA damaging agent (e.g. UV or 
MZ), both addBA deletion strains showed similar viability 
to the wt strains. This also agreed with the viability 
measurement over 120-h period during the sporulation assay. 
The viability of the addBA mutant strains observed here is 
in contrast to multiple studies that report reduced 
viability of addAB/recBCD mutants in other species. Reduced 
survival in these studies may mostly reflect cells where 
DSBs occurred from disrupted replication forks that were 
not repaired and did not complete replication. For example, 
viability of E. coli recB recC mutant is reduced by 73%, S. 
pneumoniae rexA and rexB mutants by 80%, B. subtilis addB 
mutant by 50% and B. fragilis ∆addAB has 1-2 log10 reduction 
in viable cells (Dillingham and Kowalczykowski, 2008; 
Capaldo et al., 1974; Halpern et al., 2004; Sciochetti et 
al., 2001; Parry, 2010).  
The fact that the deletion of addBA in C. difficile has not 
significantly affected the growth and viability of C. 
difficile suggests that, in contrast to the E. coli 
paradigm, the replication fork does not stop as frequently 
or if a replication fork stops, a regressed fork is not 
formed or is processed by an enzyme other than AddAB.  
 
Sensitivity to DNA damaging agents: 
The deletion of addBA in C. difficile resulted in reduced 
survival when exposed to agents known to produce DSBs 
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indirectly or directly, such as UV radiation or MZ (Bonura 
and Smith, 1975; Dachs et al., 1995; Steffens et al., 
2010). This confirmed our expectation that in C. difficile 
the AddAB complex is required for the repair of DSB 
produced by these DNA damaging agents. Similarly, for 
example, E. coli ∆recBCD, Pseudomonas syringae ∆recCBD, 
Bacteroides fragilis ∆addAB and Streptococcus pneumoniae 
rexAB mutants are sensitive to UV irradiation (Reuter et 
al., 2010; Halpern et al., 2004; Pavankumar et al., 2010). 
Moreover, B. fragilis ∆addAB shows increased sensitivity to 
MZ compared to wt (Parry, 2010). Other examples of recBCD 
or addAB mutants with increased sensitivity to antibiotics 
known to lead to DSBs include H. pylori addB and addA 
mutants with increased sensitivity to mitocycin C and 
ciprofloxacin, E. coli recD mutant and P. syringae ∆recCBD 
strains with mitomycin C sensitivity (Amundsen et al., 
2000; Amundsen et al., 2008; Pavankumar et al., 2010).  
 
SOS response:  
The presence of an SOS system in C. difficile had not 
previously been reported in the literature, so the 
involvement of the AddAB complex was investigated by the 
exposure of cells to metronidazole. During the SOS response 
cell division is inhibited, for example by SfiA in E. coli 
and by YneA in B. subtilis, resulting in a filamenting cell 
morphology reflecting the continuation of cell growth in 
the absence of cell division (Mo and Burkholder, 2010; 
Huisman et al., 1984). Therefore, the filamenting 
morphology in the presence of metronidazole indicated an 
SOS induction in all strains including the addBA deletion 
strains. FM4-64 staining confirmed that these were indeed 
elongated cells with one septum. These data lead to the 
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conclusion that AddAB is not necessary for induction of the 
SOS response in C. difficile and another exonuclease is 
generating ssDNA. In B. subtilis the SOS response is 
strongly reduced in addAB mutant cells and not abolished as 
in recA cells (Kidane et al., 2004; Sanchez et al., 2006). 
In this organism two end processing avenues have been shown 
to operate, the AddAB- and the RecJ-dependant, both equally 
contributing to the generation of 3’-tailed duplex DNA 
required for RecA filament formation (Sanchez et al., 2006; 
Kidane and Graumann, 2005). The deletion of recJ in B. 
subtilis addAB mutant cells resulted in a strong 
synergistic effect where the double mutants were as 
sensitive to DSBs as recA mutant cells (Sanchez et al., 
2006).   
To summarise, this study has demonstrated the development 
of a new genetic system for the construction of markerless 
deletions in C. difficile, using addBA as an example. The 
use of the I-sceI meganuclease in the system increases 
intramolecular recombination and without this protein 
resolution is not observed. The next step in development 
involved the construction of different deletions and a 
strain with multiple deletions to prove reproducibility and 
robustness of the genetic system. In the C. difficile 
∆addBA mutants generated here, growth was reduced slightly, 
spore formation was unaffected and viability was not 
impaired in the absence of exogenous DNA damage. However, 
when DNA damage was imposed e.g. MZ, cell survival was 
reduced. This may lead to a new avenue for therapeutics to 
increase effectiveness of treatment i.e. a combination drug 
that causes DNA damage, particularly DSB, together with 




CHAPTER 4: Optimization of the I-SceI genetic system for the 
deletion of fliC, pilT and pilA genes and investigation of the type 




Aims and Objectives: 
 To construct a non-flagellated C. difficile strain, 
impaired in flagella-mediated motility. 
 To delete the type IV pilus-associated genes pilT and 
pilA in C. difficile. 
 To optimise the genetic system for the construction of 
the fliC, pilT and pilA deletions. 
 To characterise the deletion strains. 
 To investigate the intergenic region upstream of type 
IV pilus-associated genes in C. difficile. 
 
Background: 
Type IV pili (TFP) are unique appendages on the surface of 
non-pathogenic and pathogenic bacteria and are peritrichus 
or polarly located (Jarrell, 2009). They are extremely 
flexible, strong, thin (<8 nm in diameter) and ranging 
between 1000–2500 nm in length (Strom and Lory, 1993; Craig 
and Li, 2008). These surface structures are widespread 
across β-, γ- and δ- proteobacteria and cyanobacteria 
(Nudleman and Kaiser, 2004; Proft and Baker, 2009; Bhaya et 
al., 2000). They have been mostly found in Gram-negative 
114 
 
bacteria including enteropathogenic E. coli (EPEC), 
Salmonella enterica, Pseudomonas aeruginosa, Legionella 
pneumophila, Neisseria gonorrhoeae, Neisseria meningitidis 
and Vibrio cholerae (Proft and Baker, 2009). TFP have also 
been recently found in Gram-positive bacteria particularly 
Clostridium perfringens and Ruminococcus albus (Varga et 
al., 2006; Rakotoarivonina et al., 2002).  
TFP structure and function have been extensively studied in 
Neisseria and Pseudomonas species (particularly in P. 
aeruginosa) and in the soil bacterium Myxococcus xanthus 
(Burrows, 2012; Mignot and Kirby, 2008). FIG 4.1 shows a 
model of the TFP apparatus. The major structural subunit of 
TFP is a small (15-20 kDa) pilin protein called PilA in P. 
aeruginosa and PilE in Neisseria (Burrows, 2005; Proft and 
Baker, 2009). Pilins are arranged in a helical fashion but 
the number of subunits per turn has not been established 
(Burrows, 2005; Craig et al., 2004). The pilin subunits are 
extremely variable in sequence and length, but are 
conserved in the amino acid sequence in the N-terminal 
segment (Pelicic, 2008). Pilins are initially synthesized 
as prepilins, the leader sequence is cleaved and the N-
terminal amino acid created is methylated by a prepilin 
peptidase (PilD) resulting in a mature protein (Mattick, 
2002; Nudleman and Kaiser, 2004; Lory and Strom, 1997; 
Strom and Lory, 1993). Type IV pilins can be classified 
into two groups, Type IVa and Type IVb, based on the 
lengths of the leader peptide and the mature protein (Craig 
and Li, 2008; Pelicic, 2008; Proft and Baker, 2009; 
Burrows, 2012; Giltner et al., 2012). The Type IVa pilins 
are short, have short leader peptides, are relatively 
homogeneous and are found in a variety of bacteria with 
broad host ranges. The Type IVb pilins are more diverse, 
they are either short or long, they possess long leader 
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peptides and are commonly found on enteric pathogens. C. 
perfringens PilA2 has an intermediate length of both mature 
sequence and leader peptide and does not fall clearly into 
either class (Jarrell, 2009). Type IVb pilins are further 
divided into tight adherence pili (Tad or Flp) and are 
found in a variety of Gram-positive and Gram-negative 
species (Giltner et al., 2012; Burrows, 2012). Considering 
the absence of a narrow channel in the TFP fibre the pilus 
must therefore be assembled from its base (in contrast to 
flagella), and minor pilin-like proteins (in P. aeruginosa 
PilE, PilV, PilW, PilX, FimT and FimU) are involved in 
pilus assembly (Mattick, 2002; Nudleman and Kaiser, 2004; 
Burrows, 2005; Russell and Darzins, 1994; Alm and Mattick, 
1995, 1996; Winther-Larsen et al., 2005). Pilus 
assembly/extension (addition of pilin subunits to the base) 
and/or pilus disassembly/retraction (removal of pilin 
subunits from the base) is powered by ATP hydrolysis from 
two ATPases, PilB and PilT, which have opposing activities 
(Burrows, 2005; Mattick, 2002; Nudleman and Kaiser, 2004; 
Proft and Baker, 2009; Merz et al., 2000; Maier et al., 
2002; Herdendorf et al., 2002; Jakovljevic et al., 2008). 
PilB is responsible for pilus extension and PilT is 
responsible for pilus retraction. ATP hydrolysis by these 
proteins results in a piston-like movement of a cytoplasmic 
membrane protein (possibly PilC) which leads to the 
addition or removal of pilin subunits during extension and 
retraction, respectively (Jarrell and McBride, 2008; Craig 
et al., 2006). In Gram-negative organisms, the 
translocation of the pilus through the outer membrane is 
achieved via a large oligomeric pore made by the secretin 
PilQ which appears to be stabilized by the lipoprotein PilP 
(Jarrell, 2009; Mattick, 2002; Nudleman and Kaiser, 2004; 
Wall et al., 1999; Collins et al., 2001; Collins et al., 
2004; Drake and Koomey, 1995; Drake et al., 1997; Bitter et 
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al., 1998). In Gram-positive bacteria, including the 
Clostridia, the secretin PilQ and the associated 
lipoprotein PilP are absent (Jarrell and McBride, 2008; 
Jarrell, 2009; Varga et al., 2006). The tip of the pilus is 
thought to be involved in the attachment to surfaces, 
possibly via the primary pilin pilA and/or additional 
proteins such as PilC1 (in N. gonorrhoeae) and PilY1 (in P. 
aeruginosa) (Jarrell and McBride, 2008; Mattick, 2002; 






FIG 4.1  Model of the type IV pilus apparatus in a Gram-negative bacterium 
Pilins (PilA) are synthesised as prepilins and the prepilin leader 
sequence is cleaved and the N-terminal amino acid created is methylated 
by a prepilin peptidase (PilD) resulting in a mature protein. Pilus is 
assembled from its base and minor pilin-like proteins (in P. aeruginosa 
PilE, PilV, PilW, PilX, FimT and FimU) are involved in this. PilB is 
responsible for pilus extension and PilT is responsible of pilus 
retraction and ATP hydrolysis from these proteins results in a piston-
like movement of a cytoplasmic membrane protein (possibly PilC) which 
leads to the addition or removal of pilin subunits during extension and 
retraction, respectively. In Gram-negative bacteria the pilus is 
extruded through the outer membrane via PilQ, stabilized by PilP and 
both proteins are absent in Gram-positive bacteria. Attachment of the 
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pilus to surfaces is aided through the tip.  The image is adapted from 
(Mattick, 2002). 
 
TFP are involved in a wide range of functions in bacteria 
that are important to their survival and to their success 
as pathogens. These functions include adherence to 
biological (including other bacteria) and non-biological 
surfaces (including plastic, metal, glass etc.), DNA 
uptake, bacteriophage binding, cell aggregation, 
microcolony formation, biofilm production, fruiting body 
formation, host cell invasion, secretion of exoproteins and 
flagella-independent surface translocation (which is unique 
to TFP and has been called twitching motility) (Shi and 
Sun, 2002; Nudleman and Kaiser, 2004; Burrows, 2005; Craig 
and Li, 2008; Jarrell and McBride, 2008; Proft and Baker, 
2009; Filloux, 2010; Burrows, 2012; Giltner et al., 2012; 
Henrichsen, 1972). A lot of these functions are attributed 
to the retraction of the pilus in which PilT is involved 
(Burrows, 2012). Considering the importance of TFP as 
virulence factors and their surface location, these 
structures are important targets of potential vaccine 
development (Proft and Baker, 2009).   
Multiple TFP functions exemplify their importance in 
virulence and pathogenesis, some of which are described 
here. N. gonorrhoeae and N. meningitidis initiate 
colonisation of human mucosal surfaces by binding of their 
TFP, named GC/MC pili, to non-ciliated host cells and 
possibly the receptor for both pili is the human membrane 
cofactor protein CD46 (Swanson, 1973; Kallstrom et al., 
1997; Proft and Baker, 2009). N. meningitidis PilC1 and 
PilC2 adhere to the uropod of polymorphonuclear 
neutrophils, thus escaping phagocytosis and increasing 
their ability to spread at the epithelial cell layer 
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(Soderholm et al., 2011). N. meningitidis PilT is required 
for intimate attachment to epithelial cells and for 
attaching and effacing lesions (Pujol et al., 1999). In N. 
meningitidis the minor pilin PilX is essential for 
bacterial aggregation (Helaine et al., 2005). In N. 
gonorrhoeae TFP retraction in a PilT-dependent manner, can 
enhance activation of the nuclear factor NF-kB in infected 
cells and gonococcal microcolony formation (Dietrich et 
al., 2011). In P. aeruginosa, PilA binds to 
glycosphingolipid asialo-GM1 on epithelial cells and the 
importance of pili is demonstrated by the inability of non-
piliated strains to bind to human A549 type II 
pneumonocytes (Lee et al., 1994; Chi et al., 1991; Proft 
and Baker, 2009). P. aeruginosa PilT and PilU (homologue of 
PilT) are required for epithelial cell cytotoxicity and for 
full virulence in the mouse model of acute pneumonia 
(Comolli et al., 1999). Moreover,  P. aeruginosa  pilT and 
pilU mutants are hyperpiliated, defective in twitching 
motility and impaired in the corneal infection model, while 
the pilA mutant is non-piliated and impaired in its ability 
to invade corneal epithelial cells (Zolfaghar et al., 
2003).  Twitching-mediated biofilm structure and 
development is also affected in P. aeruginosa pilT and pilU 
mutants, while pilB and pilC mutants do not form 
microcolonies due to loss of twitching-mediated cell 
aggregation (Chiang and Burrows, 2003; O'Toole and Kolter, 
1998). In V. cholerae, the type IV toxin co-regulated pilus 
(TCP) is required for success of the pathogen during 
infection and TCP has multiple functions including: 
attachment to Caco-2 human intestinal epithelial cells; 
secretion of colonization factor TcpF; microcolony 
formation by mediating bacterium-bacterium interactions; 
and protection from the antimicrobial component of bile by 
engulfing the bacterium during infection (Kirn et al., 
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2003; Krebs and Taylor, 2011). In EPEC the TFP called the 
bundle-forming pilus (BFP) initiates adhesion with the 
intestinal epithelium and recruits EPEC cells into 
aggregates resulting in microcolonies. These bacterial 
aggregates can disaggregate and then disperse, which is 
facilitated by pilus retraction driven by BfpF (putative 
ATPase) (Bieber et al., 1998; Zahavi et al., 2011). BFP 
retraction is suggested to contribute to pathogenesis by 
bringing the bacterium to close proximity with the host 
cell, allowing prompt and efficient translocation of 
bacterial protein effectors through the type III secretion 
apparatus in the host cell, resulting in the disruption of 
the epithelial barrier and generation of actin-rich 
pedestals (Zahavi et al., 2011). Salmonella enterica 
serovar Typhi adheres to the intestinal tract by binding to 
the cellular receptor cystic fibrosis transmembrane 
conductance regulator (an epithelial chloride channel) via 
the TFP structural pilin, PilS. The pili are required for 
epithelial cell invasion (Balakrishna et al., 2009).  
In C. perfringens, PilT and PilC enable the bacterium to 
move on surfaces via gliding motility. Mutations introduced 
into the pilC and pilT genes abolish both surface 
localization of TFP and motility in this organism (Varga et 
al., 2006). The observation that the pilT mutation 
abolishes detectable TFP expression in C. perfringens is a 
critical difference with all other instances studied, as 
loss or absence of pilT usually leads to hyperpiliation 
(Jarrell, 2009). In contrast to the extensively studied 
paradigms of N. gonorrhoeae, P. aeruginosa and M. xanthus, 
pilT in C. perfringens may thus also be involved in pilus 
biogenesis in addition to pilus retraction (Jarrell, 2009). 
Moreover, TFP in C. perfirgens are required for efficient 
biofilm formation (Varga et al., 2008). Expression of C. 
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perfringens pilA2 in a non-piliated N. gonorrhoeae strains 
provides the organism with the ability to attach to mouse 
and rat myoblast cell lines, while a C. perfringens pilT 
mutant has reduced ability to adhere to mouse myoblasts 
under anaerobic conditions (Rodgers et al., 2011).  
In C. difficile, two TFP-associated loci (CD3294-CD3297 and 
CD3503-CD3513) are present in the genome and are conserved 
across many strains of human and animal origin, together 
with low DNA sequence divergence (Fig. 5, Janvilisri et 
al., 2009) this would suggest a function of importance to 
the organism (Sebaihia et al., 2006; Stabler et al., 2006; 
Janvilisri et al., 2009). These TFP loci contain genes 
predicted to encode pilin subunits, prepilin peptidases and 
proteins involved in TFP assembly. Previously, Borriello et 
al. (1988) demonstrated the presence of multiple polar 
fimbriae which were 4-9 nm in diameter and up to 6 μm long 
on the surface of 5 out 15 C. difficile strains examined 
(Borriello et al., 1988). A recent in vivo study of C. 
difficile 630 infection in the Golden Syrian hamster model 
found that high numbers of bacteria were present at the 
base of the crypts of the gut tissue, and were observed to 
interact with the gut microvillus via one pole of the 
bacterium. Pilus-like structures recognised by antisera 
against PilA (CD3507) were detected on the surface of 
bacterial cells, suggesting that pili may be expressed in 
the hamster model (Goulding et al., 2009).  In addition, 
Purcell et al. (2012) demonstrated that elevated levels of 
cyclic diguanylate (c-di-GMP) enhance aggregate formation 
in C. difficile and these aggregates were visibly bound by 
long, thin fibres (10 nm thick) which are consistent with 
the size of pili, although their composition is yet to be 
determined (Purcell et al., 2012). These authors 
hypothesized that c-di-GMP may upregulate production of 
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pili to enhance aggregation of C. difficile cells and 
biofilm formation, thus aiding in colonization by the 
pathogen (Purcell et al., 2012).  It is unknown at the 
moment when TFP is expressed, how TFP genes are regulated 
in this organism and whether it is important in the 
survival and infection of C. difficile.  
This study describes further optimisations of the ISce-I 
system generated in chapter 3. The system was used to 
delete the pilT (CD3505) and pilA (CD3507) genes in C. 
difficile, predicted to encode a protein involved in TFP 
retraction and for the type IV pilin subunit, respectively. 
To enable the study of potential twitching motility in C. 
difficile, a non-flagellated C. difficile strain was first 
constructed via deletion of the fliC gene. Furthermore, an 
intergenic region hypothesised to be involved in the 

















4.2.1: Optimization of the C. difficile I-SceI genetic system and construction 
of C. difficile ∆fliC  
 
Construction of a new I-SceI site delivery vector: 
Using the I-SceI site vectors pES185 and pES2761, that were 
generated in chapter 3, allele replacement vectors were 
constructed (not described here) to delete the fliC, pilT 
(CD3505) and pilA (CD3507) genes in C. difficile. However, 
multiple attempts to conjugate and integrate these vectors 
into C. difficile were unsuccessful (data not shown). 
Therefore, a new candidate plasmid was sought to generate 
an I-SceI site delivery vector. Recently, Heap et al. 
(2012) used the E. coli – Clostridium replicative, but 
segregationally unstable, shuttle plasmid pMTL83151 (i.e. 
the plasmid replicates at a rate slower than that of the 
host chromosome) to construct an integration vector for use 
in C. difficile (Heap et al., 2012; Heap et al., 2009). The 
plasmid pMTL83151 carries a thiamphenicol resistance 
marker, catP, for selection.  The authors observed that 
following introduction of an integration vector based on 
pMTL83151 into C. difficile 630∆erm, thiamphenicol 
selection resulted in two populations of cells with 
different growth rates; i) faster growing cells, that 
represented cells in which single cross-over occurred and 
ii) slower growing cells, that corresponded to cells in 
which the vector remained in a free replicative form. This 
growth difference was attributed to the segregational 
instability of the plasmid (due to the pCB102 replicon) in 
C. difficile 630 and was considered advantageous since 
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integrants could be enriched from a population of 
transconjugants by culturing on antibiotic containing 
medium twice. Therefore, the plasmid pMTL83151 was chosen 
to construct a new I-SceI site delivery vector. Using a 
construction strategy similar to that for the pES185 I-SceI 
site delivery vector (chapter 3), oligos ISceI_F_SacI and 
ISceI_R_SacI representing the I-SceI recognition site were 
phosphorylated at 5’ ends, annealed to each other and 
ligated into the SacI site of pMTL83151, generating the new 
I-SceI site delivery vector pES242 (FIG 4.2). The use of 
pES242 in the I-SceI genetic system would aid the selection 
for a single cross-over event via thiamphenicol resistance 
and the screening for a second cross-over event via the 







FIG 4.2  Schematic representation and agarose gel analysis of pES242 
A] Oligos ISceI_F_SacI and ISceI_R_SacI carrying the I-SceI recognition 
site  and SacI restriction site (underlined)were ligated into the SacI 
site of pMTL83151 generating pES242 (4511 bp). B] Restriction digest 
analysis of pES242. Lane 1 corresponds to 1 kb ladder. Lanes 2, 3, 4 
and 5 correspond to supercoiled pMTL83151, SacI digested pMTL83151, 
supercoiled pES242 and I-SceI digested pES242, respectively. The vector 
pES242 contains a Gram-positive replicon pCB102, a Gram-negative 
replicon ColE1, a conjugative transfer traJ gene and a catP 
thiamphenicol resistance marker. 
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Construction of C. difficile ∆fliC: 
C. difficile produces peritrichous flagella (17-22 nm in 
diameter consistent with the size on other enteric 
bacteria) that are uniformly distributed on the surface of 
the bacterium and allow swimming or swarming motility 
(Delmee et al., 1990; Vedantam et al., 2012). To 
investigate twitching motility and aid visualisation of 
type IV pilus surface production in C. difficile, a non-
flagellated bacterium was constructed. In the genome of C. 
difficile 630 two flagella-associated loci (CD0226-CD0240 
and CD0245-CD0271), separated by an intervening locus, are 
present with one of these loci CD0226-CD0240 containing the 
fliC gene (Stabler et al., 2009). The FliC protein is a 39 
kDa flagellin protein which is the major structural 
component of the flagellar filament (Tasteyre et al., 
2000). It was previously shown that interruption of this 
gene results in the loss of flagellum production and 
flagella-mediated motility (Twine et al., 2009; Dingle et 
al., 2011). To delete the fliC gene (FIG 4.3) the I-SceI 






























































































































































































Construction of the fliC allele replacement vector pES2921: 
Regions(~500 bp) flanking the fliC gene were amplified by 
PCR, using primers SphI-fliC1 and fliC2 to amplify the left 
flank (LF) and primers fliC3 and SphI-fliC4 to amplify the 
right flank (RF), with C. difficile 630∆erm genomic DNA as 
template (FIG 4.4). The LF and RF PCR products were mixed 
and fused by cross-over PCR using primers SphI-fliC1 and 
SphI-fliC4, generating the fliC deletion cassette (FIG 
4.4). The deletion cassette was subsequently ligated into 
the FspI site of pES242, resulting in the allele 
replacement vector pES2921 (FIG 4.4). The use of this 
allele replacement vector in the I-SceI system would result 
in the replacement of the fliC gene (873 bp) by the fliC 
deletion cassette (~1 kb). Sequencing of plasmid pES2921 





FIG 4.4  Construction of the allele replacement vector pES2921 
A] Construction of the fliC deletion cassette. Primers SphI-fliC1 ( ) 
and fliC2 ( ) were used to amplify by PCR the left flanking region (LF, 
502 bp) of the fliC gene. Primers fliC3 ( ) and SphI-fliC4 ( ) were 
used to amplify by PCR the right flanking region (RF, 499 bp) of the 
fliC gene.  The LF and RF products were fused together by subsequent 
cross-over PCR using primers SphI-fliC1 ( ) and SphI-fliC4 ( ) 
generating the fliC deletion cassette (~1 Kb). Gel 1 lanes 1, 2 and 3 
correspond to 1 kb ladder, primers control PCR and LF PCR product, 
respectively. Gel 2 lanes 1, 2 and 3 correspond to primers control PCR, 
RF PCR product and 1 Kb ladder, respectively. Gel 3 lanes 1 and 2 
correspond to 1 Kb ladder and fliC deletion cassette, respectively. B] 
Construction and gel analysis of pES2921. The fliC deletion cassette 
was ligated into the FspI site of pES242 generating pES2921. Gel lanes 
1, 2, 3 and 4 correspond to supercoiled pES2921, SphI digested pES2921, 




Introduction of pES2921 in C. difficile 630∆erm and screening for a single cross-
over event:   
The allele replacement vector pES2921 was introduced into 
C. difficile from E. coli via an exponential mating. From 
this conjugation, three putative transconjugants were 
obtained (named 10/1, 10/2, 10/3) which were inoculated 
into liquid BHITm15 (BHI containing thiamphenicol at 15 
μg/ml) and were also streaked on BHITm15cfx8cls250 agar 
(BHI containing thiamphenicol 15 μg/ml, cefoxitin 8 μg/ml, 
D-cycloserine 250 μg/ml). The presence of pES2921 in C. 
difficile was confirmed by amplification, via PCR, of the 
fliC deletion cassette together with the wt fliC, including 
flanking regions, using plasmid DNA preparations from the 
overnight cultures grown in BHITm15 as template and primers 
SphI-fliC1 and SphI-fliC4 (FIG 4.5). In addition, the agar 
medium streaked with the transconjugant strains showed the 
presence of a mixed sized colony population (as expected 
with the use of pMTL83151-based plasmids), indicative of 
cells containing single cross-overs and cells containing 







FIG 4.5  PCR screening for pES2921 transconjugants 
Primers SphI-fliC1 ( ) and SphI-fliC4 ( ) were used to confirm the 
presence of pES2921 in putative transconjugant strains 10/1, 10/2 and 
10/3 by PCR amplification of the the fliC deletion cassette together 
with the wt fliC including flanking regions. From the wt strain only 
the wt fliC including flanking regions is amplified. Gel lane 1 and 2 
correspond to 1 kb ladder and primer control PCR, respectively. Lane 3 
corresponds to control PCR using pES2921 as template. Lane 4, 5, 6 and 
7 corresponds to PCR using plasmid extraction from wt C. difficile 









FIG 4.6  Colony sizes after the introduction of pES2921 into C. difficile 630∆erm 
BHITm15cfx8cls250 agar streaked with pES2921 transconjugant 10/1 
displaying mixed sized colony population. Red arrows indicate big 
colonies corresponding to putative merodiploids and blue arrows 




Enrichment for a single cross-over population, via a 
further sub-culture in liquid BHITm15, passaging in BHI 
broth without thiamphenicol and streaking back on BHITm15 
agar, resulted in the loss of the small sized population 
indicating the presence of putative co-integrants only. To 
screen, by PCR, for the integration of pES2921 into C. 
difficile 630∆erm, chromosomal DNA was used as template 
with primer sets INTfliC-For and SphI-fliC4 or SphI-fliC1 
and INTfliC-Rev to amplify a ~1.2 kb fragment (FIG 4.7). 
The INTfliC-For and INTfliC-Rev primers were designed to 
anneal to regions upstream (170 bp) or downstream (278 bp) 
of the fliC LF or fliC RF in the targeted chromosome. This 
confirmed the integration of pES2921 in three merodiploid 
strains (INT10/1, INT10/2 and INT10/3) via the fliC LF (FIG 
4.7). Two co-integrants (INT10/1 and INT10/3) were chosen 





FIG 4.7  PCR screening for single cross-over integration of pES2921 
A single cross-over integration of pES2921 into C. difficile 630∆erm 
chromosome was screened by PCR using primer sets INTfliC-For ( ) and 
SphI-fliC4 ( ) or SphI-fliC1 ( ) and INTfliC-Rev ( ) with chromosomal 
DNA of putative merodiploids. Note that primers INTfliC-For and 
INTfliC-Rev anneal outwith of the fliC flanking regions on the 
chromosome. Solid line represents plasmid sequence while dashed line 
represents chromosomal sequence. The amplification of a ~1.2 kb product 
with primers INTfliC-For and SphI-fliC4 confirmed three merodiploid 
strains where integration occurred via the fliC LF. Gel 1 represents 
PCR products with primers SphI-fliC1 and INTfliC-Rev and Gel 2 products 
with primers INTfliC-For and SphI-fliC4. Gel 1 lane 1 and gel 2 lane 1 
correspond to 1 kb ladder. In both gels 1 and 2, lane 2, 3, 4, 5 and 6 
correspond to primers control PCR, to PCR product from wt 630∆erm, from 





Introduction of pES288 into merodiploids INT10/1 and INT10/3 and screening for 
a second cross-over event: 
The I-SceI expression vector pES288 was introduced into the 
partial diploids INT10/1 and INT10/3, via exponential 
matings, and the resulting putative transconjugants (16 and 
8 obtained from INT10/1 and INT10/3 mating, respectively) 
were streaked twice (sub1 and sub2) on AIM containing 
erythromycin at 10 μg/ml (AIMErm10). Screening for 
thiamphenicol sensitive strains from the first subculture 
showed resolution of 0% (total 65 colonies screened) and 
2.8% (1 sensitive colony from total 35 screened) from 
INT10/1 and INT10/3, respectively. Screening for a second 
cross-over event via thiamphenicol sensitivity from the 
strains streaked twice resulted in resolution of 2% (3 
sensitive colonies from total 144 screened) and 3.6% (4 
sensitive colonies form total 111 screened) from 10/1 and 
10/3, respectively. However, this low resolution rate may 
reflect the visual screening for less rhizoid, smaller-
sized colony population. To confirm that the double cross-
over event in the merodiploids INT10/1 and 10/3 was due to 
I-SceI induced DSB repair, and not due to a spontaneous 
event, plasmid pMTL82254 was introduced into these strains 
and subsequently screened for resolution. Transconjugant 
populations streaked once or twice on AIMErm10 did not 
become sensitive to thiamphenicol (total 50 once streaked 
and 133 twice streaked colonies screened from each 10/1 and 






Verification of a double cross-over and phenotypic characterization of ∆fliC 
recombinant strains: 
The double cross-over events were confirmed via PCR using 
primers SphI-fliC1 and SphI-fliC4 and genomic DNA from the 
thiamphenicol-sensitive strains isolated above. The fliC 
deletion cassette was amplified from putative ∆fliC strains 
No. 88, 381, 383 and 415, while the wt fliC region was 
amplified from the parental strain 630∆erm and from the 
putative resolved wt strains No.382, 485 and 489 (FIG 4.8). 
Subsequent sequencing of the amplified fliC deletion 
cassette from strains No. 88, 381, 383 and 415 confirmed 
the replacement of the wt fliC allele by the deletion 
cassette in the chromosome of these strains with the 
predicted sequence joints (FIG 4.8). The ∆fliC strains No. 
381 and 383, and the resolved wt No. 382, were isolated 
from co-integrant INT10/1. The ∆fliC strains No. 88 and 
415, and the resolved wt No. 485 and 489, were isolated 
from the resolution of the INT10/3 partial diploid. It 
should also be noted that the pES288 vector was easily 
eliminated from all resolved strains simply by streaking 
twice on medium without erythromycin. This was important 
for subsequent experiments, particularly for the 





FIG 4.8  Screening and confirmation of second cross-over recombinants and ∆fliC strains 
A] A second cross-over event was identified by PCR, using primers SphI-
fliC1 ( ) and SphI-fliC4 ( ) with chromosomal DNA of putative 
recombinant strains. The amplification of the fliC deletion cassette 
(~1 kb) identified putative ∆fliC recombinant strains, while the 
amplification of the wt fliC including flanking regions (~1.9 kb) 
identified strains that resolved to wt. Gel Lane 11 corresponds to 1 kb 
ladder. Lane 1 and lane 2 correspond to primers control PCR and pES2921 
control PCR. Lanes 4, 5, 7 and 8 correspond to the amplification of the 
fliC deletion cassette from ∆fliC No. 88, 381, 383 and 415 strains, 
respectively. Lanes 3, 6, 9 and 10 correspond to the amplification of 
the wt fliC and flanks from wt 630∆erm, from resolved wt strains 
No.382, 485 and 489, respectively. B] The fliC deletion cassettes 
amplified from the ∆fliC strains were sequenced and a partial sequence 




As mentioned above, previously published studies 
demonstrated that interruption of the fliC gene in C. 
difficile resulted in non-flagellated strains that were 
impaired in flagella-mediated motility (Dingle et al., 
2011; Twine et al., 2009). Motility tests were therefore 
used, to characterize and confirm the predicted phenotype 
of the markerless deletion strains, such as soft agar 
swimming, motility examination by wet mount microscopy, 
colony morphology and electron microscopy to visualize 
flagella. The assessment of flagella-mediated motility by 
stab inoculation of the parental strain 630∆erm, together 
with wt recombinant strains No.382, 485 and 489, showed a 
spreading and diffuse growth away from the inoculation 
point after 24-h, which indicated a motile phenotype (FIG 
4.9). Microscopic examination of wet mount preparations of 
the resolved wt strains No.382, 485 and 489 showed the same 
motile behaviour as the wt 630∆erm strain. In contrast, 
strains ∆fliC No. 88, 381, 383 and 415 did not display a 
spreading phenotype in the motility agar after 24-h and 
growth was concentrated near the inoculum stab, which 
indicated a non-motile phenotype (FIG 4.9). In addition, 
these strains were non-motile as examined by wet mount 
microscopy. The ∆fliC 383 strain displayed typical C. 
difficile colony morphology, similar to the wt, with 
spreading rhizoids when streaked on BHI, AIM and Blood 
agar. Flagella production in ∆fliC No. 383 and in ∆fliC No. 
88 was examined by electron microscopy. This showed that 
the ∆fliC mutant strains did not produce any flagella 
filaments, whereas both wt 630∆erm and resolved wt No. 489 





FIG 4.9  Flagella mediated motility stab assay of ∆fliC and wt recombinant strains and wt 
630∆erm  
The result of swimming motility assay at 24-h incubation in AIM medium 
(0.175% agar) is shown. The ∆fliC strains display a non-spreading 
phenotype in contrast to the wt 630∆erm and to the resolved wt strains 







FIG 4.10  Electron microscopy of flagella production in wt and ∆fliC strains 
Transmission electron micrographs of 48-h single colonies grown on AIM 
agar medium revealing the lack of flagella production in ∆fliC 88 (3) 
and ∆fliC 383 (4) mutant strains in contrast to the wt 630∆erm (1) and 








Complementation of the ∆fliC mutants:  
To complement the ∆fliC mutants, the recombinant vector 
pES196 was constructed. To generate this plasmid, the 
intact wt fliC gene and its native promoter, previously 
documented by Dingle et al. (2011), were amplified by PCR 
using primers cmFliCFor and cmFliCRev and genomic DNA from 
630∆erm as template. The resulting PCR product was ligated 
into NotI/XhoI- digested E. coli – Clostridium shuttle 
vector pMTL84151 (FIG 4.11) (Heap et al., 2009). The 




FIG 4.11  Construction of complementation plasmid pES196 
The complementation plasmid was generated be the ligation of the wt 
fliC gene and its respective promoter in the NotI/XhoI site of 
pMTL84151. Gel 1 lane 3 represents the PCR amplification of the wt fliC 
and promoter from genomic DNA of 630∆erm using primers cmFliCFor and 
cmFliCRev. Gel 1 lane 1 and 2 correspond to 1 kb ladder and primers 
control PCR. Gel 2 represents pES196 restriction digest analysis for 
insert confirmation. Gel 2 lane 1 corresponds to 1 kb ladder. Gel 2 
lane 2 and 3 correspond to supercoiled pMTL84151 and NotI/XhoI digested 
pMTL84151, respectively. Gel 2 lane 5 and 6 correspond to supercoiled 
pES196 and NotI/XhoI digested pES196, respectively. Gel 2 lane 4 
corresponds to NotI/XhoI digested insert (1149 bp) used for 




The complementation vector was conjugated into wt 630∆erm, 
∆fliC 88 and ∆fliC 383 strains using exponential matings. 
For control experiments, the plasmid pMTL84151 was also 
conjugated into these strains. The presence of pMTL84151 or 
pES196 in the strains was confirmed by PCR amplification of 
plasmid specific products using primers Trans-1 and Trans-3 
with chromosomal DNA from transconjugant strains as 




FIG 4.12  PCR confirmation of pES196 and pMTL84151 transconjugant strains 
Transconjugant strains were confirmed to harbour pMTL84151 or pES196 by 
PCR amplification of plasmid specific products, using chromosomal DNA 
of putative transconjugant as template and primers Trans-1 and Trans-3, 
which were designed to anneal outwith of the NotI and XhoI sites of 
pMTL84151. Lane 1 of gel 1, gel 2 and gel 3 refer to 1 kb ladder and 
lane 1 of gel 4 refers to 100 bp ladder. Lane 2 of all gels refers to 
primers control PCR. Lane 3 of gels 1, 2 and 3 refer to control PCR 
using plasmid pES196 as template. Lane 4 of gel 1, 2 and 3 refer to PCR 
product produced from ∆fliC 383, ∆fliC 88 and wt 630∆erm chromosomal 
DNA, respectively. Lane 3 of gel 4 refers to control PCR using plasmid 
pMTL84151 as template. Lane 4, 5 and 6 of gel 4 refer to pMTL84151 
specific PCR product produced from chromosomal extract of wt 630∆erm, 
∆fliC 383 and ∆fliC 88, respectively.  
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The strains wt 630∆erm, ∆fliC 383 and ∆fliC 88 containing 
pES196 or pMTL84151 were stab inoculated into soft agar 
medium. After 24-h incubation, only strains of 630∆erm 
containing either plasmid showed a spreading phenotype, 
while the ∆fliC strains, containing either plasmid, showed 
a non-spreading phenotype (FIG 4.13). Wet mount microscopic 
examination of the wt 630∆erm strain, containing either 
plasmid, displayed typical C. difficile motility with 
vigorous back and forth movements. Wet mount microscopy of 
both ∆fliC 383 and ∆fliC 88 strains containing pES196 
showed some motile cells, singly or in pairs, that 
displayed a tumbling motion. In addition, both ∆fliC 383 
and ∆fliC 88 strains containing the control vector 
pMTL84151 were non-motile when examined by wet mount 
microscopy. Further examination by electron microscopy of 
the ∆fliC 383 and ∆fliC 88 strains containing the 
complementation vector, pES196, revealed production of 
flagellar filaments, while the ∆fliC 383 and ∆fliC 88 
strains containing pMTL84151 did not produce any visible 
flagella (FIG 4.14). Electron microscopy of the parental 
strain 630∆erm containing pES196 or pMTL84151 showed 






FIG 4.13  Flagella motility stab assay of complemented ∆fliC strains  
The result of swimming motility assay at 24-h incubation in BHI medium 
(0.175% agar) containing thiamphenicol at 15 μg/ml is shown. Photos 1, 
2 and 3 refer to ∆fliC 383, ∆fliC 88 and wt 630∆erm containing pES196, 
respectively. Photos 4, 5 and 6 refer to ∆fliC 383, ∆fliC 88 and wt 
630∆erm containing pMTL84151, respectively. Only, the wt 630∆erm 
containing either plasmid displays a spreading phenotype in the 







FIG 4.14  Electron microscopy of complemented ∆fliC strains for flagella production  
Transmission electron micrographs of 48-h single colonies grown on AIM 
agar medium revealed flagella production in fliC complemented ∆fliC 88 
and ∆fliC 383 mutant strains. Photos 1, 2 and 3 refer to wt 630∆erm, 
∆fliC 383 and ∆fliC 88 containing pES196, respectively. Photos 4, 5 and 
6 refer to wt 630∆erm, ∆fliC 383 and ∆fliC 88 containing control 









4.2.2: Construction of C. difficile ∆pilT, ∆fliC∆pilT, attempted construction 
of C. difficile ∆pilA and characterization of the mutant strains  
 
Arrangement of putative type IV pili genes in C. difficile and targeted pilT 
and pilA genes for deletion: 
FIG 4.15 shows one of the type IV pilus-associated loci, 
CD3503–CD3513, in the C. difficile 630 genome. The pilT 
(CD3505) and pilA (CD3507) genes which are predicted to 
encode proteins for pilus retraction and type IV pilin 
subunit, respectively, are shown. The I-SceI site vector 
pES242 and the I-SceI expression vector pES288 were used to 




FIG 4.15  Arrangement of type IV pilus locus in C. difficile 630 and genes for deletion  
The putative type IV pilus biosynthesis locus (CD3503 – CD3513) in the 
genome of C. difficile 630 is shown. Putative gene and putative protein 
nomenclature: 3- CD3503 type IV prepilin leader peptidase, 4- CD3504 
type IV prepilin peptidase, 5- CD3505 twitching motility protein PilT, 
6- CD3506 hypothetical protein, 7- CD3507 type IV pilin (PilA, 
nomenclature according to Goulding et al., 2009), 8- CD3508 type IV 
pilin, 9- CD3509 type IV pilus assembly protein, 10- CD3510 membrane 
protein, 11- CD3511 type IV pilus secretion protein, 12- CD3512 type IV 
pilus transporter and 13- CD3513 pilin protein. The genes pilT (CD3505) 
and pilA (CD3507) for deletion are coloured red. 
 
It was predicted that C. difficile pilA or pilT mutants 
would be impaired in twitching motility. The deletion of 
pilT was generated in both C. difficile 630∆erm and in C. 
146 
 
difficile ∆fliC 383 strains. The double deletion mutant C. 
difficile ∆fliC ∆pilT was constructed to: i) aid the 
investigation of TFP-mediated motility by exclusion of 
flagella-mediated motility and to aid in the investigation 
of other future TFP function tests e.g. adhesion assays, 
biofilms in which in other species flagella are known to be 
involved; and, ii) test the robustness of the genetic 
system by the construction of multiple deletions.   
 
 
Construction of a C. difficile pilT deletion strain: 
 
Construction of allele replacement vector pES2922: 
Regions flanking (~500 bp) the pilT gene were amplified by 
PCR using chromosomal DNA from 630∆erm as template, with 
primers SphI-CD3505-1 and CD3505-2 used to amplify the pilT 
LF and primers CD3505-3 and SphI-CD3505-4 used to amplify 
the pilT RF (FIG 4.16). The pilT flanking regions were 
fused together by cross-over PCR using primers SphI-CD3505-
1 and SphI-CD3505-4, resulting in the pilT deletion 
cassette (FIG 4.16), which was subsequently ligated into 
the FspI site of pES242, generating the allele replacement 





FIG 4.16  Construction of the allele replacement vector pES2922 
A] Construction of the pilT deletion cassette. Primers SphI-CD3505-1( ) 
and CD3505-2 ( ) were used to amplify by PCR the left flanking region 
(LF, 514 bp) of the pilT gene from 630∆erm genomic DNA. Primers CD3505-
3 ( ) and SphI-CD3505-4( ) were used to amplify by PCR the right 
flanking region (RF, 522 bp) of the pilT gene. The LF and RF products 
were fused together by subsequent cross-over PCR using primers SphI-
CD3505-1( ) and SphI-CD3505-4( ) generating the pilT deletion cassette 
(~1 Kb). Gel 1 lane 1 refers to 1 kb ladder. Gel 1 lane 2 and 4 refer 
to primers SphI-CD3505-1/CD3505-2 and CD3505-3/SphI-CD3505-4 control 
PCR, respectively. Gel 1 lane 3 and 5 refer to LF and RF PCR products, 
respectively. Gel 2 lanes 1, 2 and 3 refer to 1 kb ladder, primers 
SphI-CD3505-1/SphI-CD3505-4 control PCR and pilT deletion cassette, 
respectively. B] Construction and gel analysis of pES2922. The pilT 
deletion cassette was ligated into the FspI site of pES242 generating 
pES2922. Gel lanes 1, 2, 3 and 4 correspond to supercoiled pES2922, 
SphI digested pES2922, I-SceI digested pES2922 and 1 kb ladder, 
respectively.    
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Introduction of pES2922 into C. difficile 630∆erm and screening for a single 
cross-over event: 
The ∆pilT allele replacement vector, pES2922, was 
introduced into C. difficile 630∆erm by exponential mating. 
From this mating, six putative transconjugants were 
obtained (named 35/1, 35/3, 35/5, 35/7, 35/8 and 35/10) 
which were inoculated into liquid BHITm15 and also streaked 
on BHITm15cfx8cls250 agar. All putative transconjugants 
obtained were confirmed to contain the plasmid pES2922 by 
PCR amplification of the pilT deletion cassette and the wt 
pilT gene, including flanking regions, using primers SphI-
CD3505-1 and SphI-CD3505-4 with plasmid DNA prepared from 
overnight cultures as template (FIG 4.17). After overnight 
incubation of the streaked transconjugants strains on 
BHITm15cfx8cls250 agar, a mixed sized population of big and 
small colonies was observed. A single cross-over event was 
enriched as previously described which resulted in the loss 
of the small sized population. The integration of pES2922, 
by a single cross-over event, was confirmed by PCR 
amplification of a ~1.2 kb sized fragment using chromosomal 
DNA of putative merodiploids with primer set SphI-CD3505-4 
and INT3505For or SphI-CD3505-1 and INT3505Rev (FIG 4.18). 
The INT3505For and INT3505Rev primers were designed to 
anneal outwith the pilT LF and RF regions in the C. 
difficile 630∆erm chromosome. This PCR assay confirmed the 
integration of pES2922 via the pilT LF in merodiploids 
INT35/7 and INT35/8, and the integration via the pilT RF in 
merodiploids INT35/1, INT35/5 and INT35/10 (FIG 4.18). In 
the 35/3 transconjugant strain, pES2922 remained in its 
replicative form. The partial diploids INT35/5 and INT35/8 






FIG 4.17  PCR screening for pES2922 transconjugants 
PCR amplification of the pilT deletion cassette together with the wt 
pilT including flanking regions, using primers SphI-CD3505-1 ( ) and 
SphI-CD3505-4 ( ) with plasmid preparation as template, confirmed the 
presence of pES2922 in transconjugant strains 35/1, 35/3, 35/5, 35/7, 
35/8 and 35/10. From the wt strain 630∆erm only the wt pilT including 
flanking regions is amplified. Gel lanes 1 and 2 refer to the pilT 
deletion cassette used for ligation and primers control PCR, 
respectively.  Lane 11 refers to 1 kb ladder. Lanes 3, 4, 5, 6, 7, 8, 
9, and 10 refer to PCR product from pES2922, 630∆erm, 35/1, 35/3, 35/5, 







FIG 4.18  PCR screening for single cross-over integration of pES2922 
A single cross-over integration of pES2922 into C. difficile 630∆erm 
chromosome was screened by PCR, using primer sets INT3505For ( ) and 
SphI-CD3505-4 ( ) or SphI-CD3505-1 ( ) and INT3505Rev ( ) with 
chromosomal DNA of putative merodiploids as template. Note that primers 
INT3505For and INT3505Rev anneal outwith of the pilT flanking regions 
on the chromosome. Solid line represents plasmid sequence while dashed 
line represents chromosomal sequence. The amplification of a ~1.2 kb 
product using either primer set confirmed an integration event. Gel 
lanes 1 and 10 refer to 1 kb ladder. Lanes 2 and 11 refer to primers 
SphI-CD3505-4/INT3505For and SphI-CD3505-1/INT3505Rev control PCR, 
respectively. Lanes 3, 4, 5, 6, 7, 8 and 9 refer to PCR product 
obtained from 630∆erm, 35/1, 35/3, 35/5, 35/7, 35/8 and 35/10 using 
primers SphI-CD3505-4/INT3505For, respectively. Lanes 12, 13, 14, 15, 
16, 17 and 18 refer to PCR product obtained from 630∆erm, 35/1, 35/3, 
35/5, 35/7, 35/8 and 35/10 using primers SphI-CD3505-1/INT3505Rev, 





Introduction of pES288 into merodiploids INT35/5 and INT35/8, screening and 
confirmation of a second cross-over event: 
The I-SceI expression vector pES288 was introduced into the 
merodiploids INT35/5 and INT35/8 via exponential mating. 
The putative transconjugants obtained (6 and 7 
transconjugant colonies from INT35/5 and INT35/8 matings, 
respectively) were streaked twice on BHI containing 
erythromycin at 10 μg/ml (BHIErm10) and colonies from each 
subculture were then screened for thiamphenicol 
sensitivity, which is indicative of resolution. Screening 
for thiamphenicol sensitive strains from the first 
subculture showed no resolution for either merodiploid 
strain INT35/5 or INT35/8 (total 12 and 14 colonies 
screened from INT35/5 and INT35/8, respectively). Screening 
for thiamphenicol sensitive colonies from the second 
subculture showed a resolution of 29.2% for merodiploid 
INT35/5 (19 sensitive colonies from total 65 screened) and 
a 0% for merodiploid INT35/8 (total 66 colonies screened).  
The double cross-over events were confirmed by PCR, using 
primers SphI-CD3505-1 and SphI-CD3505-4 and genomic DNA 
from the thiamphenicol sensitive strains isolated above 
(FIG 4.19). The pilT deletion cassette was amplified from 
strains No. 271, 272, 288 and 292. The wt pilT region was 
amplified from resolved strains No. 273, 274, 275, 276, 
279, 281, 282, 376, 378, 379, 380, 391, 430, 432 and 434. 
Subsequent sequencing of the amplified pilT deletion 
cassette, from ∆pilT strains No. 271, 272, 288 and 292, 
confirmed the in-frame replacement of the wt pilT allele by 
the deletion cassette in the chromosome of these strains 
with the predicted sequence joints (FIG 4.19). The I-SceI 
expression vector pES288 was eliminated from these strains 





FIG 4.19  Screening and confirmation of second cross-over in ∆pilT recombinant strains 
A] A second cross-over event was identified by PCR using primers SphI-
CD3505-1 ( ) and SphI-CD3505-4 ( ) with chromosomal DNA of putative 
recombinant strains. The amplification of the pilT deletion cassette 
(~1 kb) identified putative ∆pilT recombinant strains, while the 
amplification of the wt pilT including flanking regions (~2 kb) 
identified strains that resolved to wt. Gel 1 lanes 1, 2 and 3 refer to 
1 kb ladder, primer control PCR and product obtained from pES2922, 
respectively. Gel 1 lanes 5, 6, 14 and 15 refer to PCR product obtained 
from ∆pilT strains No. 271, 272, 288 and 292, respectively. Gel 1 lanes 
4, 7, 8, 9, 10, 11, 12, 13, 16, 17, 18, 19 and 20 refer to PCR product 
obtained from wt strains 630∆erm, 273, 274, 275, 276, 279, 281, 282, 
376, 378, 379, 380 and 391, respectively. Gel 2 lane 4 refers to 1 kb 
ladder. Gel 2 lanes 1, 2 and 3 refer to PCR product obtained from 
resolved wt strains No. 430, 432 and 434, respectively. B] The pilT 
deletion cassettes amplified from the ∆pilT strains were sequenced and 
a partial sequence alignment of the pilT LF and RF together with the 




Attempted construction of C. difficile pilA deletion strain: 
 
Construction of allele replacement vector pES2923: 
Around 500 bp regions flanking the putative pilA gene 
(CD3507) in C. difficile 630∆erm were amplified by PCR 
using genomic DNA as template, with primers  SphI-CD3507-1 
and CD3507-2 to amplify the pilA LF and primers CD3507-
3 and SphI-CD3507-4 to amplify the pilA RF (FIG 4.20). The 
pilA LF and RF were fused together by subsequent cross-over 
PCR using primers SphI-CD3507-1 and SphI-CD3507-4 to 
generate the pilA deletion cassette (FIG 4.20). The 
deletion cassette was then ligated into the FspI site of 
pES242 resulting in the allele replacement vector pES2923 






FIG 4.20  Construction of the allele replacement vector pES2923 
A] Construction of the pilA deletion cassette. Primers SphI-CD3507-1( ) 
and CD3507-2 ( ) were used to amplify by PCR the left flanking region 
(LF, 521 bp) of the pilA gene from 630∆erm genomic DNA. Primers CD3507-
3 ( ) and SphI-CD3507-4 ( ) were used to amplify by PCR the right 
flanking region (RF, 477 bp) of the pilA gene. The LF and RF products 
were fused together by subsequent cross-over PCR using primers SphI-
CD3507-1 ( ) and SphI-CD3507-4 ( ) generating the pilA deletion 
cassette (~1 Kb). Gel 1 lane 1 refers to 1 kb ladder. Gel 1 lane 2 and 
4 refer to primers SphI-CD3507-1/CD3507-2 and CD3507-3/SphI-CD3507-
4 control PCR, respectively. Gel 1 lanes 3 and 5 refer to LF and RF PCR 
product, respectively. Gel 2 lanes 1, 2 and 3 refer to 1 kb ladder, 
primers SphI-CD3507-1/SphI-CD3507-4 control PCR and cross-over PCR 
product, respectively. B] Construction and gel analysis of pES2923. The 
pilA deletion cassette was ligated into the FspI site of pES242 
generating pES2923. Gel lanes 1, 2, 3 and 4 correspond to supercoiled 
pES2923, SphI digested pES2923, I-SceI digested pES2923 and 1 kb 
ladder, respectively.    
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Introduction of pES2923 into C. difficile 630∆erm, single cross-over and double 
cross-over event: 
The allele replacement vector pES2923 was introduced into 
C. difficile 630∆erm from E. coli via stationary mating. 
One putative transconjugant was obtained (named 41/2), 
which was inoculated into liquid BHITm15 and also streaked 
on BHITm15cfx8cls250 agar. The presence of pES2923 in 
630∆erm was confirmed by PCR amplification of the pilA 
deletion cassette together with the amplification of the wt 
pilA, including flanking regions, using plasmid DNA 
extracted from overnight culture of the putative 
transconjugant with primers SphI-CD3507-1 and SphI-CD3507-4 
(FIG 4.21). In addition, as observed previously, the 
overnight incubated agar streaked with the putative pES2923 
transconjugant strain 41/2 showed a mixed sized population.  
A single cross-over event was enriched and selected as 
previously, by a second subculture on thiamphenicol 
containing medium, passage through medium without 
thiamphenicol and selection of putative single cross-over 
integrants by plating on thiamphenicol. This resulted in 
the loss of small sized colonies. Integration of pES2923 
into the C. difficile 630∆erm chromosome was confirmed via 
the amplification of a ~1.2 kb sized fragment, by PCR, 
using genomic DNA of putative partial diploids with primer 
set INT3507For and SphI-CD3507-4 or SphI-CD3507-1 and 
INT3507Rev(FIG 4.22). The INT3507For and INT3507Rev primers 
were designed to anneal to regions outwith of the pilA 
flanking regions on the chromosome. This PCR screening 
confirmed the integration of pES2923 in three merodiploids, 





FIG 4.21  PCR screening for pES2923 transconjugants 
PCR amplification of the pilA deletion cassette together with the wt 
pilA including flanking regions using primers SphI-CD3507-1 ( ) and 
SphI-CD3507-4 ( ) with plasmid extract as template confirmed the 
presence of pES2923 in transconjugant strain 41/2. From the wt strain 
630∆erm only the wt pilA including flanking regions is amplified. Gel 
lanes 1 and 2 refer to 1 kb ladder and primers control PCR. Lane 3 
refers to pilA deletion cassette used for ligation. Lane 4, 5 and 6 
refer to PCR product obtained from pES2923, 630∆erm and transconjugant 









FIG 4.22  PCR screening for single cross-over integration of pES2923 
A single cross-over integration of pES2923 into C. difficile 630∆erm 
chromosome was screened by PCR using primer sets INT3507For ( ) and 
SphI-CD3507-4 ( ) or SphI-CD3507-1 ( ) and INT3507Rev ( ) with 
chromosomal DNA of putative merodiploids as template. Note that primers 
INT3507For and INT3507Rev anneal outwith of the pilA flanking regions 
on the chromosome. Solid line represents plasmid sequence while dashed 
line represents chromosomal sequence. The amplification of a ~1.2 kb 
product using either primer set confirmed an integration event. Gel 1 
refers to PCR products obtained using primers INT3507For and SphI-
CD3507-4. Gel 1 lane 1 and 2 refer to 1 kb ladder and primers control 
PCR, respectively. Gel 1 lanes 3, 4, 5 and 6 refer to PCR products 
obtained from 630∆erm, INT41/2, INT41/2/1/2 and INT41/2/2/2, 
respectively. Gel 2 refers to PCR products obtained using primers SphI-
CD3507-1 and INT3507Rev. Gel 2 lane 1 and 2 refer to 1 kb ladder and 
primers control PCR, respectively. Gel 2 lanes 3, 4, 5 and 6 refer to 
PCR product obtained from 630∆erm, INT41/2, INT41/2/1/2 and 




The I-SceI expression vector pES288 was introduced into all 
three merodiploids by exponential mating with E. coli. The 
transconjugants obtained were streaked twice on AIMErm10 
and BHIErm10 to enrich for a double cross-over event. 
However, screening for thiamphenicol sensitive strains from 
both subcultures gave no resolved colonies. Total colonies 
screened from sub1 transconjugant cultures of INT41/2, 
INT41/2/1/2 and INT41/2/2/2 were 35, 17 and 5, 
respectively. Total colonies screened from sub2 
transconjugant cultures of INT41/2, INT41/2/1/2 and 
INT41/2/2/2 were 154, 110 and 23, respectively. Therefore, 
in these merodiploids containing pES288, a second cross-
over did not occur.  
 
Construction of C. difficile ∆fliC ∆pilT: 
 
Introduction of pES2922 into C. difficile ∆fliC and screening for a single cross-
over event: 
The allele replacement vector pES2922 which carries the 
pilT deletion cassette was introduced via exponential 
mating from E. coli into the C. difficile ∆fliC 383 strain 
isolated previously. From this mating one putative 
transconjugant was obtained (named 383/35/1) which was 
inoculated into liquid BHITm15 and also streaked on BHITm15 
agar. It was confirmed that this strain contained pES2922 
by amplification of the pilT deletion cassette, together 
with the amplification of the wt pilT and flanking regions 
by PCR using primers SphI-CD3505-1 and SphI-CD3505-4 with 
DNA extracted from the overnight culture as template (FIG 
4.23). In addition, the overnight incubated BHITm15 agar 
streaked with the putative transconjugant strain showed 
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growth of mixed sized colonies, similar to all previously 
described cases following the introduction of the allele 




FIG 4.23  PCR screening for pES2922 transconjugants of ∆fliC 383 
PCR amplification of the pilT deletion cassette together with the wt 
pilT including flanking regions using primers SphI-CD3505-1 ( ) and 
SphI-CD3505-4 ( ) with plasmid extract as template, confirmed the 
presence of pES2922 in transconjugant strain 383/35/1. From the wt 
strain 630∆erm only the wt pilT including flanking regions is 
amplified. Gel lanes 1 and 2 refer to 1 kb ladder and primers control 
PCR, respectively. Lanes 3, 4, 5, and 6 refer to PCR product obtained 
from pES2922, 630∆erm, ∆fliC 383 and 383/35/1, respectively.  





FIG 4.24  Colony size after introduction of pES2922 into C. difficile ∆fliC 383 
BHITm15 agar streaked with the putative transconjugant strain 383/35/1 
showed growth of a mixed sized population. Big colonies possibly 
represent putative merodiploids and small colonies possibly represent 
strains harbouring free plasmid. Examples of big and small colonies are 
indicated with red and blue arrows, respectively. 
 
 
A single cross-over event was enriched as before, via 
subculture on thiamphenicol containing medium, passaging 
through medium lacking thiamphenicol and streaking back on 
thiamphenicol containing medium. This resulted in the loss 
of small sized colonies. Single cross-over events were 
confirmed in four selected thiamphenicol resistant strains 
via the amplification of a ~1.2 kb sized fragment using 
primer set SphI-CD3505-4 and INT3505For or SphI-CD3505-1 
and INT3505Rev with chromosomal DNA of putative 
merodiploids as template (FIG 4.25). This confirmed the 
integration of pES2922 via the pilT LF into the genome of 
three merodiploids, named 383/35/INT2, 383/35/INT3 and 
383/35/INT4, and also confirmed the integration via the 
pilT RF into the genome of one merodiploid named 
383/35/INT1. The merodiploids 383/35/INT1 and 383/35/INT2 





FIG 4.25  PCR screening for single cross-over integration of pES2922 in C. difficile ∆fliC 
383 
A single cross-over integration of pES2922 into ∆fliC 383 chromosome 
was screened by PCR using primer sets INT3505For ( ) and SphI-CD3505-4 
( ) or SphI-CD3505-1 ( ) and INT3505Rev ( ) with chromosomal DNA of 
putative merodiploids as template. Note that primers INT3505For and 
INT3505Rev anneal outwith of the pilT flanking regions on the 
chromosome. Solid line represents plasmid sequence while dashed line 
represents chromosomal sequence. The amplification of a ~1.2 kb product 
using either primer set confirmed an integration event. Gel 1 lane 1 
refers to 1 kb ladder. Gel 1 lanes 2 and 3 refer to PCR product 
obtained from ∆fliC 383 using primers SphI-CD3505-4/INT3505For and 
SphI-CD3505-1/INT3505Rev, respectively. Gel 2 lanes 1 and 8 refer to 1 
kb ladder. Gel 2 lanes 2 and 9 refer to primers SphI-CD3505-
4/INT3505For and SphI-CD3505-1/INT3505Rev control PCR, respectively. 
Gel 2 lanes 3, 4, 5, 6 and 7 refer to PCR product obtained from 
630∆erm, 383/35/INT1, 383/35/INT2, 383/35/INT3 and 383/35/INT4 using 
primers SphI-CD3505-4/INT3505For, respectively. Gel 2 lanes 10, 11, 12, 
13 and 14 refer to PCR product obtained from 630∆erm, 383/35/INT1, 
383/35/INT2, 383/35/INT3 and 383/35/INT4 using primers SphI-CD3505-




Introduction of pES288 into merodiploids 383/35/INT1 and 383/35/INT2, 
screening and confirmation of a second cross-over event: 
The I-SceI expression vector pES288 was introduced into the 
merodiploids 383/35/INT1 and 383/35/INT2 from E. coli by 
exponential mating. Putative transconjugants obtained from 
the matings were streaked twice on BHIErm10 agar to enrich 
and screen for double cross-over events. Screening for 
resolution, via loss of thiamphenicol resistance, from the 
first subculture yielded no recombinants for 383/35/INT1 
(total 80 colonies screened) but 4% resolved colonies from 
383/35/INT2 (3 sensitive colonies from total 75 screened). 
Screening of thiamphenicol sensitive colonies from the 
second subculture revealed a resolution of 0% from 
383/35/INT1 (total 40 colonies screened) and 23.8% from 
383/35/INT2 (20 sensitive colonies from total 84 screened).  
Double cross-over events, in the isolated thiamphenicol 
sensitive strains, were confirmed by PCR using primers 
SphI-CD3505-1 and SphI-CD3505-4 and genomic DNA from the 
candidate strains (FIG 4.26). The pilT deletion cassette 
was amplified from thirteen C. difficile putative 
∆flic∆pilT strains. The fliC deletion cassette was also 
amplified, by PCR, from these strains using SphI-fliC1 and 
SphI-fliC4 primers and genomic DNA as template. Together 
these data indicated successful construction of double 
deletion mutant. Subsequent sequencing of the amplified 
pilT deletion cassette from three chosen strains namely 
∆fliC ∆pilT No. 234, 238 and 250, confirmed the replacement 
of the wt pilT allele by the pilT deletion cassette with 
the predicted sequence joints in the chromosome of these 
strains (FIG 4.26). The wt pilT region was amplified from 
ten resolved strains from which the fliC deletion was also 
amplified, indicating strains that had resolved to the 
parental genotype. FIG 4.26 shows the amplified pilT and 
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fliC deletion cassettes from C. difficile ∆fliC ∆pilT No. 
234, 238 and 250 and from three resolved strains 





FIG 4.26  Screening and confirmation of second cross-over ∆fliC ∆pilT recombinants 
A] A second cross-over event was identified by PCR using primers SphI-
CD3505-1 ( ) and SphI-CD3505-4 ( ) with chromosomal DNA of putative 
recombinant strains. The amplification of the pilT deletion cassette 
(~1 kb) identified putative ∆pilT recombinant strains while the 
amplification of the wt pilT including flanking regions (~2 kb) 
identified strains that resolved to parental. Gel 1 lanes 1 and 11 
refer to primers SphI-CD3505-1/SphI-CD3505-4 control PCR and 1 kb 
ladder, respectively. Gel 1 lanes 2, 5, 6 and 7 refer to amplification 
of the pilT deletion cassette from pES2922, from putative ∆fliC ∆pilT 
No. 234, 238 and 250, respectively. Gel 1 lanes 3, 4, 8, 9 and 10 refer 
to the amplification of the wt pilT including flanking regions from 
630∆erm, ∆fliC 383, resolved parental No. 235, 236 and 249, 
respectively. Double deletion mutant strains ∆fliC ∆pilT and resolved 
strains back to ∆fliC 383 were indicated by the PCR amplification of 
the fliC deletion cassette using primers SphI-fliC1 and SphI-fliC4. Gel 
2 lanes 1 and 2 refer to 1 kb ladder and primers SphI-fliC1/SphI-fliC4 
control PCR, respectively. Gel 2 lanes 3, 4, 5, 6, 7, 8, 9, 10 and 11 
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refer to PCR product using primers SphI-fliC1 and SphI-fliC4 obtained 
from pES2922, 630∆erm, ∆fliC 383, ∆fliC ∆pilT 234, ∆fliC ∆pilT 238, 
∆fliC ∆pilT 250, resolved ∆fliC 383 No. 235, resolved ∆fliC 383 No. 236 
and resolved ∆fliC 383 No. 249, respectively. B] The pilT deletion 
cassettes amplified from the ∆fliC ∆pilT strains were sequenced and a 
partial sequence alignment of the pilT LF and RF together with the 
joining point is shown.      
   
   
Phenotypic characterization of the C. difficile pilT mutant strains: 
 
Twitching motility: 
Bacteria can swim in a liquid medium or swarm across a 
surface, powered by flagella rotation. They can translocate 
on solid and semi-solid surfaces via a flagellum-
independent form, but type-IV pilus-dependent motion, 
called twitching motility (Mattick, 2002; Burrows, 2005; 
Jarrell and McBride, 2008). Twitching motility is unique to 
TFP and the mechanism is attributed to repeated pilus 
extension, tethering and retraction resulting in a jerky 
movement (Henrichsen, 1972; Burrows, 2012; Giltner et al., 
2012). Multiple pieces of evidence have demonstrated that 
PilT is responsible for pilus retraction (Nudleman and 
Kaiser, 2004; Burrows, 2005). Therefore, twitching motility 
was investigated in the pilT mutant strains and it was 
hypothesised that these mutants would be impaired in this 
type of motility. Preliminary tests for twitching motility 
involved two methods; 1) colony expansion on the surface of 
semi-solid agar medium, and 2) colony expansion at the 
interstitial surface between agar and a plastic surface. It 
has been documented that different factors can influence 
twitching motility, including nutrients of the growth 
medium (Henrichsen, 1983; Semmler et al., 1999; Huang et 
al., 2003; Pamp and Tolker-Nielsen, 2007; Burrows, 2012). 
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In C. perfringens, gliding motility on a semi-solid agar 
surface is abolished in a pilT mutant and pilT expression 
is depressed in the presence of glucose with minimum 
inhibition observed at 0.5% and  maximum inhibition 
observed at 1% glucose concentration (Varga et al., 2006; 
Mendez et al., 2008). Therefore, in this study, twitching 
motility was investigated using AIM (does not contain 
glucose), BHI (contains 0.2% dextrose) and Blood agar 
medium without glucose addition or with glucose added at 
concentrations of 0.2%, 1% or 2%. Twitching motility was 
investigated in the wt C. difficile 630∆erm but also in 
strains containing ∆pilT (∆pilT 271), ∆fliC ∆pilT (∆fliC 
∆pilT 250) or ∆fliC (∆fliC 383) mutations.  
  
Translocation and morphology on semi-solid surface: 
Exponential cultures of the strains were spotted onto AIM, 
BHI and Blood agar medium with or without glucose and 
colony morphology and surface expansion of the cultures 
were recorded after five days of incubation. This was 
tested at least twice for each growth medium used. 
All strains tested (630∆erm, ∆pilT 271, ∆fliC ∆pilT 250, 
∆fliC 383), behaved similarly between them regarding 
culture expansion on the different media used (FIG 4.27). 
Under the conditions used in this study, the strains 
lacking the pilT gene did not show any obvious impairment 
in the surface translocation compared to the parental 
strain. Addition of glucose to the growth medium had very 
little effect on the culture surface expansion with 
reduction of 1 mm on AIM and Blood agar and 2 mm on BHI 
agar compared to medium without glucose.  
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The morphology of the colony spots of all strains, although 
different on different media, displayed the same pattern 
(FIG 4.27). All strains were irregularly shaped and more 
rhizoid or more undulate shaped at glucose concentrations 
less than 1%, and had a more entire margin and displayed a 
more concentrated colony mass at glucose concentrations of 
1% and 2%. On Blood agar without glucose the fliC deficient 
strains, ∆fliC ∆pilT 250 and ∆fliC 383, displayed thinner 
rhizoids than the wt 630∆erm or the ∆pilT 271 mutant. On 
Blood agar with 1% and 2% glucose, all strains displayed a 
thin outline of cells. On BHI with glucose at 0% and 0.2%, 
all strains were more undulate shaped than on BHI with 1% 
glucose, which also displayed a thin outline of cells. All 
strains on BHI with 2% glucose were not undulate but had an 
entire margin. Similar to BHI, all strains displayed a more 
undulate shape on AIM at glucose concentrations of 0% and 
0.2%, compared to those containing glucose at 1% and 2%. On 
AIM with 1% glucose concentration, the wt 630∆erm and ∆pilT 
271 mutant were more undulate shaped than the fliC 
deficient strains ∆fliC ∆pilT 250 and ∆fliC 383. All 
strains on this medium displayed a thin outline of cells. 
Together these data indicate that any differences observed 
between the strains was due to absence or presence of 
flagella. Representative examples of all strains on 














FIG 4.27  Twitching surface motility assay 
Photos are shown of five day incubated Blood (A), BHI (B) and AIM (C) 
agar(0.7% agar) medium with increasing glucose concentration spotted 
with exponential cultures of wt 630∆erm, ∆pilT 271, ∆fliC 383, and 
∆fliC∆pilT 250. All strains behaved similarly under the conditions 
tested. Colony expansion was the same between pilT deletion and pilT 
proficient strains. Less rhizoid or less wavy shaped and smaller colony 




Colony expansion at the interstitial surface between agar 
and a plastic petri dish was measured for strains ∆pilT 
271, ∆fliC∆pilT 250, ∆fliC 383 and wt 630∆erm. Measurements 
were made in triplicate and used Blood or BHI agar with 
glucose omitted or with glucose at a concentration of 0.2%, 
1% and 2%. Colony expansion was the same for all strains 
with each medium used. As with surface translocation, the 
pilT mutant strains did not show an obvious phenotype. 
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Moreover, as described above, the addition of glucose at 1% 
and 2% reduced (1–2mm) the colony expansion of all strains 
(data not shown).  
 
Colony morphology:  
At the macroscopic level all strains, ∆pilT 271, ∆fliC 
∆pilT 250, ∆fliC 383 and wt 630∆erm, displayed the same 
colony morphology and colony size when streaked to single 
colonies on BHI, AIM and Blood agar medium. In addition, 
when these strains were streaked on BHI or AIM containing 
1% glucose they produced the same size colonies as growth 
without glucose. While the gross morphology was the same, 
there was a greater biomass present. 
 
Electron microscopy for type IV pilus:  
The strain ∆fliC 383 was examined for the presence of pili. 
This strain was chosen for visualisation of pili surface 
production since it is non-flagellated. Single colonies of 
the ∆fliC 383 strain grown on BHI, Blood, AIM and AIM 
supplemented with 0.2% fucose (fucose was used to mimic the 
types of sugars present on the surface of epithelial cells 
in the GI tract), were examined by EM for the presence of 
pili. No visible pili were observed on the surface of any 
of the cells examined, despite a large number of cells 
being examined. A representative image obtained from the EM 






4.2.3: Gene regulation of C. difficile type IV pilus biosynthesis locus 
 
Introduction and bioinformatics analysis of an intergenic region upstream 
of the TFP biosynthesis locus: 
Under the conditions used in this study the ∆fliC 383 
strain revealed lack of pili on the surface of the cells, 
as demonstrated by electron microscopy, which indicates 
that TFP are regulated and the TFP locus may be repressed 
at the transcriptional level. In the genome of C. difficile 
630 there is an intergenic region, with no annotated genes, 
immediately upstream of the TFP locus. Bioinformatics 
analysis of this sequence demonstrated no potential open 
reading frames with potentially significant translation 
products. FIG 4.28 shows the TFP biosynthesis locus in the 
genome of 630 and the 1087 bp upstream intergenic region 
which is located between the putative pilin protein 





FIG 4.28  C. difficile type IV pilus locus and location of the intergenic region  
The eleven type IV pilus associated genes in the CD3503 – CD3513 locus 
in the C. difficile 630 genome are shown. Nomenclature of genes is 
given in FIG 4.15. The intergenic region (1087 bp) located between the 
CD3513 locus (13, putative pilin protein) and the prs gene (putative 




Intergenic regions in bacteria are rare and may contribute 
to gene regulation of downstream genes. Considering the 
location of this region, we hypothesised that it may be 
involved in regulation of TFP genes in C. difficile 630. 
Comparison of the intergenic region to the genomes of eight 
other C. difficile strains (R2091, CD196, M68, Bl1, Bl9, 
M120, 2007855 and CF5) revealed a high percentage of 
sequence similarity (97% - 99%). Conservation of this 
region in other strains implies importance. In addition, 
further computational analysis showed that, the intergenic 
region in two C. difficile strains, R20291 and CD196, is 
also located upstream of the genes predicted to encode type 
IV pilus proteins. This further supports the hypothesis 
that this region may be associated with the regulation of 
TFP biosynthesis in C. difficile.   
To identify potential binding sites for regulatory proteins 
in the intergenic region, computational analysis, using DNA 
fold, was performed which revealed the presence of inverted 
repeats (FIG 4.29). Downstream of the prs gene a putative 
intrinsic terminator was identified, therefore 
transcription of the TFP locus would most likely start 
downstream of this terminator. In addition the region was 
scanned for putative promoters, using as a reference point 
the promoters described in C. difficile for the rRNA and 
glutamate dehydrogenase genes (Mani et al., 2006). However, 
a promoter was not easily identifiable because the 
intergenic region is AT rich, with a total AT content of 
78%. The genome of C. difficile 630 features a low CG 
content of 29.06% (Sebaihia et al., 2006). The aim of this 
study was to look for promoter activity in the intergenic 
region. This involved the use of a thiamphenicol expression 





FIG 4.29  Intergenic region sequence 
The sequence of the intergenic region between the CD3513 locus and the 
prs gene on the forward strand from the C. difficile 630 genome is 
shown. The direction of transcription of the genes is shown in yellow 
arrows. The inverted repeats identified in this region are highlighted 
in grey and complementary sequences are coloured red. The terminator 
sequence downstream of the prs gene is underlined. The 5’-end (blue 
highlighted bases) and direction of primers (blue arrows) used to 
amplify fragments of the intergenic region described in FIG 4.30 are 
indicated. Promoters predicted in the intergenic region using the BPROM 
(Softberry) program are listed in Appendix I. Nucleotide content of the 
sequence; A content: 424 (39.0%), C content: 166 (15.27%), G content: 




















































Construction of the catP reporter vectors pES2241-7: 
A series of plasmids containing fragments of the intergenic 
region were constructed using the catP reporter plasmid 
pMTL82254 (Heap et al., 2009). As described in chapter 3, 
this plasmid is an E. coli – Clostridium shuttle vector 
that carries an erythromycin resistance gene and also 
contains a promoter-less catP gene (Heap et al., 2009). 
As shown in FIG 4.30, primers were designed to amplify 
fragments of the intergenic region, starting with the 
largest fragment at 1071 bp upstream of the methionine 
codon of the CD3513 gene and creating consecutive deletion 
PCR fragments ending at 101 bp upstream of the CD3513 gene 
start codon. The fragments were designated pilprom1 
(excluding added restriction sites) (101 bp), pilprom2 (229 
bp), pilprom3 (330 bp), pilprom4 (494 bp), pilrpom5 (692 
bp), pilrom6 (824 bp) and pilprom7 (1071 bp), and were 
amplified by PCR using genomic DNA from C. difficile 
630∆erm as template with primer NdeI-pilprom in combination 
with primer NotI-pilprom1, NotI-pilprom2, NotI-pilprom3, 
NotI-pilprom4, NotI-pilprom5, NotI-pilprom6 or  NotI-
pilprom7 (FIG 4.30). These fragments were subsequently 
ligated into the NotI/NdeI site of pMTL82254 such that each 
fragment was directly upstream to the promoter-less catP 
gene in this vector. Ligation of fragments pilprom 1 to 7 
generated the vectors pES2241 to pES2247 (FIG 4.30). The 







FIG 4.30  Construction of pES2241-7 catP reporter recombinant plasmids 
175 
 
A] Seven deletion fragments pilprom1-7 were amplified by PCR using 
genomic DNA of C. difficile 630∆erm as template and primer NdeI-pilprom 
in combination with primer NotI-pilprom1, NotI-pilprom2, NotI-pilprom3, 
NotI-pilprom4, NotI-pilprom5, NotI-pilprom6 or NotI-pilprom7. The sizes 
of fragments are shown without restriction sites added from primers. 
Gel lane 1 refers to 100 bp ladder. Gel lanes 2, 3, 4, 5, 6, 7 and 8 
refer to PCR fragment pilrpom1, pilprom2, pilprom3, pilprom4, pilrpom5, 
pilprom6 and pilrom7 obtained, respectively.                                            
B] NotI and NdeI digested pilprom1-7 fragments were ligated into the 
NotI/NdeI sites of pMTL82254 generating pES2241-7. The gels refer to 
restriction digest analysis of pES2241-7. Lanes 1, 2 and 3 of all gels 
refer to 1 kb ladder, supercoiled pMTL82254 and NotI/NdeI digested 
pMTL82254, respectively. Gel 1 lane 4, 11 and 16 refer to NotI/NdeI 
digested pilprom1, pilprom2 and pilprom3 fragments, respectively. Gel 1 
lanes 5-10 refer to pES2241 from three clones with lanes 5, 7 & 9 
representing supercoiled pES2241 and lanes 6, 8 & 10 representing 
NotI/NdeI digested pES2241. Gel 1 lanes 12-15 refer to pES2242 from two 
clones with lanes 12 & 14 representing supercoiled pES2242 and lanes 13 
& 15 representing NotI/NdeI digested pES2242. Gel 1 lanes 17-20 refer 
to pES2243 from two clones with lanes 17 & 19 representing supercoiled 
pES2243 and lanes 18 & 20 representing NotI/NdeI digested pES2243. Gel 
2 lanes 4, 9 and 16 refer to NotI/NdeI digested pilprom4, pilprom5 and 
pilprom6 fragments, respectively. Gel 2 lanes 5-8 refer to pES2244 from 
two clones with lanes 5 & 7 representing supercoiled pES2244 and lanes 
6 & 8 representing NotI/NdeI digested pES2244. Gel 2 lanes 10-15 refer 
to pES2245 from three clones with lanes 10, 12 & 14 representing 
supercoiled pES2245 and lanes 11, 13 & 15 representing NotI/NdeI 
digested pES2245. Gel 2 lanes 17-20 refer to pES2246 from two clones 
with lanes 17 & 19 representing supercoiled pES2246 and lanes 18 & 20 
representing NotI/NdeI digested pES2246. Gel 3 lane 4 refers to 
NotI/NdeI digested pilprom7 fragment. Gel 3 lanes 5-8 refer to pES2247 
from two clones with lanes 5 & 7 representing supercoiled pES2247 and 













Conjugation of vectors and expression of the catP gene: 
From the seven constructs made, four plasmids pES2241, 
pES2244, pES2246 and pES2247 were successfully introduced 
into C. difficile 630∆erm from E. coli by exponential 
conjugation. For control experiments, the pMTL82254 vector 
was also conjugated into C. difficile 630∆erm. 
Transconjugants were confirmed via PCR using pMTL82254 
specific primers Trans-1 and Trans-2 with plasmid extracts 
from putative transconjugants (FIG 4.31).  
An initial qualitative test for promoter activity in the 
intergenic region involved streaking the strains harbouring 
pES2241, pES2244, pES2246 and pES2247 to single colonies on 
growth medium containing thiamphenicol. It was assumed that 
strains harbouring the recombinant plasmids with a promoter 
would be thiamphenicol resistant. Single colonies of the C. 
difficile 630∆erm strains containing pES2241, pES2244, 
pES2246 or pES2247, were streaked on AIMErm10 agar (AIM 
agar containing erythromycin at 10 μg/ml to select for the 
plasmid), on AIMErm10Tm15 agar (AIM agar containing 
erythromycin at 10 μg/ml and thiamphenicol at 15 μg/ml) and 
on AIMTm15 (AIM agar containing thiamphenicol at 15 μg/ml). 
As a control, the strains C. difficile 630∆erm and C. 
difficile 630∆erm containing pMTL82254 were also streaked 
to single colonies on the same media. FIG 4.31 shows photos 
of 48-h incubated plates. As expected, C. difficile 630∆erm 
containing pMTL82254 grew on the medium containing 
erythromycin but not on the medium containing 
thiamphenicol, while C. difficile 630∆erm did not grow on 
any antibiotic containing medium. All C. difficile 630∆erm 
strains containing pES2241, pES2244, pES2246 or pES2247 
grew on all media used. The transconjugant strain 
harbouring pES2241, containing the first 101 bp upstream of 
the CD3513 locus grew less well and showed patchy colony 
177 
 
growth on thiamphenicol containing medium, particularly on 
AIMTm15, compared to the rest of the strains. These data 
suggest that transcription is being initiated within the 
first 500 bp upstream of the CD3513 locus. The reduced 
thiamphenicol resistance in the strain harbouring pES2241 
may either suggest that a promoter exists 101 bp upstream 
of the CD3513 codon, but is being repressed or that a 
promoter does not exist within this region. The latter 
suggestion would agree with the observation that a promoter 
sequence was not easily defined within the first 100 bp of 
the intergenic region when compared to other described C. 








FIG 4.31  Thiamphenicol resistance of pES224 transconjugant strains 
A] C. difficile 630∆erm strains were confirmed to harbour pMTL82254, 
pE2241, pES2244, pES2246 or pES2247 by PCR, using pMTL82254 specific 
primers Trans-1 and Trans-2 which anneal outwith of the NotI/NdeI sites 
of pMTL82254 and as a template plasmid extracts of putative 
transconjugants. Gel lanes 1 and 14 refer to 100 bp ladder and 1 kb 
ladder, respectively. Lane 2 refers to primers control PCR. Lane 3 
refers to PCR product obtained from wt C. difficile 630∆erm plasmid 
extract. Lanes 5, 7, 9, 11 and 13 refer to PCR product obtained from 
plasmid extracts from transconjugant strains containing pMTL82254, 
pES2241, pES2244, pES2246 and pES22547, respectively. Lanes 4, 6, 8, 10 
and 12 refer to pML82254, pES2241, pES2244, pES2246 and pES2247 control 
PCR product obtained from E. coli plasmid extracts, respectively.                                                      
B] Photos of 48-h incubated AIMErm10, AIMErm10Tm15 and AIMTm15 agar 
media streaked with strains wt C. difficile 630∆erm (2), C. difficile 
630∆erm containing pMTL82254 (1), C. difficile 630∆erm containing 
pES2247 (3), C. difficile 630∆erm containing pES2246 (4), C. difficile 
630∆erm containing pES2244 (5) and C. difficile 630∆erm containing 
pES2241 (6). All strains containing pMTL82254-based plasmid grow on 
AIMErm10. Only strains containing pES224 plasmids grow on AIMErm10Tm15 
and AIMTm15. The strain C. difficile 630∆erm containing pES2241 shows 
reduced thiamphenicol resistance with sporadic colony growth 












In this study the optimization of the I-SceI genetic 
system, particularly the construction of a new I-SceI site 
delivery vector for the construction of various deletions 
in C. difficile, was described. The I-SceI delivery vector 
pES242 (chapter 4) and the I-SceI expression vector pES288 
(chapter 3) were used to delete the fliC, pilT and pilA 
genes in C. difficile. In this system, as with the genetic 
system in chapter 3, single cross-over integration was 
selected via thiamphenicol resistance and second cross-over 
resolution was screened via loss of thiamphenicol 
resistance. The use of the optimized system has shown its 
robustness and reproducibility by construction of the C. 
difficile ∆fliC and C. difficile ∆pilT strains, and 
construction of the double deletion strain C. difficile 
∆fliC ∆pilT. The ability to construct multiple deletions, 
using this system, is attributed to the fact that 
resolution results in the complete loss of thiaphenicol 
resistance and elimination of I-SceI expression vector 
pES288 is easily achieved by streaking twice on medium 
without erythromycin.  
Despite the recent development of other markerless deletion 
systems in C. difficile, it is important to note that a 
markerless double gene deletion of C. difficile has not 
been reported previously, supporting the uniqueness of this 
system over currently used genetic systems in C. difficile 
(Cartman et al., 2012; Ng et al., 2013). In addition, one 
of the systems uses a pyrE-based allelic exchange that 
requires the construction of an auxotrophic mutant strain 
before use of the mutagenesis system (Ng et al., 2013). 
Resulting strains therefore, carry additional mutations 
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that are not representative of the wild type and may have 
unforeseen consequences. The system can be used to convert 
the pyrE mutant strain with the modified target gene back 
to a pyrE
+
 strain, but this could add to laboratory work 
load. Although the widely used ClosTron system includes FRT 
sites to allow excision of ermB via the action of FLP 
recombinase for the re-use of the system for multiple gene 
interruptions, the ermB gene has never been excised in C. 
difficile, despite multiple attempts. This can be bypassed 
by using different ClosTron plasmids containing a 
retrotransposition activated marker (RAM) carrying 
different antibiotic resistance genes, with the end result 
being interruption of different genes of interest by 
different antibiotic genes (Kuehne and Minton, 2012). 
Nevertheless, this approach still produces inactivation of 
genes of interest by interruption and thus has potential 
polar effects and limits the number of genes that can be 
knocked out. 
Introduction of the I-SceI delivery vector into C. 
difficile in all cases, whether C. difficile 630∆erm or C. 
difficile ∆fliC 383, and in the presence of thiamphenicol 
selection resulted in a mixed sized colony population (2-3 
mm and pinpoint size) where larger colonies represented 
single cross-over strains and smaller colonies represented 
strains with free plasmid. The loss of the small sized 
population in all cases, after single cross-over 
enrichment, supports the hypothesis that bigger colonies 
may represent a merodiploid population. This was the 
predicted phenotype with the use of an allele replacement 
vector based on a plasmid carrying the pCB102 replicon, as 
previously observed by two different studies (Heap et al., 
2012; Cartman et al., 2012). According to observations from 
other studies, to enrich for single cross-over by growth 
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rate under antibiotic selection in other Clostridia, such 
as C. difficile R20291 and C. sporogenes, the Gram-positive 
replicons pBP1 (for C. difficile R20291) and pIM13 (for C. 
sporogenes) would be appropriate instead of pCB102 (Cartman 
et al., 2012; Heap et al., 2012).  
Introduction of the I-SceI expression vector pES288 in the 
co-integrant strains displayed a low resolution, with a 
maximum of 29%, which increased with subculturing, as 
previously discussed in chapter 3. However, the resolution 
observed in this study, as well as described in chapter 3, 
was due to I-SceI expression and not due to spontaneous 
second cross-over event as demonstrated by the lack of 
resolution after the introduction of pMTL82254 in the 
merodiploid strains INT10/1 and INT10/3 (pES2921 integrated 
in C. difficile 630∆erm chromosome). An intriguing 
observation was that introduction of pES288 did not always 
result in resolution of the merodiploid and it seemed that, 
for a particular gene deletion, a second cross-over event 
occurred in only one of the merodiploids that resulted from 
a right flank (RF) or left flank (LF) integration but not 
necessarily both.  For example, when pES288 was introduced 
into the merodiploids, resolution occurred in both fliC 
INT10/1 and INT10/3 both generated from LF integration, 
resolution occurred in pilT INT35/5 generated from RF 
integration but not in pilT INT35/8 generated from LF 
integration, and resolution occurred in fliCpilT 
383/35/INT2 generated by LF integration but not in fliCpilT 
383/35/INT1 generated by RF integration. Introduction of 
pES288 into the three pilA integrants (INT41/2, 41/2/1/2 
and 41/2/2/2) all generated by RF integration, did not 
result in resolution. It would be intriguing to test if a 
pilA integrant that had recombined via the LF could 
generate a second cross-over event. The resolution observed 
182 
 
according to integration site may be attributable to the 
positioning of Chi sites in relation to the integrated 
construct, and/or the distance that AddAB must translocate 
before encountering a Chi site.  
Deletion of the fliC gene in C. difficile resulted in a 
strain incapable of flagella-mediated motility. This 
phenotype agreed with the phenotype observed previously by 
two other groups when the fliC gene was insertionally 
inactivated (Twine et al., 2009; Dingle et al., 2011). 
Introduction of the complementation vector, pES196, into 
two ∆fliC strains, produced cells with a tumbling motility 
phenotype, as observed by wet mount microscopy. This non-
directional motility presumably prevented the strains from 
penetrating the soft agar medium, despite the EM 
observation that flagella were produced. The lack of a 
spreading phenotype in the soft agar was in contrast to the 
previously reported complemented strain containing an 
interrupted fliC gene were the spreading phenotype was 
restored (Dingle et al., 2011). The parental C. difficile 
strain containing pES196 showed a typical vigorous motility 
and a spreading phenotype in the soft agar medium, which 
excludes the possibility of adverse effects from flagellin 
overproduction. The observed phenotype of the complemented 
∆fliC strains may be attributed either to the out of frame 
deletion of the fliC gene or, alternatively, the deletion 
of the fliC gene may have also deleted a region that may be 
involved in the regulation of flagella-associated genes 
downstream, resulting in improper flagella function. Maybe 
a precise amount of FliC or other proteins is required for 
appropriate flagellar function. Immediately downstream of 
fliC is the CD0240 locus which encodes a 
glycosyltransferase enzyme. It has been shown that 
interruption of CD0240 results in cells that display a non-
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spreading phenotype in soft motility agar and produce 
limited amounts of flagellar filaments that are truncated 
in length (Twine et al., 2009). In addition, it is thought 
that the rotational force of the flagella motor is 
generated by the interaction between the rotor component 
FliG and the stator component MotA (Terashima et al., 
2008). In the genome of C. difficile 630, genes predicted 
to encode for FliG and MotA are located downstream of the 
fliC gene and an effect on their transcription and 
subsequent stoichiometry may be critical for flagellar 
rotation. Nevertheless, the non-flagellated ∆fliC 383 
strain was further used to search for presence of pili and 
twitching motility experiments. 
To characterize the isolated ∆pilT
 
strains, this study 
performed preliminary tests to investigate twitching 
motility. The measurement of colony expansion on the 
surface of agar or the interstitial surface revealed that 




, expanded to the same 
size. Moreover, there was no obvious difference in colony 




 strains.  These 
observations were in contrast to a previous study on TFP-
mediated motility in C. perfringens, where surface motility 
was abolished in a pilT mutant (Varga et al., 2006). It 
should be noted that these tests were only preliminary due 
to time constrains, and certain factors should be taken 
into account before the interpretation of results and 
future work is suggested. First, it is important to note 
that twitching motility at the macroscopic level varies 
between different species and in vitro culture conditions 
need to be optimal for twitching to occur (Semmler et al., 
1999; Mattick, 2002). For example, in N. gonorrhoeae and N. 
meningitidis twitching zones formed from surface-grown 
colonies are so thin they can only be visualized 
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microscopically (Wolfgang et al., 1998; Mattick, 2002). In 
vitro culture conditions that have been reported to 
influence (stimulate or inhibit) twitching motility, 
particularly the composition of the growth medium include; 
nutrients or other compounds that influence the osmolality 
conditions, viscosity, hydrophobicity, tension of the 
medium surface i.e. tryptone, yeast extract, sucrose, 
glucose, mucin, bovine serum albumin, salts (e.g. NaCl, 
KCL), agar concentration, surfactants (e.g. Tween 20)and 
polyvinylpyrrolidone (Henrichsen, 1983; Semmler et al., 
1999; Huang et al., 2003; Pamp and Tolker-Nielsen, 2007; 
Burrows, 2012). In addition, available humidity and 
smoothness of the surface are also influencing factors, 
with the latter being important for the agar-air surface 
translocation experiments (Henrichsen, 1983; Semmler et 
al., 1999).  
In the current study, both surface and subsurface 
translocation were tested using various growth media, 
including Blood, BHI and AIM agar without glucose or with 
varying glucose concentrations. Plates were all kept in a 
sealed bag to maintain humid conditions, although for the 
agar-air surface translocation motility assay the agar was 
set against air possibly resulting in an unsmooth surface. 
However, the edges of the expanded colonies, whether grown 
on the agar surface or subsurface, were not examined 
microscopically in search of cell protrusions or raft 
arrangement indicative of twitching cells, or for any other 
subtle differences that may not be visible to the naked 
eye. Spotted cultures on the surface of agar medium 
containing high glucose concentration (1-2%) produced a 
thin outer cell zone and it would be intriguing to see the 
arrangement of these cells microscopically. In P. 
aeruginosa (where twitching motility has been extensively 
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studied), microscopic examination of the edges of the 
twitching zones at the interstitial surface between a glass 
coverslip and growth medium, the wt PAK strain which is 
capable of twitching shows typical twitching zone with 
large rafts, while the PAK pilA mutant strain not capable 
of twitching does not produce any rafts (Semmler et al., 
1999; Huang et al., 2003). In C. perfringens, observation 
of the edges of surface grown colonies by time lapse 
microscopy revealed the migration of cells as multicellular 
curvilinear shaped flares which were similar to those 
produced in M. xanthus via TFP-dependent social motility 
(Varga et al., 2006). These flares are not formed in a C. 
perfringens pilT mutant, but they are formed in a 
complemented C. perfringens pilT mutant (Varga et al., 
2006). In a recent study, microscopic visualization of the 
edges of colonies of C. difficile 630, grown between a 
glass surface and BHI agar medium (0.7% agar)in a glass 
bottom dish, revealed diffuse edges with directional 
protrusions which resembled those produced by C. 
perfringens TFP-mediated motility (Reynolds et al., 2011). 
This may suggest that twitching motility does occur in C. 
difficile and exclude the possibility that even if TFP 
retraction occurs in C. difficile via the putative 
retraction protein PilT, it may not be involved in 
twitching motility. This is the case with EPEC where TFP 
bundle-forming pili can retract but are not involved in 
twitching motility (Giltner et al., 2012).  Perhaps an 
experiment similar to the one used by Reynolds et al. 
(2011) with the same growth medium and glass bottom dish 
could be performed with the strains isolated in this study 
before any conclusions on twitching motility are formed. 
Further to this, it has been demonstrated that TFP are 
produced mainly by cells in the outermost zone of the 
expanding colonies, where twitching motility is actively 
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taking place, than across the whole colony (Semmler et al., 
1999; Henrichsen, 1983). Therefore, in future searches for 





via electron microscopy, samples would be best prepared 
from the leading edge of the bacterial growth, by flooding 
the colony edge with a drop of negative stain or other 
liquid and floating the grid on top of the drop, allowing 
the attachment and the selection of the most actively 
twitching cells on the grid. It would be interesting to see 
if electron microscopy of the ∆pilT
 
strains isolated in this 
study would reveal hyperpiliation or lack of TFP production 
on the surface of cells. Electron microscopy examination of 
the strain ∆fliC 383, grown on different media, for the 
presence of pili used samples prepared from the whole 
colony. Although many cells were examined, none were 
observed to produce pili, which might indicate that TFP 
expression is regulated and may only be expressed in 
certain cells under certain conditions. Previous studies 
reporting possible TFP expression in C. difficile and the 
presence of type IV pilus-associated genes in the C. 
difficile genome encoding all genes required for TFP 
biosynthesis and assembly, support this hypothesis 
(Sebaihia et al., 2006; Stabler et al., 2006; Janvilisri et 
al., 2009; Goulding et al., 2009; Borriello et al., 1988). 
It would be intriguing to test whether pili are observed on 
∆fliC cells at the colony outer edge. Perhaps a future 
experiment may involve fusing the pilT gene to a reporter 
gene and investigating its expression under different 
conditions, which may shed light on the optimal conditions 
required for TFP gene expression.  
The last aspect of this study involved the investigation of 
an intergenic region located upstream of the C. difficile 
TFP-associated genes, which might potentially be involved 
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in regulation. Preliminary qualitative results suggested 
that a promoter may exist between 100 bp and 500 bp 
upstream of the CD3513 locus. The thiamphenicol resistance 
displayed by the C. difficile strains containing pES2244, 
pES2246 and pES2247 suggested that transcription is 
initiated in the 500 bp region upstream of the CD3513 
locus. This observation contrasts with the lack of pili 
obtained from the ∆fliC 383 electron microscopy data. An 
explanation for this may be that low levels of catP 
transcription are sufficient for resistance, while a high 
level of transcription of TFP associated genes may be 
required for TFP production. In M. xanthus, a minimum level 
of pilin expression is necessary (more than 50% of the 
maximum wt level) for efficient pilus assembly and motility 
(Jelsbak and Kaiser, 2005). Further research is required 
for any conclusions to be formed which includes, the 
quantification of the catP expression under appropriate 
conditions in the strains containing the catP reporter 
recombinant plasmids and the identification of the 5’ 
transcription start site for the TFP operon.  
In C. perfringens carbon catabolite repression (CCR), a 
regulatory mechanism that responds to carbohydrate 
availability, regulates TFP-dependent gliding motility, 
where the catabolite control protein (CcpA) plays a central 
role acting as a repressor or activator (Mendez et al., 
2008). In the presence of glucose (1%) gliding motility is 
inhibited through the CcpA-mediated repression of pilT and 
pilD genes, while in the absence of glucose CcpA positively 
regulates gliding motility. Moreover, in C. perfringens 
TFP-mediated gliding motility is necessary for optimal 
biofilm formation that is dependent on a functional CcpA 
protein (Varga et al., 2008). C. difficile has all genes 
involved in CCR and recently, it was shown that CcpA is 
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involved in the glucose-dependent repression of C. 
difficile toxin genes, tcdA and tcdB, by binding directly 
to their regulatory regions (Antunes et al., 2011). 
Therefore, questions that arise are, whether the intergenic 
region is subject to glucose catabolism and whether CcpA 
has a regulatory role in the expression of TFP genes in C. 
difficile.  
A molecule that is also considered as a candidate of future 
investigation for the regulation of the intergenic region 
and TFP genes is the second messenger c-di-GMP. C-di-GMP is 
synthesized by diguanylate cyclases (DGCs) that contain a 
GGDEF domain and is degraded by phoshodiesterases (PDEs) 
that contain an EAL or HD-GYP domain (Hengge, 2009). C. 
difficile encodes a large number of proteins, predicted to 
be involved in c-di-GMP metabolism.  The enzymatic 
functionality of many of the homologues was confirmed in V. 
cholerae (Bordeleau et al., 2011). The high number of 
functional DGCs and PDEs, encoded by conserved genes in the 
genomes of different C. difficile strains, indicates that 
c-di-GMP signalling is important in this organism and might 
play a role in regulating diverse phenotypes (Bordeleau et 
al., 2011). It has been shown that c-di-GMP regulates 
flagella-mediated motility in C. difficile (Purcell et al., 
2012; Sudarsan et al., 2008). A c-di-GMP riboswitch is 
located upstream of the large flgB flagella operon and this 
riboswitch functions as an ‘off switch’ in response to c-
di-GMP (Sudarsan et al., 2008). C-di-GMP decreases 
flagella-mediated motility and represses production of 
flagella by reducing transcription of flagellar genes 
(Sudarsan et al., 2008; Purcell et al., 2012). As 
mentioned, c-di-GMP regulates aggregate formation in C. 
difficile where aggregates are bound by structures that 
resemble pili (Purcell et al., 2012). Two c-di-GMP-related 
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proteins, namely FimX and PilZ, involved in TFP biogenesis 
have been identified (Burrows, 2012; Guzzo et al., 2009; 
Huang et al., 2003; Kazmierczak et al., 2006). In P. 
aeruginosa, FimX possesses both a GGEF and EAL domain and 
is implicated in TFP assembly and twitching motility 
(Kazmierczak et al., 2006; Huang et al., 2003). PilZ is 
required for TFP biogenesis and has various TFP-associated 
functions in different bacterial species including P. 
aeruginosa, N. meningitides and Xanthomonas campestris 
(Guzzo et al., 2009). In Xanthomonas spp. PilZ binds to 
PilB (a pilin polymerase) and to the EAL domain of XAC2398 
(a homolog of the TFP regulatory protein FimX of P. 
aeruginosa) and has been suggested that PilZ and FimX might 
regulate the function of PilB in a c-di-GMP-dependent 
manner (Guzzo et al., 2009).    
To conclude, TFP are important to the survival and success 
of many pathogens in infection and their surface location 
makes them targets for vaccine development. TFP in C. 
difficile may be expressed in vivo during infection and may 
be involved in biofilm formation and colonization (Goulding 
et al., 2009; Purcell et al., 2012). Therefore, pursuing 
further research to investigate the function of these pili 
in C. difficile (e.g. adhesion assays, biofilm formation) 
could be important in shedding light on the disease 
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Appendix I. Promoters predicted in the intergenic region located between 
the CD3513 locus and the prs gene using the BPROM (Softberry) program 
 
Length of sequence-      1087 
 Threshold for promoters -  0.20 
 Number of predicted promoters -      3 
 Promoter Pos:    968 LDF- 10.46 
 -10 box at pos.    951 ttttaaact Score    69 
 -35 box at pos.    932 tttact    Score    42 
 Promoter Pos:    309 LDF-  9.02 
 -10 box at pos.    294 ttatataat Score    75 
 -35 box at pos.    271 atgtat    Score    12 
 Promoter Pos:    646 LDF-  4.26 
 -10 box at pos.    631 gtgcaaaat Score    51 
 -35 box at pos.    613 tttaca    Score    47 
 
 Oligonucleotides from known TF binding sites: 
 
 For promoter at    968: 
       phoB:  TAATATAT at position     908 Score -  15 
      argR2:  TTTATTTT at position     927 Score -   7 
     rpoD17:  TTTTACTT at position     931 Score -   8 
     rpoD19:  TACTTAAA at position     934 Score -   8 
        crp:  TATACATA at position     942 Score -  13 
       tyrR:  TTTACAAT at position     970 Score -   8 
       phoB:  TAATATAT at position     977 Score -  15 
       tyrR:  AATATATA at position     978 Score -  15 
       lexA:  ATATATAC at position     979 Score -  12 
 For promoter at    309: 
       glpR:  TTCAAAAT at position     250 Score -   6 
       cysB:  TGTATATA at position     272 Score -  12 
       lexA:  TATATACA at position     274 Score -  13 
        crp:  TATACATA at position     276 Score -  13 
     rpoS17:  TTATATTA at position     289 Score -  14 
      argR2:  CATATTTT at position     309 Score -   8 
       nagC:  ATATTTTA at position     310 Score -   7 
     rpoD17:  TAGCAACA at position     316 Score -   7 
 For promoter at    646: 
       lexA:  TATATAAA at position     593 Score -  14 
       trpR:  TACTCTTT at position     640 Score -   7 
 
*Please note that this software is designed to identify promoters 
based on the E.coli sigma70 promoter consensus. Therefore may not be 
accurate for use in C. difficile.  
 
